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Abstract
Sleeping sickness caused by Trypanosoma brucei rhodesiense and transmitted by tsetse flies
(Glossina spp.) is a re-emerging zoonotic disease in eastern Africa. The disease may occur in large
scale epidemics or be maintained at endemic levels, but in both cases, it is transmitted by the fly
vector from the animal reservoir to humans. In Uganda, the principal animal reservoir is domestic
cattle.
This thesis explores a number of components of T.b. rhodesiense epidemiology in Uganda. Firstly,
unrest and cattle raids in some regions of Uganda has led to the depletion of the cattle population,
which has subsequently been restocked, resulting in a mobile national cattle herd. Following an
outbreak of sleeping sickness in the previously unaffected district of Soroti, eastern Uganda,
retrospective data were collected from cattle markets and used to assess the risk, over the period of
restocking, of importing cattle infected with T.b. rhodesiense. Secondly, a case-control study is
presented, in which the epicentre of the Soroti outbreak and the temporal and spatial changes in the
distribution of the affected villages are quantified. Thirdly, molecular epidemiological tools were
used to characterise parasite isolates derived from the Soroti outbreak, and, by comparing their genetic
structure to parasites collected in other regions, the parasite populations from which they were derived
have been determined, and aspects of the population structure of trypanosomes more generally
discussed. Finally, a retrospective analysis of clinical data from the 1900-1910 sleeping sickness
epidemic in southern Uganda was carried out. There has been some controversy over the species of
parasite involved in this outbreak (T.b. rhodesiense or Trypanosoma brucei gambiense), and the
analysis of the historical records definitively addresses this question.
The risk analysis using the cattle market data shows that in Soroti, 54% of animals traded in the
market in question originated from outside the district, from known sleeping sickness risk areas, and
that up to 12.5% of the monthly imports from these areas may have been carriers of T.b. rhodesiense
parasites. The theoretical impact that the alternative control options of mass chemotherapy or
selective treatment following screening by microscopy would have had on reducing this risk are also
considered, highlighting the limitations of field microscopy as a diagnostic tool for trypanosomiasis.
Results from the case-control study showed that the epicentre of the outbreak which started in 1998
was Brookes Comer cattle market, the site through which most of the cattle in the restocking
programme passed. Although residence in a village in proximity to the market was a highly
significant risk factor for becoming a sleeping sickness case at the start of the outbreak, the average
distance of cases to the market increased with time, indicating that the outbreak is expanding away
from that point source. The results of the molecular analyses confirm that the parasites circulating in
Soroti were similar to strains from the established sleeping sickness regions further south in Uganda,
and shed further light on the nature of trypanosome population structures. T.b. rhodesiense and T.b.
gambiense are distinguished primarily by the differences in clinical presentation; comparing the 1900-
1910 sleeping sickness data to a contemporary dataset of T.b. rhodesiense cases shows clearly that the
clinical course of the disease in 1900-1910 was identical to that seen at present in Uganda. These
results confirm that T.b. rhodesiense was present in Uganda at the time.
The results are discussed in relation to the management of human trypanosomiasis in the cattle
reservoir, with particular attention given to the implications of trypanosomiasis control polices aimed
at livestock but which also benefit the health of the human population. Policies aimed at controlling
disease in this way need to be made at a national level, and the importance of collaboration between
medical and veterinary authorities for zoonotic disease control is stressed.
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Resume
La maladie du sommeil, provoquee par Trypanosoma brucei rhodesiense et transmise par la mouche
tse-tse (Glossina spp.) est une zoonose re-emergente en Afrique de Test. La maladie peut survenir en
grandes epidemies ou se maintenir a l'etat endemique, mais dans les deux cas, elle est transmise par la
mouche depuis le reservoir animal vers les etres humains. En Ouganda, le principal reservoir animal
est constitue par le cheptel domestique.
Cette these examine differents aspects de l'epidemiologie de la maladie. En premier lieu, il est decrit
comment des troubles sociaux et des vols de betail dans certaines regions de l'Ouganda ont provoque
l'epuisement des populations de betail qui ont ete ensuite reconstitutes, la resultante etant un troupeau
mobile de betail a l'echelon national. A la suite d'un debut d'epidemie de maladie du sommeil dans le
district de Soroti en Ouganda oriental, qui jusque la n'en avait jamais ete affectt, des donnees
retrospectives ont ete collectees sur les marches de betail et utilisees pour evaluer le risque, pendant la
periode de restockage, de l'importation de betail atteint de trypanosomiase. En deuxieme lieu, l'auteur
presente une etude quantitative de cas-temoins, a partir de l'epicentre de Soroti de la distribution des
villages affectes, dans le temps et dans l'espace. En troisieme lieu, etat est fait des outils
d'epidemiologic moleculaire, utilises pour caracteriser les souches de parasites derivees de l'epidemie
de Soroti, et en comparant leur structure genetique avec celles de parasites collectes dans d'autres
regions, la population de parasites dont elles etaient derivees a ete determine. Finalement, une analyse
retrospective des cas releves pendant l'epidemie de maladie du sommeil en Ouganda du sud pendant
la periode 1900 a 1910 a ete effectue. Une controverse existe quand a l'espece de parasite concerne
par cette epidemie (T.b. rhodesiense ou Trypanosoma brucei gambiense), et l'analyse historique des
archives adresse cette question de fa?on definitive.
L'analyse du risque utilisant les donnees des marches de betail montre qu'a Soroti, 54% du betail
echange sur le marche en question provenait de l'exterieur du district, et de regions connues comme
etant des zones a risque pour la maladie du sommeil, et que jusqu'a 12,5% des importations
mensuelles depuis ces regions pouvaient avoir teste positif pour le parasite T.b rhodesiense. L'impact
theorique pour la reduction du risque entre les options de controle par chimiotherapie massive et par
traitement selectif faisant suite a un examen par microscopie, a aussi ete compare, tout en faisant
ressortir les limites de l'emploi de la microscopie sur le terrain en tant qu'outil de diagnostique pour la
trypanosomiase. Les resultats de 1'etude de cas-temoins ont montre que l'epicentre de l'epidemie de
1998 etait le marche de betail de Brookes Corner, carrefour ou avait transite la plupart du betail
pendant le programme de repopulation. Alors que le fait de resider dans un village a proximite de ce
marche representait un risque significatif d'etre victime de l'epidemie a ses debuts, la distance entre
les nouveaux cas et le marche allait en augmentant avec le temps, indiquant ainsi que l'epidemie
s'etendait de son point d'origine. Les resultats de l'analyse moleculaire confirment que les parasites
qui circulaient a Soroti etaient similaires aux types provenant de regions ou la maladie du sommeil
etait etablie plus au sud de l'Ouganda, et eclaircissent la nature des structures de la population de
trypanosome de fa?on plus generale. T.b rhodesiense et T.b gambiense sont distingues essentiellement
par des differences de presentation clinique. Une comparaison des donnees de l'epidemie de maladie
du sommeil de 1900-1910 avec les donnees contemporaines de cas dus au T.b rhodesiense montre
clairement que le cours clinique de la maladie de 1900-1910 etait identique au cours de la maladie
actuellement observee en Ouganda. Ces resultats confirment que T.b rhodesiense etait present en
Ouganda a cette epoque.
Les resultats sont discutes en relation avec le traitement de la trypanosomiase dans le reservoir de
betail, et une attention particuliere est portee a l'implication des politiques de controle du betail qui
pourront aussi beneficier a la sante des populations humaines. Les politiques destinees a un tel
controle de la maladie doivent etre elaborees a l'echelon national et l'importance de la collaboration
entre les autorites vet6rinaires et les autorites medicales dans le controle des zoonoses est soulignee.
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1.1 Zoonoses, emerging zoonoses and public health
Zoonoses are defined as "diseases and their agents which are naturally transmitted
between (other) vertebrate animals and man" (WHO, 1959), and can be either so
called accidental infections, or those for which humans are an obligate part of the life
cycle. Emerging and re-emerging infectious diseases are defined as communicable
infections of humans which are either newly recorded as infections, or more
generally for which the incidence has increased exceptionally in the past two decades
(CDC, 1994). A recent study (Taylor et al., 2001) was the first to comprehensively
enumerate all human infectious diseases, and concluded that of 1415 organisms
identified as causative of disease in humans, 61% were zoonotic; zoonotic species
are, in addition, twice as likely to be associated with emerging or re-emerging
diseases than non-zoonotic species. Public health efforts therefore need to be
directed at this important group of pathogens. Recently, interest in such diseases has
grown at the international level, with institutions such as the World Health
Organization (WHO) and the U.S. Centres for Disease Control (CDC) making
surveillance, applied research and control activities targeted at them a priority (CDC,
1994; Meslin, 1997).
The factors underlying disease (re)emergence are probably only partly related to
virulence of the organisms or other biological factors directly related to the
pathogens themselves. Significant social issues (e.g. civil unrest and poverty,
international travel), the breakdown of control programmes (often due to lack of
funds), resistance to anti-microbial treatments and resistance to pest control
compounds such as insecticides, ecological changes (often anthropogenic
environmental change) or other emerging diseases (e.g. HIV/AIDS), may allow
pathogens to emerge or re-emerge (Morse, 1995; Schrag & Wiener, 1995; Heymann,
1997). An important factor leading to disease (re)emergence, for zoonoses or
infectious diseases in general, is the contact of human populations with habitats
marginal to the distribution of humans. There are many examples of this, such as the
emergence of lyme disease in the USA (Dister et al., 1997; Kitron & Kazmierczak,
1997; Kitron, 1998), Echinococcus multilocularis in central China (Craig et al.,
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2000), malaria in the forest regions of southeast Asia (Fevre et al., 1999; Kidson et
al., 1999), leishmaniasis in many regions (Ashford, 2000) and finally Kyasanur
Forest Disease virus in India (LeDuc, 1989). Understanding the extent to which
these diseases affect rural communities and the significance of the zoonotic reservoir
in the maintenance and propagation of the causative organisms, is fundamental to the
design and implementation of control programmes.
Trypanosomiasis is a further example of a re-emerging disease (Molyneux, 2001b).
The incidence of infection with the causative organism has been increasing during
the second half of the twentieth century (see Figure 1.1). In Uganda, for example,
the parasite has recently spread to previously unaffected areas in the east of the
country. The investigation of that spread makes up the bulk of this thesis. In other
regions, such as Tanzania's Serengeti, sleeping sickness was recorded from the
1920s onwards (Geigy et al., 1971; Onyango et al., 1971), and following a long
period of apparent absence, cases have occurred recently, highlighted by a number of









Figure 1.1: Officially recorded cases of sleeping sickness in Africa from 1941 to 1998,
showing the extent of disease re-emergence in recent years; the reduction in number of
people screened is indicative of high under-reporting rates. Screening in this context is
by active case detection in affected areas. Data reproduced with permission fromWHO.
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1.2 Trypanosomes: basic biology and distribution
Trypanosomas are kinetoplastid protozoan parasites, with a wide potential host range
(see Section 1.4). In humans, two species-groups are of importance, Trypanosoma
cruzi, transmitted by reduviid bugs (Triatoma spp.) in South America, and
Trypanosoma brucei s.L, which is restricted to sub-Saharan Africa. There are two
sub-species of African human trypanosomes, Trypanosoma brucei gambiense and
Trypanosoma brucei rhodesiense. Generally, T.b. gambiense occurs in west and
central Africa and T.b. rhodesiense in East Africa (see Figure 1.2). A third sub¬
species of T. brucei s.l. is Trypanosoma brucei brucei, which is pan-African in
distribution and which affects cattle, but is not pathogenic to East African breeds
(Killick-Kendrick, 1971). Interestingly, the continental division between T.b.
gambiense and T.b. rhodesiense follows very closely the line of the African Rift
Valley. This and other biological differences between the parasites has led to the
suggestion that trypanosomes may have played a role in the exodus ofHomo sapiens
from Africa (Welburn et al., 2001a).
Figure 1.2: Recognised foci of African sleeping sickness superimposed on
African topography. The line divides the regions affected by Gambian (west)
and Rhodesian (east) sleeping sickness, shown in yellow and red respectively.
Foci data from WHO; USGS digital elevation data provided by Eric
Augenstein of Earthstar Geographies (USA).
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1.2.1 T.b. rhodesiense and T.b. gambiense
T.b. rhodesiense is an acute infection in humans, the condition of the patient
deteriorating rapidly as the parasite moves from the blood stream (early stage
infection) through to the central nervous system (CNS), which is diagnostic of late
stage infection. The pathology resulting from infection with the parasite is described
in detail by Kristensson and Bentivoglio (1999). Briefly, initial infection results in a
chance at the site of inoculation by the fly. The chancre, well illustrated by Moore et
ol. (2002), is a localised immune response resulting in inflammation. Parasites then
move to the lymph nodes and are disseminated in the circulatory system, multiplying
in both the blood and lymph. Following invasion of the CNS, inflammation of the
brain tissue occurs (meningo-encephalitis), as well as cellular infiltration of spinal
nerve tissue and inflammation of visceral organs. In the absence of treatment, death
usually occurs within 6-8 months (Apted, 1970; Odiit et al., 1997a).
T.b. gambiense, by contrast, is usually described as a chronic infection, often with a
long asymptomatic stage of several years, and a chronic meningoencephalitic
condition during the late stage (Apted, 1970). The important epidemiological
distinction between these clinical courses is the length of the incubation period and
the degree of disability resulting from infection (see Section 1.7.1). Debilitating
symptoms appear rapidly with T.b. rhodesiense, and human-tsetse-human
transmission which would require the patient to venture into tsetse habitat, is unlikely
to occur and thus to play an important epidemiological role. With T.b. gambiense,
however, the long, asymptomatic incubation period and apparently restricted host
range makes humans the most significant reservoir of parasites (Welburn et al.,
2001a). As humans are the main reservoir of T.b. gambiense, the most successful
disease control paradigm is human case finding and treatment. The detailed
epidemiology of T.b. gambiense, which will not be considered further here, has been
reviewed recently by Pepin and Meda (2001). Each year, over 300,000 cases of
African sleeping sickness (due to both parasite species) are reported on the continent,
although this is generally thought to be an under-estimate; 50 million people live in
risk areas (WHO, 1986), and as many of these have poor access to health care
facilities, under-reporting rates are likely to be high.
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T.b. gambiense was first described by Forde (1902) and named T. gambiense by
Dutton (1902). T.b. rhodesiense, then called T. rhodesiense, was first identified by
Stephens and Fantham (1910), in Zambia, and was first incriminated explicitly as the
cause of human sleeping sickness in Uganda by MacKichan (1944), in an outbreak in
the Busoga region. The organism responsible for outbreaks prior to this in Uganda is
a cause for discussion, and the issue is addressed in Chapter V. Sub-specific status
for the human infective trypanosomes was proposed by Hoare (1966). The life cycle
and morphology of the human infective trypanosomes, including the obligate fly
stages, are well understood (Vickerman, 1985); the details of the developmental
stages of the parasite are less important in the context of this thesis than the
transmission cycle, and the transmission cycle of T.b. rhodesiense (Baker, 1974) is
shown in Figure 1.3. The vectors of human and animal trypanosomiasis on the
African continent are flies of the genus Glossina. In eastern Uganda, the fly species
responsible is Glossina fuscipes fuscipes. Trypanosomes take approximately 20-40
days to develop in the tsetse host (Dale et al., 1995) depending on the susceptibility
of the fly, which remain infectious until the end of their lives, which last
approximately 5-6 weeks in the field (Welburn & Maudlin, 1999).
Figure 1.3: The transmission cycle of T.b. rhodesiense, after Baker (1974). In the
context of this thesis, the detailed life cycle of trypanosomes with the various
parasite stages, is not as significant as the transmission cycle. The former is well
described in Vickerman (1985). T.b. rhodesiense and T. b. brucei occur in a tsetse-
bovid-tsetse cycle. The occasional infection of humans with T.b. rhodesiense results
in sleeping sickness. The nature of human-fly contact and the acute nature of the
disease make it unlikely that humans act as a reservoir of infection. By contrast, in
T.b. gambiense, which is chronic, and for which the role of an animal reservoir is
uncertain, humans are the main reservoir (Welburn et al., 2001a). See text for
discussion.
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1.3 Description of southeast Uganda and the sleeping
sickness foci
Uganda lies astride the Equator (1.5°S to 4.2°N, 29.3°E to 34.9°E). The south¬
eastern region is characterised by a bimodal rainfall cycle, with dry seasons between
December and February and July to August. Peak rainfall is in the period April to
May and September to October. Most of the populated area of eastern Uganda is at
approximately 1100 metres above sea level, with drainage (other than the Nile River)
mainly as sluggish streams and swamp networks (Abaru, 1985). Annual average
rainfall in the region is approximately 1300 mm. and the maximum average
temperature is approximately 30°C (Philips, 1997).
1.3.1 Administrative structure
The largest administrative unit in Uganda is the district, of which there are currently
45. Increasing moves towards decentralization as a consequence of public sector
reform in the country is resulting in the creation ofmore districts by the subdivision
of existing ones. Below the district, are the county, sub-county, parish and village
levels. Each level is represented by a chairman, LCI for the village up to LC5 for
the district. The health infrastructure is presently based on health sub-districts
(Jeppsson, 2001), which, rather than corresponding to existing administrative
boundaries, correspond to the distribution of the population, such that heath service
provision is evenly distributed.
Trypanosomiasis caused by T. congolense, T. brucei s.l. and T. vivax all occur in the
domestic cattle population in south-east Uganda (P.G. Coleman, unpublished; E.M.
Fevre, pers. obs.). In terms of human trypanosomiasis, Uganda has the misfortune of
suffering from both T.b. gambiense and T.b. rhodesiense, although within Uganda,
the former occurs only in the north west of the country, west of the river Nile. T.b.
rhodesiense occurs in the south-east (see Figure 1.4). Sleeping sickness has been
recorded in Uganda since the start of the last century; the pattern of disease
occurrence has been defined by large epidemics separated by long endemic periods.
The most recent epidemic started in Kamuli, Iganga, Bugiri and Jinja districts - the
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Busoga region - in the last years of the 1970s. In the 14 years up to 1990, 40,000
cases were confirmed parasitologically in Busoga, with 6,000 additional cases in
surrounding regions (Smith et al., 1998).
Figure 1.4: District boundaries in Uganda, highlighting (in green)
those districts considered to be part of the "established foci" of
sleeping sickness. Blue shaded areas are areas of open water and
extensive swamp. The red dot is the location of Serere Health
Centre (see Chapter III).
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The first cases of sleeping sickness seen in Tororo district (now separated into
Tororo and Busia districts) were in the mid 1980s. Since 1987, over 12,000 cases .
have occurred in these two districts alone. The mechanism by which sleeping
sickness came into Tororo and Busia districts has not been investigated, but it is
likely that it was the result of an expansion eastwards of the Busoga focus to the
West. An outbreak in Soroti, discussed in Chapters H-IV, presents an opportunity to
study the spread of the disease in a way that was not possible previously, for reasons
linked to politics, advances in geographical data handling and limitations in the
technology available for the analysis of parasite strains.
Sleeping sickness incidence in Uganda varies annually. In 1998, during the current
"endemic period," a total of 1,247 cases were reported nationwide (COCTU, 1998).
Of these, 979 patients (78.5%) suffered from T.b. gambiense in the northwest
(including Sudanese refugees), and 268 (21.5%) suffered from T.b. rhodesiense in
the southeast of the country (including 15 Kenyan nationals who reported to
Ugandan health services and were treated by them).
1.4 Hosts and reservoirs of T. brucei s.l.
1.4.1 Wild hosts
Traditionally, the bushbuck (Tragelaphus scriptus) has been considered the
archetypal animal reservoir host for T.b. rhodesiense, as a result of the fact that a
human infective trypanosome was first isolated from this species by Heisch and
others (1958). Other wild animals, especially bovids, may also be hosts (Geigy et
al., 1971). These may include hartebeest (Alcelaphus buselaphus) and lion
(Panthera leo). In Uganda, there has been a drastic change in land use as pressure to
grow more food and more cash crops has increased since the 1940s. This, in
combination with political factors which influence land tenure and occupancy, has
resulted in changes in the natural environment. Although MacKichan (1944)
observed that game was plentiful in the mid 1940s, southeast Uganda currently
supports very little wild game and correspondingly few wild species of bovids
(Eltringham & Malpas, 1993). Few formal studies have been undertaken on this
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subject, but the work by Eltringham and Malpas {op. cit) relating to encroachment in
game reserves shows a reduction in natural forest cover and wild species abundance,
and can be taken as indicative of the general situation in agricultural areas of
Uganda. Work in south-western Ethiopia also suggests that anthropogenic changes
are having an effect on the tsetse population and consequently on sleeping sickness.
Some Glossina species that occurred there are no longer present, and game animals
are being hunted out to make room for raising domestic stock (Nigatu et al., 1992).
This part ofEthiopia may be a model for the changes that have already taken place in
Uganda.
1.4.2 Domestic hosts
A number of domestic animal species, including pigs, dogs, goats, sheep and cattle
may carry human infective trypanosome species (Stephen, 1970). Bruce and co¬
workers (1910; 1911) were the first to suggest that domestic animals might be
important in the epidemiology of trypanosomiasis, and attached particular
importance to cattle as a potential reservoir. Parasites isolated from domestic bovids
were able to produce patent infections in monkeys (Bruce et al., 1910). They state,
fore-shadowing the development of the veterinary public health discipline, that
"no branch of sleeping sickness investigation is of greater
practical importance than the identification of animals which
can serve as reservoirs of the sleeping sickness parasite"
(p.236).
Onyango et al. (1966) isolated T. brucei s.l. parasites from domestic cattle and
successfully infected a human, showing for the first time, that T. brucei s.l. had
zoonotic potential (that is, their isolate was T.b. rhodesiense). Their study was
conducted on the Kenyan shores of Lake Victoria, where a prevalence of T. brucei in
cattle of 21.2% was found (Onyango et al., 1966). Large numbers of cattle are kept
in East Africa, in intimate contact with humans. Both humans and cattle may also
have close contact with tsetse fly habitat. This makes cattle a potentially important
reservoir of parasites. Maudlin et al. (1990) found that 4.9% of cattle tested in
Iylowa county, southeast Uganda during 1988 were carrying T. brucei s.l. infections,
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and 25% of these were human serum resistant, indicating that they were probably
T.b. rhodesiense. In contrast to the above, Okia et al. (1994) insist that cattle do not
play an important role in the epidemiology of human sleeping sickness. They
questioned sleeping sickness patients and controls in southeast Uganda on their
behaviour, and observed that cases of sleeping sickness had fewer animals grazing
near areas of human-tsetse contact than controls. Other species of trypanosomes of
importance in Uganda, namely T. vivax and T. congolense, affect domestic cattle,
pigs, sheep and goats (Stephen, 1986).
If cattle are indeed a significant reservoir of human infective trypanosomes, treating
them, in the context of a bovine trypanosomiasis control programme, could
theoretically prevent human disease. Welbum et al. (2001a)1 have modelled the
impacts of this control technique, and found that it would have a significant public
health impact, in an established sleeping sickness focus. The model was based on a
previous model of trypanosome transmission (Rogers, 1988). It is a one vector
(tsetse) and two host model (humans and cattle); Welburn et al. (op. cit.) add an extra
component, that of the effects of drug treatment on both mammalian components of
the life cycle. They concluded that if > 60% of infected cattle are treated soon after
becoming infected with T. brucei, and if human treatments are maintained at a high
enough level (20% of cases) to prevent them from becoming a reservoir, the outbreak
will die out as the number of flies picking up infections and infecting both humans
and cattle with the parasites, will not be high enough. An important concept in the
study of infectious disease epidemiology is Rq, the basic reproduction number
(Anderson & May, 1992). If Ro is less than 1 (/?0<1), then each infected individual
gives rise, on average, to less than one new infection, and an outbreak would not
sustain itself. For values of Ro greater than 1 (Ro>l), the opposite is true as each
infected individual gives rise to more than one new infection. Reducing the size of
the animal reservoir in order to minimise the chances of human hosts becoming
infected with trypanosomes, as described by Welburn et al. (2001a), is the
application of the concept - keeping the number of infective vectors low enough such
that transmission of the disease is interrupted.
1 The article cited was partly the result of work carried out during the course of PhD study.
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1.5 Hosts of Glossina
Blood meal analysis is the most objective method for identifying natural sources of
food for tsetse (Weitz, 1970), and Weitz (op. cit.) notes that G.f. fuscipes, which is a
riverine fly, has adapted to feed on a variety of hosts due to the nature of the
ecological niche it occupies. Okoth and Kapaata (1988) studied the hosts of G. f
fuscipes during the recent epidemic in Busoga and Tororo by identifying the source
of blood meals in wild caught flies. Humans, bushpig (Potamochoerus porcus),
bushbuck and monitor lizards (Varanus niloticus) and bovids, including cattle, were
the main sources of blood meals. Mohamed-Ahmed and Odulaja (1997), working in
the Hoima Bay area of the Lake Victoria shore (in Kenya), reported a high
prevalence of blood meals on monitor lizards (Varanus spp.) by G.f fuscipes - up to
98.4%. The importance of the reptiles was emphasised by the concurrent low
monitor lizard density in the study area. Gouteux et al. (1995) found that, compared
to non-baited control traps, biconical traps baited with live monitor lizards caught 1.7
times more G. f. fuscipes, suggesting that the flies are in fact positively attracted to
the reptiles rather than simply feeding on them opportunistically. Flies were also
strongly attracted to cow urine, indicating a strong preference for these domestic
animals. Jordan (1995) has reviewed the use of a range of attractants in tsetse
control. Spath (2000), by contrast, working in West Africa, concludes that the
principle motivation for a fly to feed on any particular host is the general availability
of that host, and in an area where there are few mammals but abundant monitor
lizards, these are likely to play a more significant role. Flies, in short, feed on what
is available in their habitats. It should be noted that different species of fly in
different habitats may have different behaviours, including feeding preferences.
Although the existence of a reptilian host for the maintenance of certain tsetse
populations is likely, a reptilian contribution to the maintenance of trypanosomes is
uncertain, but would raise important epidemiological questions. Under experimental
conditions, V. niloticus maintained a patent infection of T. brucei for 2 weeks (Njagu
et al., 1999). The animals were, however, kept at 'ambient' temperature (the actual
temperature is not stated by the authors), which may not be representative of the field
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situation in which wide temperature fluctuations might occur. In the same study, out
of 19 lizards caught in Busia, Uganda, over 1.5 years, one was T. brucei positive. If
temperatures are consistently within the range allowing T. brucei to survive, it is
conceivable that the lizard could be a host. Further studies are required to quantify
the potential contribution of reptiles to trypanosomiasis epidemiology.
1.6 Treatment of trypanosomiasis
1.6.1 Treatment of human trypanosomiasis
There are relatively few drugs available for treating sleeping sickness, and with all of
these, there are issues of high toxicity, and hospitalisation is required during
administration (WHO, 1995). The choice of treatment is dependent on the parasite
species involved and on the stage of the disease; drugs for the treatment of late stage
disease are designed to cross the blood brain barrier in order to clear trypanosomes in
the cerebro-spinal fluid. T.b. rhodesiense is preferably treated with suramin or
melarsoprol (an arsenical compound) in the early and late stages respectively,
whereas T.b. gambiense is treated with suramin or pentamidine in the early stage and
melarsoprol in late stage disease (WHO, 1995; Van Nieuwenhove, 1999). There are
reports of clinical failures with melarsoprol in the treatment of T.b. gambiense (Burri
& Keiser, 2001; Matovu et al., 2001a), but no significant reduction in efficacy has
yet been demonstrated for T.b. rhodesiense. The alternative drugs for melarsoprol
refractory-late stage T.b. gambiense treatment are nifurtimox or eflornithine (Van
Nieuwenhove, 1999), but these cannot be used for T.b. rhodesiense.
1.6.2 Treatment of bovine trypanosomiasis
The drugs available for bovine use currently include the salts of only three
compounds, videlicet diminazene aceturate, homidium bromide/homidium chloride
and isometamidium chloride. Diminazine is used for curative rather than
prophylactic treatment, while latter two drugs have a prophylactic effect.
Trypanosomiasis control in cattle might be undermined by the development of
resistance to these veterinary drugs (Geerts et al., 2001). No serious reports of drug
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resistance have been made in Uganda; however, T. congolense resistance to
isometamidium chloride has been reported to in Kenya (Gray et al., 1993) and to all
available trypanocides in different parts of Ethiopia (Codjia et al., 1993; Afewerk et
al., 2000), and T. vivax resistance to all trypanocides other than diminazine has been
reported in Kenya and Somalia (Schonefeld et al., 1987). Drug resistance is thus a
potentially serious issue in Uganda.
1.6.3 Treatment of zoonotic trypanosome species
Although not yet a problem at the clinical level, recent in vitro studies (Matovu et al.,
1997) have shown a reduced sensitivity to diminazine and isometamidium of human
serum resistant (T.b. rhodesiense) stocks isolated in the Busoga focus in Uganda. In
that study, which set out specifically to test the potential usefulness of animal
treatments for public health purposes, parasites were found to have a reduced
sensitivity to both drugs simultaneously (multi-drug resistance). Combination
therapy may therefore be necessary for animal treatments, especially in areas where
animals are a reservoir of human infective trypanosomes (see White and Olliaro
(1996) for a discussion of the rationale of combination therapies). Drug resistance is
discussed further in Chapter VI.
1.7 Disease burden imposed by human sleeping
sickness
1.7.1 GBD study
The Global Burden of Disease study, undertaken under the sponsorship of the World
Health Organization (WHO), is a attempt to assess, in an objective manner and at a
global scale, the importance of different conditions that result in adverse health
outcomes, with the aim of prioritising interventions. Health problems are ranked at
the population level on the basis of deaths caused, termed 'years of life lost due to
premature mortality' (YLL), and disability caused by the health problem, termed
'years of life lived with a disability' (YLD). The severity of the disability resulting
from any particular condition is quantified, as shown in Table 1.1 (Murray, 1994;
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Murray & Lopez, 1994; Murray & Lopez, 1996). The disability weight ascribed to
sleeping sickness is 0.35 (Murray & Lopez, 1996), a Class 3 disability weight
(disability resulting in a limited ability to perform certain daily activities). The YLD
and YLL are combined, resulting in an estimate of the total Disability-Adjusted Life
Years (DALYs), such that the population-level impact of any disease problem can be
stated.
Disability weight Description of disability
0.096 Limited ability to perform at least one activity in one of the following
areas: recreation, education, procreation or occupation
0.220 Limited ability to perform most activities in the above 4 areas
0.400 Limited ability to perform activities in two or more of the above areas
0.600 Limited ability to perform most activities in all of the above areas
0.810 Needing assistance with instrumental activities of daily living such as
meal preparation, shopping or housework
0.920 Needing assistance with activities of daily living such as eating,
personal hygiene or toilet use
1 Death
Table 1.1: Disability weights and type of disability associated with each weight (Murray,
1994).
The most recent estimate of global disease burden by cause (WHO, 2001b) puts that
due to sleeping sickness at 1.6 million DALYs. Sleeping sickness thus ranks
approximately 80th (WHO, 1996) in comparison to the other major health problems
considered, including HIV/AIDS (90 million DALYs) ischaemic heart disease (56
million), lymphatic filariasis (5.5 million), multiple sclerosis (1.5 million) and
dengue fever (0.4 million).
1.7.2 T.b. rhodesiense specific DALY in Uganda
The published DALY estimates, with the disability weight given above, refer to T. b.
gambiense sleeping sickness. There are more cases of T.b. gambiense than T.b.
rhodesiense annually across Africa, but the burden incurred by communities affected
with T.b. rhodesiense may be greater. With reference to the criteria for selection of
disability weights (Table 1.1), acute sleeping sickness resulting from T.b.
rhodesiense infection should be classified as a Class 5 disability (resulting in
assistance being required for carrying out tasks essential to daily life), that is, a
disability weight during the episode of 0.81 (Murray, 1994). With that in mind, T.b.
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rhodesiense-specific DALY estimates have been calculated2 at a regional and local
level using data from Uganda. When accounting for under-reporting, the sleeping
sickness DALY score in the region of Uganda where this study was carried out was
161, while that for malaria in the same population was 271 (a ratio of 2:1). The ratio
of the number of malaria to sleeping sickness cases was 178:1. Simply in terms of
the number of cases, malaria thus appears 178 times more significant than sleeping
sickness. However, when disability and death are considered (using the DALY), the
relative importance of sleeping sickness is shown to be greater. There is a need,
therefore, especially at the local scale, to use properly weighted measures in
prioritising health interventions.
1.8 Importance of sleeping sickness research
The lack of safe drugs, compounded by the possible development of drug resistance,
and the need for better diagnostic tools for treating and detecting sleeping sickness is
an unfortunate reality. In terms of the epidemiology of trypanosomiasis, the fact that
the disease has not been successfully controlled in the 100 years since the aetiology
was first studied, is testament of the need to continue research on the subject.
Maudlin et al. (in press) point out3 that although much has been written on the causes
of sleeping sickness outbreaks, the subject has rarely been approached from a
scientific perspective. The disease is re-emerging across Africa, especially that
caused by T.b. gambiense, but also T.b. rhodesiense, which, as we have seen, has a
high disease burden. In the case of T.b. rhodesiense, two processes are seen to result
in this re-emergence. First, the historically recognised tendency of the disease to
expand rapidly from small foci and cause epidemics. Secondly, the spread of the
disease to areas previously unaffected. There is an important distinction between
these processes, and it is the latter that is principally dealt with in this work.
This thesis is divided as follows. Chapters II and III present a mechanism for the
establishment of a new sleeping sickness focus that has been observed in eastern
Uganda, and Chapter IV provides evidence, derived from molecular studies of
2 Work carried out during the course of this PhD research.
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parasites isolated in the field, for the origins of the parasites that were responsible for
disease in that new focus. In the light of the evidence presented in Chapters II-IV,
Chapter V analyses a set of historical data answering important questions as to the
causes of the most devastating sleeping sickness epidemic recorded in East Africa at
the start of the 20th Century. Chapter VI summarises the overall conclusions that can
be drawn and proposes an orientation for continued sleeping sickness epidemiology
studies in Uganda and more widely in East Africa.




the spread of disease
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2.1 Introduction
The importance of the animal reservoir of T.b. rhodesiense is discussed in detail in
Chapter I. This Chapter deals with movements of the cattle reservoir population in
Uganda, and the possible implications of those movements between 1995 and the
start of the Soroti outbreak in eastern Uganda in 1999 (Fevre et al., 2001). The
historical background to recent cattle movements through the region, and the
methods used in the study, are discussed in this section.
2.1.1 The Karimojong and raiding
The tribal lands of the Karimojong stretch from eastern central Uganda northwards to
the Sudanese border, and include Moroto and Kotido districts (see Figure 1.4). This
is an area characterised by a dry savanna climate, dominated by acacia trees and open
grassland (Otim, 1982). The Karimojong, a predominantly nomadic pastoral group
of people of Nilo-Saharan origin, are well adapted to their environment, and have
subsisted off this land for many hundreds of years. Their main subsistence
production is livestock and livestock-derived products, mainly cattle, but also sheep
and goats. Farming compliments this on a relatively small scale, although some sub¬
groups of the Karimojong practice arable farming more extensively (Emunyu, 1992).
Indeed, although in the discussion that follows the term "Karimojong" will be used
generically, it must be borne in mind that this is by no means a homogenous cultural
group, and that different clans have quite different behavioural characteristics.
In an anthropological work following a long-term study of the Karimojong, Dyson-
Fludson (1966) described in detail the relationship between Karimojong society and
their animal herds. A Karimojong statement he records reads:
"Everyone wants to find a wife, friends, happiness; to
become a man of importance and influence. Without cattle,
he cannot achieve any of these things. So each person thinks
to himself, 'Where shall I find cattle?' (And the answer is)
'From foreigners. So he resolves to go into enemy country
and kill for cattle." (p. 103).
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He later states that
"... .the herds of foreigners are a legitimate prize, and seizure
of them does not count as theft but as enterprising self-
improvement. It is laudable to kill foreigners of any age or
sex...." (p. 231).
The social changes that led to armed cattle raids started during the colonial period,
and continue to the present. Instability at various times has been exploited by the
Karimojong, as well as other opportunistic groups on the periphery of Karamoja,
resulting in large scale cattle raids. Innumerable social, ecological (Gray, 2000) and
political factors continue to drive the heavily armed Karimojong (Mirzeler & Young,
2000) to raid cattle within and out with Karamoja (Emunyu, 1992; Mamdani et al.,
1992; Ocan, 1992). Such raiding took place during the late 1980s and early 1990s.
The cattle population in Soroti district (see Figure 1.4), where livestock farming was
the basis of the economy, was reduced dramatically; estimates vary but the order of
magnitude of the reduction was from over 400,000 head to approximately 12,000 (D.
Mugenyi, pers. com.). That is, 97% of the animals were removed. As in other parts
of sub-Saharan Africa, cattle are kept as a "living bank" in Soroti (Becker, 2000;
Fevre, 2001), sold when the need for cash arises (such as paying children's school
fees). The dramatic loss of capital had severe social consequences, and resulted in a
considerable degree of emigration of the human population from Soroti at the same
time.
2.1.2 Restocking
Since the return of civil stability, the human population has been resettling in Soroti
and restocking has been implemented to renew the livestock population. Up-to-date
data on the size of the cattle population in Soroti are, however, lacking (the last
census was carried out before restocking), although one estimate (Anon., 1999) puts
it at around 80,000 - that is, since re-stocking began, the cattle population may have
grown by 68,000 head (660%), and is certainly still growing. Both government
(Angoru, 1999; Mufumba, 1999) and NGO funds (Herbert, 1999) have been
dedicated to the re-stocking process. By way of example, a UK-based NGO named
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'Send-a-Cow,' which operates in Uganda, recently raised £ 241,000 in donations to
fund cattle restocking in Uganda (Deedes, 2000), and has a project focussing on
sustainable development targeted at women's groups in Soroti district (Send-a-Cow,
1998). The restocking has mainly aimed at the individual farmer/family level, with a
system by which offspring of donated cattle are given to neighbours within the
village so that the whole community eventually benefits. This methodology is shared
by several organisations involved in such work (A.S. Mubiru, pers. com.).
Wellde et al. (1989a) reported that during an outbreak of T.b. rhodesiense sleeping
sickness in the Lambwe valley, Kenya, trypanosome-positive cattle that had been
ear-tagged in the study area were later found some distance away, on the shores of
Lake Victoria, where they were taken for trading. Eleven sleeping sickness cases
occurred in the vicinity, where G. f. fuscipes is also present, and the authors
concluded that, in general terms, cattle movements might have an effect on the
spread of sleeping sickness. The transportation of domestic livestock across long
distances, acting as reservoirs of the parasite, might thus be a potentially important
issue in the causation of sleeping sickness outbreaks within tsetse infested areas.
Wilde and French (1945), on studying the lack of pathology in cattle infected with
human-derived trypanosomes, also came to this conclusion.
2.1.3 Hypothesis and specific aims
It is hypothesised that livestock movements linked to restocking might have been
responsible for the introduction of sleeping sickness in Soroti. Here, a retrospective
study was carried out to investigate whether cattle from endemic areas have been
imported to Soroti as part of the re-stocking exercise. A separate, full analysis of the
outbreak itself is presented in Chapter III. The outbreak in Soroti began in December
1998. In that month, 16 cases were treated in Serere Health Centre (see Chapter III).
The specific aims of the work presented in this Chapter were to determine: 1) if
animals have indeed been imported into Soroti as part of a re-stocking process; 2) the
magnitude of the cattle movements into Soroti in the recent past; 3) the origin of the
imported animals, especially with regard to the sleeping sickness status in the sites of
origin; 4) how the risk of importing human infective parasites with these imported
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cattle varied through time; and finally 5) to determine the theoretical potential of
different control strategies to reduce the risk of importing these human infective
parasites. A quantitative risk assessment (Covello & Merkhofer, 1993) was carried
out to achieve these aims.
2.1.4 Risk assessments
Risk assessments are used widely in veterinary public health; for example, in
assessing the risks of importing a disease to a non-affected country along with live
livestock imports. Often, there is a legal requirement for such an assessment to be
carried out at national and international levels. Four entire volumes of the OIE
(Office International des Epizooties) scientific review have recently been devoted to
"risk analysis, animal health and trade" in 1993 (Ahl et al., 1993; Kellar, 1993;
MacDiarmid, 1993; Miller et al., 1993; Morley, 1993b; Morley, 1993a), "risk
assessment for veterinary biologicals" in 1995 (Metcalf & McElvaine, 1995; Moos,
1995), and two volumes in 1997, "contamination of animal products: prevention and
risks for animal health and for human health" (Galland, 1997; Vose, 1997).
The ultimate goal of a risk assessment procedure is to quantify risk and identify those
components of the process towards which interventions could be targeted, and
ultimately to implement some form of policy to reduce the risk posed by that
component. There are several steps in complete risk assessment, and these have been
described by Samet et al. (1998), Covello and Merkhofer (1993) and Ahl et al.
(1993). The assessment is a logical process; some important definitions relating to
risk are given in Table 2.1.
2.1.4.1 Stochastic or deterministic assessments
In common with other modelling applications, risk events can be described
stochastically or deterministically (Anderson & May, 1992). A deterministic model
does not involve chance at any stage, and is the more straight forward of the two
approaches. A stochastic risk assessment takes account of uncertainty, and rather
than assigning a particular fixed probability for a particular event, the probability of
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an event occurring can be sampled from a range of possibilities that have been
previously defined. The uncertainty inherent in the estimations is accounted for and






Elements or events which represent potential harm
The likelihood of occurrence of an (adverse) event; a measure of the probability
ofharm
The process of identifying and evaluating the risk of a specific hazard, in either
absolute or relative terms. This process may include estimates of uncertainty
An overall process of risk assessment, and the management of risk
Table 2.1: Relevant definitions relating to the study of risk. Adapted from Ahl et al. (1993).
In most cases, the assessment of risk involves breaking down an event into sequential
parts; thus, the overall risk of spreading a disease through the movement of livestock
from one place to another or the risk of introducing livestock pathogens into the food
chain can be modelled by quantifying the chances of particular events occurring at
each stage in the process. In addition, the efficacy of prevention and control
interventions, such as carcass disinfection in an abattoir or screening at entry sites,
can be accounted for at each stage. The overall risk in such a model is a function of
the probability of individual outcomes occurring, and is dependent on the input
probabilities for each stage in the process.
2.1.4.2 Case studies
Gale and Stanfield (2001) assessed the risk of transmission of BSE (Bovine
Spongiform Encephalopathy) to grazing cattle and to humans eating root vegetables
following the large-scale application of sewage sludge to farmland in the UK. The
potential risk is derived from the washing away of prion-contaminated particulate
matter from abattoirs in the sewage system. The risk of cattle contracting BSE
following consumption of prion-containing soil or of humans consuming prion-
contaminated soil with their root vegetables was assessed, taking into account the
number of BSE-infected cows reaching abattoirs, the amount of particulate material
from the cow carcasses entering the sewage system, the amount of sludge produced
from sewage, the probability of the prion particles surviving sludge treatment, the
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concentration of sludge on different types of farmland and the probability of the
prion particles being leached in the soil (Gale & Stanfield, 2001). The model used
was deterministic, in that the probability at each step was characterised by a single
value, rather than being drawn from a range of possible values, and the final risk was
similarly described by a single value. The risk of ingesting a prion unit from
unwashed root crops was thus estimated at 1.92 xlO"7 fD5o prion units per person per
year.
Alban et al. (2002) quantified the risk to humans of infection with Salmonella
typhimurium DTI04, a food-borne bacterial pathogen, due to consumption of cured
pork sausages in Denmark. They accounted for different prevalences of bacterial
contamination in locally produced and imported pork products, the effects of the
preparation process (mainly fermentation) on the survival of the bacteria and finally
the rate of consumption of pork sausage products in Denmark. The model used was
stochastic; for example, the prevalence of bacterial infection in pork was allowed to
vary for different batches of meat according to a beta distribution (Evans et al.,
1993), and the reduction in the quantity of bacteria present during processing and the
amount of pork sausage consumed by different age groups also varied according to
appropriate distributions. The product of the different components of the model
gives the final output, which was the number of potential diarrhoea cases due to S.
typhimurium DTI04 from pork sausage consumption each year. This was estimated
to be between 0 and 10 cases per year, with a mode of 4 cases per year. In a
stochastic model such as this, where a range of potential values are assigned to a
particular event (e.g. importation of S. typhimurium DTI04 infected pork) from a
given distribution, several simulations are run, selecting, at random, a particular
value for that event at each simulation from the distribution of potential values. The
final output, rather than being a single output, is a range of possibilities, with
confidence intervals for that range. The uncertainty inherent in the estimates of each
component of the risk are thus taken into account in the analysis.
Cleaveland et al. (2002) also used a stochastic model to carry out a risk assessment
for the development of rabies in humans bitten by domestic dogs in rural Tanzania.
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Based on official figures, rabies is responsible for the loss of 1.11 million DALYs
annually, worldwide (Fevre et al., 2000), but this figure is thought to be an under¬
estimate. The study in Tanzania was based on a number of disparate data sources,
including the prevalence of bite injuries, the distribution of bites on the body
(patients with bites near the head are at greater risk of developing clinical
symptoms), the probability of developing rabies following a rabid bite, the
prevalence of rabies in domestic dogs and the probability of receiving post-exposure
treatment. Values for the probability of developing rabies following bites to the head,
neck or arms were randomly selected from triangular distributions (Evans et al.,
1993) with defined limits, while the probability of receiving post-exposure
prophylaxis was assumed to be binomially distributed. The study found that,
depending on the source of dog bite statistics used, the actual number of rabies
deaths in Tanzania might be 10 to 100 times higher (for national bite statistics and
active surveillance, respectively) than officially reported rabies deaths in the country.
The risk of rabies to the rural population is thus considerable, and meaningful




2.2.1 Cattle and human population interactions
In order to examine broad relationships between human and cattle populations, data
on country-wide cattle and human populations were obtained from Rwabwoogo
(1998) and the 1991 (which is the latest) Ugandan National Population and Housing
Census (Government of Uganda, 1992b), respectively. Rwabwoogo (1998) is a
secondary data source, presenting data supplied by the Ministry of Agriculture,
Animal Industry and Fisheries, from 1993. The resolution of these data was the
District level. The preferred resolution for such data is the sub-county level as this
level is more relevant to the demographic pattern of the region. However, sub-
county data were unavailable.
2.2.2 Cattle tracing
A retrospective study of cattle trading in a livestock market in Soroti District was
undertaken between October and December 1999. The investigation was centred on
the principal site involved with restocking in Soroti, Brookes Corner Market (D.
Mugenyi, pers. com.). The site was chosen on the basis of discussions with the
veterinary authorities locally. Kimwanga market in Mbale district was also studied
as it was found to be a major supplier of livestock to Brookes Comer market.
The data were acquired from local government veterinary records collected by staff
working in the market; it is a legal requirement in Uganda for the owner of any
livestock animal (sheep, goats, cattle) transported to market to carry a movement
permit. These permits are issued by the chief administrator at the site of origin (for
example, the Local Council Chairman), and are collected by the District veterinary
staff upon arrival at the market. The name of the owner, the number and type of
animals transported and the point of origin are recorded. Upon leaving the market, a
new movement permit is issued, and if the animal has been sold, the price paid is
also recorded. Point of origin information is usually recorded to the sub-county level
if the animal originated within the district; if it was sourced outwith the district
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boundary, the district of origin or the name of the market of origin was usually
recorded. Animals presenting a risk of harbouring human infective trypanosomes
were assumed to be those sourced within districts that are part of the traditional
southeast Uganda sleeping sickness focus (Kamuli, Tororo, Iganga, Mukono and
Jinja), as shown in Figure 1.4.
The records for Brookes Corner (Soroti District) and Kimwanga (Mbale District)
markets were entered into a database (Microsoft Excel®). The data covered the four
years leading up to the study. Data prior to this time are unavailable as a result of the
civil unrest in the region. Both markets are held once a week, and market records
were thus entered as weekly units and agglomerated to monthly units for the
analysis. A proportion of cattle are known to be unofficially transported and sold,
and these are, by definition, not included in the market data, which represent only
official movements. Field veterinary staff with whom discussions were held
estimated that an additional 10-25% of the market sales are traded unofficially.
2.2.3 Risk assessment
A quantitative risk assessment was carried out to estimate the risk of human infective
parasites entering Soroti through Brookes Corner market, and to determine the
theoretical effects, in terms of reducing this risk, of two different control options that
could have been applied over the period (mass treatment or selective treatment
following microscopy diagnosis). A number of parameters determine the overall
risk, as represented in Figure 2.1. The risk assessment model used was based on that
of Covello and Merkhofer (1993), which is summarised by Wooldridge (1996). The
hazard in this study was the importation of cows from sleeping sickness endemic
regions that were potentially carrying T.b. rhodesiense.
2.2.3.1 Data quality and parameter estimation
A stochastic model was used to estimate risk, and the risk was determined in terms of
the number of animals imported per month infected with T.b. rhodesiense, referred to
here as the risk per month during the restocking process. Input parameters were
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drawn from various sources, as detailed below. A Monte-Carlo simulation was run
in the @Risk version 4.0 software package (Palisade, Newfield, NY, USA);
probability distributions were attached to each input parameter, and the model was
run for 1000, 5000 and 8000 iterations. Convergence was reached between 5000 and
8000 iterations, and 8000 iterations were taken as the final output. At each iteration,
the value of each input parameter was sampled at random from within the defined
probability distribution for that parameter (see Table 2.2). The characteristics of the
different distributions used are described by Evans et al. (1993). Of all animals
traded, 12.7% (95% CI 11.5-13.9%) were from unknown areas, and were excluded
from the analysis. The period under study was from April 1996 (start of the
restocking) to December 1998 (start of the outbreak). Data from January 1999
onwards (restocking in Brookes Corner continued until approximately the start of
2001) were excluded. Not all the weeks during the study period are represented by
the data, due to either markets not being held (such as for security reasons or closure
due to foot-and-mouth quarantine), or missing data. In particular, data for the final 3
months before the outbreak started were unavailable. The estimates of the volume of
importations are therefore conservative.
2.2.3.2 Monthly imports
2.2.3.2.1 Kimwanga market records
Kimwanga market in Mbale District was the major source of animals to Brookes
Corner. Kimwanga is outside the sleeping sickness area; however, the data from
Kimwanga market, relating to 1998, showed that on average, 37.2% (95% CI 35.7-
38.7%) of the animals traded there originated in Tororo District, which does lie
within the risk area. For each month, therefore, the number of animals recorded as
having arrived in Brookes Comer from Kimwanga that probably originated in Tororo
was determined. The probability of an animal from Kimwanga having originated in
Tororo was 0.372 (binomially distributed). The monthly number imported from
Kimwanga that originated in Tororo was the product of the monthly number from
Kimwanga and this proportion.
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2.2.3.2.2 Official imports
The total official monthly imports from risk areas (areas known to be affected by
sleeping sickness) was the sum of the recorded monthly number of animals from
districts affected sleeping sickness areas and the number of Kimwanga market
animals that had originated in Tororo.
2.2.3.2.3 Unofficial imports
On the basis of discussions with local field staff and the District Veterinary Officer
for Soroti, it was estimated that the unofficial imports to Serere from sleeping
sickness areas was between 10-25% of the total imports from those risk areas. The
proportion of unofficial imports in each month, and at each iteration of the model,
was determined from these data, using a Beta Pert distribution, which is similar to a
triangular distribution in which the mean is less dependent on the maximum and
minimum values of the distribution (Palisade Corporation, 1997). The total number
of unofficial imports from the risk areas was then estimated for each month, from the
data on official imports, using a binomial distribution.
2.2.3.3 Proportion of T. brucei s.l. infections
Recent parasitological studies in Tororo District showed that the prevalence of T.
brucei s.l. in the district was between 1-6% (Magona et al., 1998) and 0-1.4%
(Magona et al., 2000), using the Buffy Coat Technique, BCT (Murray et al., 1977)
for the former and the Haematocrit Centrifugation Technique, HCT (Woo, 1970) for
the latter. However, a more recent study4 (unpublished obs.) has shown that
microscopy has a very poor sensitivity compared to diagnosis using the Polymerase
Chain Reaction (PCR); the prevalence by PCR in two livestock markets in Tororo
District (Omonyole and Tuba markets) in 2001 was 28% (95% CI 19.2-36.8). The
proportion of animals imported to Brookes Corner from all risk areas and estimated
to be carrying T. brucei infections was therefore taken to be binomially distributed
and assigned a probability of 0.28.
4 Carried out as part of this project
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2.2.3.4 Proportion of T.b. rhodesiense infections
Very recent work in Soroti district, carried out as a result of the preliminary findings
of this project and using a novel screening technique (see Section 2.4.2.1) show that
up to 18% of all animals in the sampled areas are infected with T.b. rhodesiense
(Welburn et al., 2001b). There is no evidence, however, that the prevalence of T.b.
rhodesiense in Tororo was that high during the study period, nor is there evidence
that it has reached those levels anywhere outside Soroti District now; the novel
screening method for T.b. rhodesiense (Welburn et al., 2001b) has not yet been
applied to a representative collection of bovine samples from Tororo. Therefore, the
subset of T. brucei s.l. infections that are in fact human infective T.b. rhodesiense
was estimated as 23%, based on RFLP results obtained from samples collected
between 1988 and 1991 in Tororo (Hide et al., 1994; Hide et al., 1996).
2.2.3.5 Risk reduction
The data on importations of T.b. rhodesiense-infected cattle to Soroti through
Brookes Corner were used to assess the theoretical effects of two potential
interventions aimed at limiting the risk of importing these human pathogens in the
reservoir host. This was done assuming that one or other of two possible treatment
protocols was in place at the market, and that all animals in the market were
subjected to one of the protocols. No systematic control mechanism was actually in
place during the restocking process, but knowledge of the potential effectiveness of
different interventions is useful for understanding the best methods for reducing the
risk of importing infected animals in the future.
2.2.3.5.1 Effect of screening and selective treatment
First, the effect of screening cattle at the market by microscopy was investigated (see
Figure 2.2a). Despite the objection raised above to the use of microscopy, it remains
the mainstay of diagnosis at the field level. It was assumed that 100% of animals at
the market were screened. Unofficial imports were assumed to be unscreened. The
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sensitivity of microscopy was taken as 32.6% (95% CI 27.9-37.6), compared to the
gold standard which is PCR diagnosis with standard primers (Artama et al., 1992; de
Almeida et al., 1998; Kabiri et al., 1999). It was then assumed that all animals that
tested positive for T. brucei by this method were treated with diminazine, that drug
resistance was not an issue and that the efficacy of treatment was 100%. This is
reasonable in Uganda where resistance to the drug has not been conclusively
demonstrated in field isolates, although there is some evidence (one human-derived
trypanosome stock) of decreased sensitivity of T.b. rhodesiense to diminazine
(Matovu et al., 1997).
2.2.3.5.2 Effect ofmass treatment
Second, the effects of mass treatment with diminazine of all cows in the market
during the market day were investigated (see Figure 2.2b). Again, it was assumed
that treatment with the trypanocide was 100% efficacious, and that the correct dose
was always given. These treatments were only applied to officially imported
animals, so some risk of parasite importation through unofficial imports would still
exist.
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Parameter Distribution Estimate/Value
Number of official imports from
Kimwanga originating in Tororo
entering Brookes Corner each month
Number of official imports from other
risk areas entering Brookes Corner each
month




Total official imports from risk areas sum of official imports from Kimwanga
originating in Tororo and official imports
from other risk areas entering Brookes
Corner
Proportion of unofficial imports
originating in risk areas
Number of unofficial imports from risk
areas entering Brookes Corner each
month
Proportion of risk area cattle infected
with T. brucei spp.
Beta Pert min=0.1, mode=0.15, max=0.25
Binomial n=official imports from risk areas
p= proportion of unofficial imports
originating in risk areas
Binomial n=total imports (unofficial+official) from
risk areas
p=0.28
Proportion of T. brucei spp. that are T.b. Point
rhodesiense estimate
0.23
Proportion of risk area cattle infected
with T.b. rhodesiense
Number of unofficial risk imports that
are T.b. rhodesiense-positive each month
Number of official risk imports that are
T. b. rhodesiense-positive each month
field data x (proportion T. brucei s.l.
positive actually infected with T.b.
rhodesiense)
Binomial n=total unofficial imports
p=proportion of risk area cattle
with T.b. rhodesiense
Binomial n=total official imports
p=proportion of risk area cattle
with T.b. rhodesiense
Total number of T.b. rhodesiense-
positive imports entering Brookes
Corner each month
Number of T.b. rhodesiense-positive
cows detected by microscopy
total official T.b. rhodesiense-positive
imports + total unofficial T.b.
rhodesiense-positive imports
n=official risky imports that are
T.b. rhodesiense positive
p=probability of detection by
microscopy (=0.326)




Broad-scale relationships between cattle and human populations were not detected in
this study; the available cattle population and cattle population density data for the
traditional sleeping sickness districts in southeast Uganda (Iganga, Jinja, Kamuli,
Mukono and Tororo) did not show a significant relationship with the number of
sleeping sickness cases recorded (r2=0.006, p=0.9 and r2=0.03,/?=0.78, respectively).
This was also the case when the data were log-transformed. This may be the result
of the low resolution of the data, which obscures relationships at more realistic
biological levels. Higher resolution data for these parameters is not available in
Uganda.
60%
Potential risk area Intra-Soroti Unknown origin Non risk area
Figure 2.3: Origins of cattle traded at Brookes Corner during the study period.
Of those animals sourced from potential risk areas, a large proportion (36%)
were sourced from Mbale district (shown in orange).
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2.3.2 Cattle tracing
The Brookes Corner market records show that, of the recorded 2796 head of cattle
known to have been traded from April 1996 to December 1998, 54% (95% CI 52-
55%) originated from areas where there was a potential risk of infection with T.b.
rhodesiense. The origins of the traded animals are summarized in Figure 2.3. 26%
(95% CI 24-27%) of the trade in cattle at Brookes corner is accounted for by local
(intra-district) trade. The major sources of animals from outside Soroti are Mbale
(Kimwanga market) and Tororo districts.
2.3.3 Risk assessment: disease introduction
The monthly total and cumulative total of T.b. rhodesiense-infected cattle traded in
Brookes Corner market over the time period are shown in Figure 2.4. The monthly
numbers of T.b. rhodesiense-positive traded cattle were highly variable, with a peak
between October 1996 and June 1997, reflecting a peak in both the total number of
imports and the proportion of imports from known sleeping sickness areas. The
volume of livestock imports and the variations in their origins are likely to be
influenced by a number of external factors such as changes in the value of livestock
elsewhere in the country and the intensity of the restocking programme at any
particular time. Although the socio-economic aspects of cattle trading in parts of
West Africa are well understood (Josserand & Sullivan, 1979; Ariaz-Nino et al.,
1980; Delgado & Staatz, 1980), a comprehensive study of the driving forces behind
the cattle trade in this part of East Africa has not yet been carried out. The risk
assessment shows that over the study period, between 0 and 16 T.b. rhodesiense-
positive animals were imported each month. Over the entire period, a mean of 68
(95% CI 47-92 animals) T.b. rhodesiense infected animals might have been
imported. As there were several months for which data were unavailable (see
Section 2.2), this estimate is conservative. The estimate also assumes that the
unofficial imports were always between 10 and 25% of the official importations. It
is possible, however, that during months with few official imports, the proportion of
unofficial imports increased, and that the risk of introducing disease during those
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months was higher than estimated here (official closures ofmarkets due to foot-and-
mouth disease or other factors may have resulted in more unofficial trading).
During the months for which data are available, the mean proportion of all imported
cattle (all traded cattle excluding those originating in Soroti district) that were T.b.
rhodesiense positive per month was between 1-6% (see Figure 2.5), and may have
been up to 12% in some months. Given that tsetse are abundant in the area
surrounding Brookes Corner, and that the cattle that passed through the market were
usually taken to local homesteads as part of organised rural development
programmes (N. Machila-Eisler, pers. com.), it might have been advantageous to
implement control activities in this imported cattle population during restocking.






Figure 2.4: a) Monthly and b) cumulative imports of T.b. rhodesiense-positive animals to
Brookes Corner market. Error bars in a) show the 95% confidence intervals.
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Figure 2.5: Proportion of all imports (all traded cattle excluding those originating in Soroti)
that are T.b. rhodesiense positive. Error bars show the 95% confidence intervals.
2.3.4 Risk assessment: disease control
The effects of two alternate control options were modelled. Figure 2.4b shows that a
cumulative number of 68 (95% CI 47-92) T.b. rhodesiense infected animals passed
through Brookes Comer during the study period, when no control was implemented.
The first control scenario modelled in the risk analysis was microscopy plus selective
treatment of positives found by this method. In this scenario, 49 (95% CI 33-69) T.b.
rhodesiense infected animals would have entered Soroti through Brookes Comer,
which is not significantly different from the number entering in the absence of any
control (see Figure 2.6). This is the result of both unofficial trade that would not
have been screened, but especially the poor sensitivity of microscopy, highlighting
the inadequacy of field-based microscopy on bovine blood as an effective diagnostic
tool during control operations.
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Time (months)
Figure 2.6: Cumulative number of T.b. rhodesiense-positixe animals entering Brookes
Corner following either microscopy and treatment with trypanocides (in green) or block
treatment with trypanocides alone (in red).
Routine control in a market setting could also have involved block treatments; that is,
trypanocidal treatment of all animals in the market. The possible effects of such an
activity are also shown in Figure 2.6. Significantly fewer (11; 95% CI 4-18) T.b.
rhodesiense-infected animals would have entered Soroti if this control intervention
had been implemented in the market during the study period, compared to both no
intervention and to microscopy plus selective treatment. Those that would have
entered would all have been unofficially traded; unofficial trading would be difficult
to intercept with any type of intervention. The benefits and problems associated with
both types of intervention modelled here (mass and selective treatment) are discussed
in more detail in the next section, with additional reference to other disease systems.
48
2.4 Discussion
The results of the work presented in this Chapter emphasise that where livestock
trading is taking place with neighbouring areas that are endemic for diseases carried
by livestock, there is the potential for the diseases to spread, and that efforts may be
required to prevent this spread. This is especially the case with diseases such as
trypanosomiasis which are of substantial public health importance (especially if, as
in Serere, the local health infrastructure is not equipped to deal with the problem),
but also applies to other infections such as foot-and-mouth disease, which is also a
problem in eastern Uganda. A recent outbreak of foot-and-mouth disease in the UK
spread quickly as a result of the large scale movements of livestock (Gibbens et al.,
2001; Woolhouse & Donaldson, 2001). Uganda attempts to prevent the spread of
foot-and-mouth disease within its borders by shutting down livestock markets during
recognised outbreaks; it is a question of political will and financing to prioritise
diseases such as sleeping sickness in the same way.
2.4.1 Importation and transmission
It is certainly possible that one local tsetse could feed on one T.b. rhodesiense-
infected imported cow, and later feed on a human, resulting in clinical disease in that
person. In Chapter I, the evidence favouring the reservoir-tsetse-human transmission
cycle of T.b. rhodesiense over a human-fly-human cycle was discussed. In the next
Chapter, the start of a major outbreak of sleeping sickness is described; in the genesis
of a T.b. rhodesiense outbreak of that magnitude, with many cases reporting over a
short time from different villages, the single tsetse-single cow scenario is unlikely.
Rather, two possible alternate scenarios can be envisaged. The first is that a large
number of infected cattle were imported to Soroti through Brookes Corner over a
short time period close to the start of the outbreak, resulting in many tsetse
infections. However, the risk analysis presented here has shown that the actual
numbers of infected cattle that were imported to Serere through Brookes Corner was
probably not very large (up to 90 over the entire period with the data available), and
was spread over the entire restocking period. These were probably also widely
distributed to villages around the market. The second scenario is that following the
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importation of a number of infected cattle, as described by the risk analysis in this
Chapter, local tsetse transmitted the parasites between the infected imports and the
growing number (through restocking) of non-infected cattle. That is, the prevalence
of infection in the cattle and tsetse population increased over a period of time,
eventually reaching a level that made infection of a number of humans who were in
contact with tsetse habitats inevitable. Eventually, the T.b. rhodesiense prevalence in
cattle reached 18%, as reported byWelbum et al. (2001b).
With a given tsetse population, the probability of an outbreak, in simple terms, would
be a product of the probability of importation of T.b. rhodesiense in cattle and the
probability of transmission by the tsetse. WHO (2001a) discusses the probability of
the occurrence of a major epidemic given the introduction of a disease agent (in the
context of bio-terrorism). The occurrence of an epidemic, given a disease agent and
vector, is a stochastic process, partly dependent on R0, the basic reproduction
number, and Iq, the number of primary cases. Although estimates for these
parameters are available (R0 for T. brucei was estimated to be between 0.11 and 2.54
by Rogers (Rogers, 1988)), the theoretical context proposed by WHO (2001a)
applies only to much larger populations, and does not consider the outbreak situation
such as that in Soroti. It would be desirable to model the probability of transmission
of trypanosomes from (relatively) small populations of reservoir hosts to the human
population via the vector, in order to assist in the prediction of future outbreaks in
Uganda and elsewhere. Problems with such a modelling approach might include the
inadequate understanding of cattle distributions and their utilisation of habitat in
eastern Uganda; tsetse habitats are not uniformly distributed (detailed knowledge of
tsetse distributions is particularly lacking in Soroti District and sleeping sickness free
areas), and exposure of both cattle and humans to vectors and thus trypanosomes is
dependent on their contact with these habitats. Tsetse, habitat and cattle interactions
have been successfully studied elsewhere, including in The Gambia (Wacher et al.,
1993; Wacher et al., 1994) and the Sideradougou area ofBurkina Faso (de la Rocque




Welburn et al. (2001a) have argued that controlling T.b. rhodesiense in the animal
reservoir is the best way to reduce the incidence of sleeping sickness in the human
population. They modelled the effects of different levels of chemoprophylactic
coverage in cattle on the effective reduction in R0 for both T.b. rhodesiense and T.b.
gambiense. The Ro value for T.b. rhodesiense was reduced by almost 100% when
100% of cattle in T.b. rhodesiense areas were treated, as they are the principal
reservoir. This implies that mass treatment of cattle could theoretically reduce
transmission of T.b. rhodesiense from the reservoir to the human host. In the risk
analysis presented in this Chapter, mass treatment of cattle at markets was more
beneficial than selective treatment following microscopy, as a large number of
infected animals would have escaped detection (Figure 2.6) when using this latter
method. Mass treatment of a large enough proportion of the cattle entering through
the market might have reduced the risk of later transmission enough to prevent the
outbreak, despite the unofficial trading that is known to occur. Woolhouse et al.
(1997) tested Pareto's Principle (Pareto, 1906), termed the 80/20-rule, in the context
of the epidemiology of vector-borne and infectious diseases. This rule suggests that
only 20% of the host population accounts for 80% of the value of Ro, and that this
20% needs to be preferentially targeted in control campaigns to reduce contact rates
between infected reservoir hosts and tsetse. In the context of the importation of T.b.
rhodesiense parasites in cattle via livestock markets, it suggests that only 20% of the
cattle from risk areas might need to be treated to prevent disease importation, or at
least prevent widespread transmission of the parasite.
Mass treatment is not a novel concept; mass pentamidine prophylaxis (Van Hoof et
al., 1944; Waddy, 1970) has been applied in the context of T.b. gambiense control.
Shaw et al. (1999) have shown, for schistosomiasis resulting from infection with
Schistosoma haematobium in Senegal, that mass treatment may be a more
appropriate control option in terms of reducing worm burdens and infection levels
than targeted chemotherapy based on the observation of trematode eggs in urine.
Targeting the most significant 20% of hosts to reduce infection rates is often
practically difficult (Woolhouse et al., 1997), although in the case of both
schistosomiasis and ascariasis (caused by Ascaris lumbricoides), it is known that a
subset of the human population at risk does indeed carry most of the infections
making the targeting more straight forward. For schistosomiasis, this subset is
school age children (King et al., 1992; Bausch & Cline, 1995), and the targeted mass
treatment of this group is a cost-effective control strategy. Similarly, mass
chemotherapy with levamisole was effective in reducing the prevalence of A.
lumbricoides in a village in Nigeria, and adult infections were significantly reduced
in another village by selective treatment of children 2-15 years old (Asaolu et al.,
1991). Mass treatment has also been attempted in the context of other disease
systems, with varying success. Mass prophylaxis of malaria patients in Cambodia
and Thailand (Verdrager, 1986) was ineffective in reducing levels of infection with
P. falciparum and resulted in the development of drug resistance to chloroquine. In
contrast, the reduction in onchocerciasis prevalence and eventual elimination of the
disease as a significant public health problem from large areas ofWest Africa is the
result of mass chemotherapy with ivermectin combined with large-scale vector
control (Boatin et al., 1998; Kale, 1998; Mutabazi & Duke, 1998). Sexually
transmitted diseases have been controlled using targeted mass drug administration
(Boily et al., 2000), although coverage of both low and high risk groups must remain
high (over 80%), and mass treatment must reoccur often, for this to be an effective
strategy. The effective reduction in the prevalence of taeniasis due to the Taenia
solium has been shown following mass treatment of both humans and pigs with
praziquantel or niclosamide (Allan et al., 1997; Sarti et al., 2000), and a 90%
reduction in the prevalence and the interruption of transmission of lymphatic
filariasis due to Wuchereria bancrofti has also been shown (Ottesen et al., 1997), a
more effective strategy in the case of this parasite than selective chemotherapy
(Simonsen etal., 1995).
Cattle in a market are a subset of the potentially T.b. rhodesiense-infected
population, and mass treatment of the cattle in Brookes Corner that originated in risk
areas can be equated to targeted mass chemotherapy. Whether Pareto's Principle
applies to cattle infections with T.b. rhodesiense is not clear however, as most studies
on this population of host organisms have been cross-sectional rather than
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longitudinal. Longitudinal studies are ongoing in southeast Uganda (M. Eisler and I.
Anderson, pers. com.), and should assist in identifying subgroups of the cattle-
population that might carry more infections. Torr and Mangwiro (2000) found that
some cows within a cattle herd were more significant sources of blood meals to
tsetse than others, a finding which was particularly associated with the age of the
cattle, where older cows were fed upon more often. This older subgroup of cattle
was contributing disproportionably to the maintenance of the fly population, and
would thus also be a more significant potential reservoir of trypanosomes. If
Pareto's Principle does apply in this way, the development of a simple T.b.
rhodesiense screening test (Welburn et al., 2001b) would be of additional help in
specifically targeting T.b. rhodesiense-poshive animals. Such a test, for use in field
conditions, has yet to be developed (see next Section). Targeting would be beneficial
in reducing the T.b. rhodesiense prevalence in the cattle population, but would also
address the concern that mass trypanocidal treatments of entire herds might select for
higher levels of drug tolerance and lead to drug resistance (Barrett, 2001).
2.4.2.1 SRA
SRA, or serum resistance associated protein, first described by de Greef et al. (1989)
and de Greef and Hamers (1994), is a gene that confers resistance to human serum in
T.b. rhodesiense parasites, making them able to survive in the human host. The
insertion (transfection) of SRA into serum sensitive T. b. brucei by Xong et al.
(1998), rendering them serum resistant, confirmed its role. The presence or absence
of SRA in serum resistant (T.b. rhodesiense) or serum sensitive (71 b. brucei)
parasites collected in the field was shown by Welburn et al. (2001b), using a PCR
assay. Details of the mechanisms for serum resistance and lysis of trypanosomes in
human hosts are discussed by Milner and Hajduk (1999). Detection of the SRA gene
itself, or the protein for which it codes, could form the basis of a diagnostic test.
2.4.3 Cost-effectiveness of interventions
Although cost-effectiveness studies have recently been carried out in relation to 7. b.
gambiense control (Shaw & Cattand, 2001) and animal trypanosomiases more
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generally (Kristjanson et al., 1999), similar studies on T.b. rhodesiense control have
not been undertaken. Two major factors require consideration in assessing the cost-
effectiveness of trypanosomiasis control interventions targeted at cattle. The first is
whether chemotherapy of cattle is the most efficient means of control, rather than
treatment of humans or tsetse trapping. Welburn et al. (2001a) have shown that this
is probably the case, and cost-effectiveness analyses should thus focus on controlling
the parasite in the cattle component of the transmission cycle.
The question then arises as to whether mass or targeted chemotherapy, both
discussed in the previous section, is most cost-effective. The infrastructure costs of a
regular microscopy screening programme are considerable, and such screening has
been shown in the analysis presented here not to be very effective in reducing the
numbers of imported infected cattle. For human intestinal helminth parasites, for
which cost-effectiveness analyses are well developed, Bundy (1990) estimated that
screening with microscopy prior to treatment increased the cost of interventions 2-6
fold, while the overall effect ofmass treatment was actually greater (Evans & Guyatt,
1995). In addition, mass treatment interventions can be made even more cost-
effective by targeting known groups at particularly high risk, such as children in the
case of helminth infections (Evans & Guyatt, 1995), as already discussed.
The possible future development of an SRA-based screening technique for T.b.
rhodesiense has already been suggested (Welburn et al., 2001b). Such a test could
be similar to the dipstick diagnostic tools developed for field diagnosis of malaria
(Mills et al., 1999; Stephens et al., 1999), and it can be assumed that using this test at
the market level, to select animals for targeted treatment, would not cost more in
terms of infrastructure than blanket mass treatment (similar numbers of field staff
and other costs). If that were the case, it would be cost-effective to use if the
combined cost of the test itself, and the cost of the doses of diminazine for the
positive animals were less than the cost of treating all the animals in the market with
diminazine. If it is assumed, for example, that the cost per treated cow with
diminazine is US$ 0.5 (M. Eisler, pers. com.), on a market day when, for example,
100 animals are traded in the market, the cost of block treatment (manpower and
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infrastructure excluded) would be US$ 50. If an SRA test at US$ 0.3 was used, the
cost of screening all animals would be US$ 30 and the cost of treating 6 positives
(assuming approx. 6% prevalence), would be US$ 3, coming to a total of US$ 36. It
would thus be important that the cost of screening the animals be less than the cost of
treating them.
Controlling human trypanosomiasis by targeting the cattle reservoir would also
benefit livestock health (Fevre et al., 2001), as other species of trypanosome would
also be removed. In the absence of estimates of these overall benefits, however,
livestock-targeted chemotherapy against T.b. rhodesiense can be assessed in terms of
the reduction in human disease and the cost of this reduction in a new focus such as
Soroti. Goodman et al. (1999) considered the cost-effectiveness of different malaria
interventions in terms of DALYs averted, highlighting the need to rate potential
interventions according to an objective outcome such as the DALY. There have
been 168 sleeping sickness cases recorded so far in Serere (see Chapter IH). At a
cost of US$ 250 per complete treatment (WHO, 1998), the outbreak has cost the
health services US$ 42,000, which does not include lost production and other social
costs. If diminazine costs US$ 0.5 per treatment, 84,000 cows could have been
treated for the same cost, which is the equivalent of treating every imported cow at
Brookes Corner market for 53 years, at the importation rate shown by the data used
in this study. Clearly, policy decisions at the national level need to consider long
term costs and benefits in choosing a preferred prevention strategy.
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Chapter III:







Soroti district, which was, until 1980, part of South Teso district, lies in eastern-
central Uganda, bordering Lake Kyoga (see Figure 1.4). The latest national human
population census for Uganda (Government of Uganda, 1992b) counted 430,390
people in Soroti. The economy is mainly agricultural; 89% of the population live in
rural areas, and the remainder in urban areas. This is reflected in the statistics for
occupation, where 84.5% of the population in the district in the working age group
(15 years and above) is employed in subsistence agriculture, while the national
average is 70% (Government of Uganda, 1992a). This working age group is that at
most risk of contracting sleeping sickness due to occupational exposure (M. Odiit,
pers. com.), making the potential burden of disease heavy (see Section 1.7).
3.1.1.2 Sleeping sickness in Soroti
Sleeping sickness was identified in Soroti at Serere Health Centre6, in the southern
half of the district, in December 1998 by health staff from the Livestock Research
Institute (LIRI) in Tororo attending to referred patients. This was only the second
time in recorded history that sleeping sickness had been seen in Soroti, which lies
outside the traditional Busoga and Tororo foci in south-eastern Uganda. As a result,
an active surveillance activity was undertaken during January 1999, during which 14
cases were identified over 4 days. All cases showed symptoms consistent with
Trypanosoma brucei rhodesiense infection.
Tsetse control measures were implemented in Serere from February to July 1999,
through the deployment of insecticide-treated pyramidal 'Lancien' traps in the areas
around affected villages (Magona, pers. com.). Despite these measures, the outbreak
5 The work presented in this chapter has formed that basis of a published paper (Fevre et al., 2001).
6 Serere Health Centre was recently designated as a Hospital (Serere Hospital), but was still a Health
Centre at the time of the study, and will be referred to as such throughout.
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persisted, and between 31st December 1998 and 2nd August 2001, a total of 168 cases
were recorded. Some of the characteristics of the reported cases are shown in Figure
3.1 and Figure 3.2. There was a 1.18:1 male:female ratio in the cases. The case
fatality rate for treated sleeping sickness patients has been reported as 6% in Tororo
District (Odiit et al., 1997b); all patients who presented at Serere Health Centre were
treated, with a case fatality rate during the total time period in question of 4.8%.
77% presented with late stage symptoms.
Further studies by Odiit and colleagues (in prep) report that for each sleeping
sickness case presenting at Tororo over the past 15 years, up to 15 cases do not
present. That is, reporting rates among sleeping sickness patients are low, with as
few as 7% reporting to hospital. Death occurs in untreated T.b. rhodesiense patients.
There are many reasons for the low rate, including poor local knowledge of disease
symptoms and reliance on traditional treatments, as well as limited access to health
care facilities. These constraints are likely to be similar in Soroti, where the degree
of under-reporting is almost certainly considerable.
The only reported human sleeping sickness in this part of the country prior to 1998
was a single patient found with late stage T.b. rhodesiense in the late 1960s
(Onyango, 1967). There was some doubt over the history of this case as the patient
had recently travelled to and from Tanzania, a journey that would have taken her
through sleeping sickness endemic areas. The case did prompt an investigation,
where 650 people were examined. Apart from this one case, no parasitological
evidence for infection was found, although 2.9% of those tested had high levels of
IgM in their serum samples. The observation of high IgM levels is characteristic of
trypanosome infections (Omerod, 1970) as a result of the antigenic variation
undertaken by the parasites, although high IgM levels may also result from a variety
of other conditions (Mims, 1991) and is not strictly diagnostic. A cattle survey was
also undertaken (Mwambu, 1969a; Mwambu, 1969b) showing low levels of infection
with T. vivax, but no T. brucei s.l. were found. A survey of the fly population was
also carried out following the human case report (Persoons, 1967). G.f fuscipes was
the only fly species caught, and of 1800 flies, 0.1% (two flies) were infected with
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parasites that had pre-patent periods of between 5 and 7 days when injected into
mice, which the author (Persoons, 1967) suggests is indicative of T. brucei s.l.
infection. One of these strains was experimentally inoculated into a human, and
found to be infective. No other cases have been reported from this area of Uganda
since, and it has been considered sleeping sickness-free. Large tracts of the district
are, however, thought to be infested with the tsetse vector G. f. fuscipes (J. Magona,
pers. com), and Soroti lies within the fly belt (see Figure 3.6).
3.1.2 Hypothesis
In this chapter, it is hypothesised that the outbreak of sleeping sickness in Soroti
resulted from the introduction of human infective trypanosomes to a single point
source, from which they were disseminated. The sleeping sickness data are analysed
using both traditional and spatial epidemiological tools, in order to test this
hypothesis, and the evolving spatial dynamics of the outbreak are also investigated.
A diversity of tools exist for studies of this nature, and selection of a particular
methodology depends on the exact nature of the questions being asked of the data.
The principal tools available are given consideration in the sections that follow.
3.1.3 Case control studies
Case-control studies are useful tools in epidemiology when a sample of a specific
population or sub-population is analysed, and when it is necessary to have
complimentary information relating to the rest of the population for comparative
purposes. The diversity of uses of the case-control methodology, as well as the
principal issues arising during study design, are highlighted by Schulz and Grimes
(2002). Case-control studies differ from cohort studies (Grimes & Schulz, 2002) in
that they are necessarily retrospective. Final outcomes, such as HIV infection or
development of symptoms of asthma, are known at the start, and the proportion of
individuals with (the cases) and without (the controls) the final outcome and who
were all exposed to possible risk factors in the past, such as infection with herpes
simplex virus (del Mar Pujades Rodriguez et al., 2002) in the case of HIV, or
residence in proximity to a main road in the case of asthma (Venn et al., 2001), are
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compared. An essential aspect of case-control study design is the avoidance of bias
in the selection of controls. The controls and the cases must be derived from the
same population and must share the same population characteristics other than the
outcome of interest (Altman, 1997). One way of achieving this is by matching, such
that the controls for any one case are drawn from a particular age range that
corresponds to the age of the case. For example, in assessing the risk of intracerebral
haemorrhage and the effect of the type of physical activity undertaken by patients,
Thrift et al. (2002) matched cases by both age and sex. In matching, the power of
the analysis can be increased by matching more than one case for each control in a
one-to-many design (Woodward, 1999), although in a field situation, this many not
always be possible; a one-to-one design requires extra care with the selection of
controls, but properly designed studies of this nature will still yield useful findings
on the aetiology of disease.
3.1.4 Spatial statistics
Point data sets are relatively easily collected and can reveal many aspects of the
distribution of cases of a disease. The methods used to analyse such data sets vary
considerably depending on the purpose of the analysis, the type of data involved and
the characteristics of the population under study. Many examples of different sorts
of analysis of point data exist in the literature, although there is often little indication
of the relative merits of different tests in different contexts. A notable exception is
Wartenberg and Greenberg (1993), although among their conclusions for choosing
one methodology over another is 'common sense.' Many point data sets do not
represent the population as a whole; that is they do not include control points. Only
if control points are included can meaningful analyses be carried out.
3.1.5 The concept of spatial clustering
The identification of clusters of points within a defined geographical area may be
complicated for a number of reasons. For example, many datasets are averaged over
artificial administrative boundaries (such as parish- or national-level borders),
whereas real world processes are governed by geographical boundaries such as
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coastlines or climatic zones. These issues require consideration at both the statistical
analysis and mapping stages of a study. Also of importance is the fact that a
population is rarely distributed evenly in space; some areas (e.g. settlements) have a
higher population density, and are therefore more likely, by chance, to see cases of a
disease. Techniques are required to accommodate this (in the data collection
process, it can be accounted for by the case-control methodology). For diseases that
tend to affect particular age groups, confounding effects of age need to be
accommodated in any analysis of clustering (Kulldorff, 1997), and these effects may
also be accounted for by using a case-control design.
3.1.6 Moving window statistics
Early tools for cluster detection were able to provide likelihoods of a cluster being
present or not, but were unable to identify the cluster's location in geographic space.
The former are termed 'tests of clustering,' and the latter 'methods for detecting
clusters,' or 'moving window statistics.' The distinction between these is made by
Besag and Newell (1991), and moving window statistics are reviewed by Wakefield
et al. (2000).
Openshaw et al. (1987) developed a geographic analysis machine (GAM) which
identified clusters in a point data set by drawing a large number of circles offixed
size and determining which circle contained the greatest number of points. This was
then defined as the cluster. Turnbull et al. (1990) improved on this by fixing the
circle size depending on the size of the dataset, and running a Monte-Carlo
simulation to test the signifigance of the cluster identified. Anderson and
Titterington (1997) present a similar method. The method of Turnbull et al. (1990)
was further improved by Kulldorff and Nagarwalla (1995) and Kulldorff (1997), who
allowed the circle size to vary during each iteration of the analysis, and therefore
estimate the likelihood of a potential cluster from a theoretically infinite number of
circles of different sizes. The different methodologies are fully reviewed (with
reference to the supporting statistical literature) elsewhere (Kulldorff & Nagarwalla,
1995; Wakefield et al., 2000).
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3.1.6.1 The Kulldorff and Nagarwalla spatial scan statistic
The spatial scan statistic (Kulldorff & Nagarwalla, 1995; Kulldorff, 1997) moves a
circle systematically over the entire study area, centred at each permutation over one
of the points in the dataset. The size of the circle is allowed to increase up to a
defined size, ideally no more than to include 50% of the dataset in question
(Kulldorff et al., 1998). For each circle size and location, the observed number of
cases included in the circle is determined, and compared to the number that would
have been expected under the null hypothesis. The null and alternative hypotheses
are compared by maximum likelihood, as described in Kulldorff and Nagarwalla
(1995). The final scan statistic output is the maximum likelihood ratio as calculated
over all the different circle sizes tested. The probability, p, that this occurred by
chance is evaluated using a Monte-Carlo simulation. This procedure randomly
assigns points from the dataset as cases a pre-determined number of times, and
recalculates the test statistic using this randomly generated dataset. If the value of
the statistic calculated with the observed dataset ranks in the top 5% of the values
calculated with the generated data, the result is considered significant. The rank of
the actual statistic is the /7-value returned (Kulldorff& Nagarwalla, 1995).
Importantly, the output of an analysis with the spatial scan statistic is a probability
that clustering exists, and, if it does, that it exists in a defined location, returned as a
fixed point. This point location should not be taken too literally, however; the cluster
is most likely to occur somewhere within the given cluster radius around that point
(Kulldorff& Nagarwalla, 1995).
3.1.6.1.1 Bernoulli or Poisson
The spatial scan statistic (Kulldorff, 1997) can be applied with one or other of two
assumed distributions in a dataset, Poisson or Bernoulli. The Bernoulli model is
most suitable for binary data, that is, infected or not infected (case-control type data).
The Poisson model is more suitable for detecting clusters in data sets where the total
population at risk is known. In such a case, the spatial unit might be the same as that
in a population census (e.g. an administrative division). By either considering the
62
entire population (Poisson model) or using a control data set matched to the positive
disease points (Bernoulli model), the scan statistic also accounts for heterogeneity in
the underlying spatial distribution of the population at risk. In the case of the
Bernoulli model, the "representativeness" of the control points is dependent on the
stringency in the study design. It is assumed that the clusters of interest involve
clusters of positive points, where being positive means being affected by a disease.
Under the null hypothesis (Ho) in the Bernoulli model, the probability (p) of being
positive is equal to the probability ofbeing negative (q).
3.1.6.1.2 Examples: human medicine
An early application of the spatial scan statistic relates to a study of breast cancer
clustering in the north-eastern United States (Kulldorff et al., 1997). Census data for
the population under study was available (total population of women by county), so
the Poisson model was applied. Various possible confounders, such as age, parity
and race were adjusted for, and a principal cluster was identified in the New York-
Philadelphia urban area. The analysis was conducted using county centroids, which
resulted in a loss of resolution and a consequent inability to draw firm conclusions.
In Kossi, Burkina Faso, Sankoh et al. (2001) identified particular clusters of villages
that suffered from excess child mortality. This was carried out as a first step in
devising and targeting population-based health improvement activities, and, using
population census data and mortality surveys, spatial clustering that remained
consistent over a 5-year time period was identified. The data were suitable for the
Poisson model. Cousens et al. (2001) studied the distribution of cases of new-variant
Creutzfeldt-Jakob (vCJD) disease in the UK. Meat consumption was weakly
correlated with vCJD incidence, but, in general, their analysis of risk factors was
fairly non-conclusive. However, a significant cluster of 5 cases in the Leicestershire
region was detected using a Poisson model in SaTScan (the software environment
developed to run the spatial scan statistic - see Section 3.2.2.3).
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3.1.6.1.3 Examples: animal health studies
Work attempting to clarify the reasons for the emergence of Bovine Spongiform
Encephalopathy (BSE) in the UK in the late 1980s/early 1990s (Stevenson et al.,
2000a), and using parish centroids to represent the locations of affected cattle farms
(in common with other studies, a central point was used to represent the smallest
administrative unit), also used the spatial scan statistic. The Poisson model was used
as the distribution of cases was compared to the complete cattle population in the
country, and significant clustering was found in southwest England (most likely
cluster), Cheshire and Cumbria (secondary and tertiary clusters respectively).
Further studies went on to identify the reasons for this clustering (Stevenson et al.,
2000b; Wilesmith et al., 2000), which concluded that regional differences in the
methods of preparation ofmeat and bone meal were partly responsible. Norstrom et
al. (2000) used the scan statistic (with a temporal component) to identify clustering
of acute respiratory disease in Norwegian cattle, using a Bernoulli model. They
identified clustering in a limited number of veterinary districts, and suggested that
the clustering of the cases was indicative of an infectious origin of the disease. A
general discussion of spatial analyses in animal health can be found in Pfeiffer
(2000).
3.1.7 Definitions: sleeping sickness in Soroti
In the present chapter, a cluster of disease is defined as an area within the study
region in which the number of disease positive points exceeds that which would be
expected if the positive points were distributed in a random fashion. In other words,
that more cases are occurring in particular locations than in others. This is the
alternative hypothesis {Hi). The null hypothesis {H0) is that disease positive points
had an equal chance of occurring anywhere in the study region, taking into account
the underlying distribution of the population (Wartenberg & Greenberg, 1993).
Additionally, the interest is not only spatial, but also the temporal change in disease
distribution. The null hypothesis in the case of possible temporal change is that if
sleeping sickness does follow a clustered pattern, there is no change in the location of
this cluster over time, whereas the alternate hypothesis can be stated such that if
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sleeping sickness does follow a clustered pattern, the location of the cluster expands




A retrospective case control study was undertaken in Soroti District, eastern Uganda,
in June 2000. All the cases of sleeping sickness recorded by Serere Health Centre up
to this time were entered into a database. All the cases had presented from within the
catchment area of the Health Centre, which extends to Serere and Kasilo counties,
covering an area of 1967 sq. km. The area served by the health centre is
homogenous with regard to ethnicity, the principal occupation of the inhabitants
(subsistence agriculture), livestock production systems and other population
characteristics.
3.2.1.1 Cases
All sleeping sickness cases were considered for inclusion, but any case lacking
complete data for age, sex, month of admission or place of residence at the time of
contracting the disease was automatically excluded.
3.2.1.2 Controls
Each case was matched with one control, on the basis of age, sex and month of
admission to the health centre. The age classes used were <1, 1-9, 10-14, 15-19, 20-
49, 50-64 and >65 years. The health centre inpatient, outpatient, tuberculosis, and
maternity ward records were used, in that order of preference, to find a control for
each case. Over 50% of controls were drawn from the inpatient records. Patients
diagnosed with any vector-borne disease (including malaria) were excluded, given
the possibility that similar vector habitats might bias the results. Patients were also
excluded from being controls if a definitive diagnosis or details of village of
residence were not reported or if they were referred from another health unit. All
controls resided within the Serere Health Centre catchment area.
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3.2.1.3 Georeferenced data
The basic unit of analysis was the village. Village population sizes in the study area
range from under 100 to 1000 people. Village locations were recorded using a
Garmin GPS//+ hand-held global positioning system (GPS). Readings taken with
this instrument have been accurate to within ±20 metres since the United States
military removed the selective availability signal on May 2nd 2000 (Clinton, 2000).
This study was conducted after that date. The data were entered in Microsoft® Excel,
and geographical manipulations were conducted in the ArcView version 3.1
Geographic Information System (ESRI Systems®, Redlands, CA, USA), in which
Euclidean (straight line) distances from each case and control point to Brookes
Corner livestock market, were calculated.
Base layers of geographical data were obtained from the National Biomass Study of
the Uganda Forestry Department (Uganda Forest Department, 1996), and geographic
projections for all the collected data were transformed to conform to this dataset
before any distance calculations were carried out (see Table 3.1).
Map projection - Transverse mercator
Spheroid - 1880
Central meridian - 33
Reference latitude - 0
Scale factor - 0.9996
False Easting - 500,000
False Northing - 200,000
Table 3.1: Projection details for the National
Biomass Study dataset (Uganda Forest
Department, 1996).
Distances were calculated in ArcView using the Nearest Features version 3 add-in
(developed by Jeff Jenness7). Distances between points were calculated from






3.2.2.1 Distance varying with time
Analysis of covariance (ANCOVA), conducted in GLIM v. 4 (Crawley, 1993), was
used to investigate how the distance to Brookes Corner market (km) for cases and
controls varied with time since the start of the outbreak. Case or control status was
defined as a categorical variable with two levels, while time (in days) since the start
of the outbreak on December 31st 1998 was considered a continuous covariate.
Significance of the model was tested using an F-test and the residuals were inspected
for normality. This was carried out for the time period December 1998 to June
2000.
3.2.2.2 Logistic regression
The use of logistic regression for analysing case-control data is described by
Lilienfeld and Stolley (1994), Woodward (1999) and Altman (1997). A conditional
logistic regression was performed in S+ (MathSoft, Inc.), using the coxph command.
This procedure is a variation of the Cox's Proportional Hazards model (Woodward,
1999), a regression model normally used in survival analyses (see Section 5.2.3.1).
Logistic regression is appropriate for datasets with binary response variables, which
in this instance are case (1) and control (0) status. Conditional logistic regression is
applicable in cases, such as this, where the cases and controls are matched
(Woodward, 1999). It was carried out to test whether distance from Brookes Corner
market was a risk factor for sleeping sickness, and whether this changed over the
time course of the outbreak. While the case-control status was used as the response
variable with a unique number (1 to 113) used to identify each pair (set) of matched
cases and controls, three conditional logistic regression models were fitted; distance
alone (in km), time alone (in days since the first case on December 31st 1998) and the
maximal model, distance and time with their interaction (distancedime interaction
term). These were fitted as continuous explanatory variables. Significance was
• 2tested by comparing the reduction in deviance against the value in a x table. For the
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analysis, data was structured into four columns (set number, case/control status, time
and distance).
3.2.2.3 Cluster detection
The spatial scan statistic (Kulldorff & Nagarwalla, 1995; Kulldorff, 1997) was used
to determine the most significant spatial cluster of cases, if any, over various time
periods of the outbreak. An emphasis was placed on the first 32 days of the
outbreak, from the first recorded case (December 31st 1998) to the start of February
1999, prior to the 6 month-long vector control intervention, implemented around
Brookes Corner market. Other times were also investigated. Analysis of clustering
was performed using SaTScan8 version 2.1.3 (Kulldorff et al., 1998), and was run
under the assumption that cases and controls followed a Bernoulli distribution
(Kulldorff & Nagarwalla, 1995). In searching for clusters over different time
periods, both 30- and 90- day periods were examined. The maximum cluster size
was set at 50% of the total population at risk. The analysis was run to specifically
identify areas of clustering (the 'high rates' option) rather than areas with no
clustering (Kulldorff et al., 1998). The analysis was consistently run with 999
Monte-Carlo iterations, which produced the same results as 9999 iterations in
preliminary work, but required less computing time.




Between December 1998 and the beginning of August 2001, 168 cases of confirmed
sleeping sickness presented at Serere Health Centre. The number of cases reporting
through time is shown in Figure 3.1. The case-control study was undertaken in June
2000, and at that time, 119 cases had reported. Of these cases, 113 were included in
the case-control study. The age distribution of the 113 cases (and therefore the age-
matched controls) is shown in Figure 3.2. The mean age was 29.8 years (SD 19.9
years), and 60% were male (data not shown). Six cases were excluded because no
control matches were found (4 cases) or because the village of origin was unknown
(2 cases). Although visual inspection of the data suggests a seasonal effect on
sleeping sickness admissions, a longer time period would be required for statistical













Figure 3.1: Sleeping sickness cases in Soroti, December 1998 - August 2001. The orange
section of the bar in January denotes active surveillance. There appears to be seasonality in
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Figure 3.2: Age distribution of sleeping sickness cases in Serere, December 1998-June
2000.
3.3.2 ANCOVA analysis
The results of the ANCOVA are shown in Figure 3.3. The minimal adequate model
(F-ratio=131.3, df=2;223, p<0.001) contained significantly different intercepts (F-
ratio-95.1, df=l;224, pO.OOl) for the cases (3.70 km, 95% CI = 2.22-5.18 km) and
controls (10.22 km, 95% CI = 8.44-12.00 km) and a positive slope for distance of
cases from Brookes Comer market with respect to time since the start of the outbreak
(0.014 km per day, 95% CI = 0.008-0.020 km per day, F-ratio=17.5, df=l;224,
p<0.001). The slope for distance of controls from Brookes Comer against time since
the start of the outbreak was not significantly different from zero and was removed
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Figure 3.3: Results of the ANCOVA analysis. Blue squares are controls and
red circles are cases. The blue line is fitted to the control points, and shows no
variance of distance with time. The red line is fitted to the cases, and shows an
increasing distance of the cases from Brookes Corner over time. See text for
details.
3.3.3 Logistic regression analysis
When tested by itself using conditional logistic regression, increasing distance from
Brookes Corner market was highly significantly associated with lower risk
(X =69.30, df=l, p<0.001). Distance from Brookes Comer market was therefore a
significant risk factor for sleeping sickness. Time since start of the outbreak (in
days), when tested individually, was not significant (x2=0.168, df=l, p>0.05), as
expected as time was controlled for in the study design. When both continuous
variables (distance and time) and their interaction were tested together, the statistical
model was highly significant (x2=81.98, df=3, p<0.001). This maximal model could
not be simplified by the removal of the interaction term, without a significant loss of
explanatory power (x2=12.60, df=l, p<0.001). The parameter estimates for this
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model are given in Table 1. These parameters suggest that there is no change in
overall risk through time, but that the spatial distribution of risk does change with
time, moving away from the market.
Term Parameter estimate SE
Distance from Brookes Corner market -0.5472 per km 0.0258
Time since start of outbreak -0.0229 per day 0.1533
Distancextime interaction 0.00098 per kmxday 0.00036
Table 3.2: Parameter estimates from the conditional logistic regression with two
continuous variables and the interaction term. Parameter estimates are expressed as
natural log odds.
3.3.4 Cluster detection
The detailed results of the spatial scan statistic outputs are shown in Table 3.3.
During the first month of the outbreak, before any control activities were in place, a
significant cluster (overall relative risk=1.93, log-likelihood ratio=30.19, p<0.001) of
cases was detected (as shown in Figure 3.4). The cluster, centred on Oburiekori
village, had a predicted radius of 4.2 km, and included Brookes Corner market.
Twenty-seven of the 28 cases during that first time period were included in this
cluster. It should be pointed out that the nature of spatial scan statistic means that the
cluster centre has to be located over an existing point, and that the results therefore
provide information on the most likely cluster centre, and not necessarily the true
cluster centre. Cluster data for a selection of other relevant time points is shown in
Figure 3.5, along with the significant cluster covering the entire time period. The
details for each time point are given in Table 3.3. Although the size of the cluster
changed over time, as different villages became affected by the disease and the
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3.4 Discussion
Given that domestic cattle are the principal reservoir of T.b. rhodesiense in Uganda
(Welburn et al., 2001a), the results of this investigation on the origins of a recent
sleeping sickness outbreak are highly suggestive of a cattle origin for sleeping
sickness in Soroti. The outbreak is centred on Brookes Corner livestock market,
where, as demonstrated in Chapter II, a significant proportion of the animals
imported in the 3-4 years prior to the outbreak were potential carriers of the parasite.
The location and spatial pattern of the outbreak are consistent with this conclusion.
The results show that the outbreak was initially centred close to Brookes Corner
cattle market. Proximity to the market was a significant risk factor at the start of the
outbreak, and although there is no change in overall risk through time, the
distribution of that risk changes, moving away from the market at a rate of 1
kilometre approximately every 70 days. This suggests that sleeping sickness
dispersed outwards from the initial focus during the time of the study; proximity to
the market was a significant risk factor for being a case throughout, but this
relationship became weaker over time. How far this dispersion will continue
remains to be determined.
The clustering of cases detected in the first month, prior to the tsetse control, is
consistent with tsetse acquiring infections near the market and transmitting the
disease in the local area. Although the exact location of the cluster changed slightly
when examined on a month by month basis, it remained centred close to Brookes
Corner market through the duration of the study. The village locations (case points)
in themselves are not influenced by the location of the market, and the market itself
is not in a village, so the cluster centre could not fall exactly on the market itself,
although it always included it. Scanning for clusters using the spatial scan statistic
is based on "circular quadrats" (Kulldorff & Nagarwalla, 1995); if the distribution
of case villages had been determined by a linear geographical feature (for example a
river), the cluster would have included areas outside the zone of influence of that
feature, that were not really part of the cluster. Although this is clearly not the case
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here, it re-enforces the point that testing for clustering gives only an approximate
area of increased risk because a circle is only one possible shape for a cluster. The
market and the surrounding landscape lie within an area of tsetse habitat, and most of
the farmers in surrounding areas who purchase animals at Brookes Comer reside in
homesteads close by (N. Machilla-Eisler, pers. com.). Although there is another
market within the catchment area of Serere Health Centre (Kasilo livestock market),
it is over 20 km from Brookes Comer and there was no association between this
market and sleeping sickness cases.
The movement of infected people into Soroti is unlikely to have resulted in the
introduction of the parasite, as none of the cases of sleeping sickness at Serere Health
Centre had a history of travel outside of the district. Rather, parasites were probably
introduced with cattle as part of the restocking activities (see Chapter II), and were
transmitted by the local tsetse. In addition, the prevalence of T. b. rhodesiense in
cattle is much higher than that in humans (Hide et al., 1996), and tsetse blood meal
analysis shows that G. f. fuscipes is much more likely to feed on cattle than on
humans (Hide et al., 1996). Molecular characterisation of T. brucei isolates from
Soroti, and their comparison to isolates from the known endemic foci follows in
Chapter IV. Material for genetic studies is available from all the recorded human
cases and from cattle living in the vicinity of Brookes Comer market during 2000.
There was, however, no screening of cattle brought to the market itself at the start of
the outbreak, as no surveillance work was ongoing at the time.
Given that the restocking activities in Uganda are being implemented on a country¬
wide scale as part of a long-term poverty eradication plan, it is conceivable that
sleeping sickness could spread to other tsetse-infested districts of Uganda where it
does not currently occur, as a result of cattle movements. The region around Lake
Kyoga where this outbreak occurred, and beyond, is well endowed with riverine
forest vegetation ideal for G.f fuscipes (see Figure 3.6); much of this habitat became
established during the times of civil unrest when the area was depopulated and left
uncultivated, reverting to a bush habitat that is more suitable for the fly (no tsetse
surveys were done as part of this study, however, and the contemporary distribution
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of fly populations requires investigation). Since civil stability was re-established, the
return of the human population has led to significant contact with this habitat and a
large increase in the cattle population from restocking. The resultant interactions
between humans, their livestock and the tsetse infested environment led to an
increased risk of introduced parasites being transmitted. The continued spread of
sleeping sickness would be expected in an area such as this, where marginal lands are
being exploited. For example, Kasilo market, mentioned above, is currently
involved in restocking activities, separate to those that were centred on Brookes
Corner market. Initial studies (Fevre et al., unpublished) show that animals
involved in that restocking are being sourced from the Busoga sleeping sickness
region, and that many animals in the market are T. brucei s.l. positive (K. Picozzi,
pers. com.). The need for monitoring and further identification of parasites
circulating in these animals cannot be stressed enough.
Figure 3.6: Map of Uganda showing the distribution of the major tsetse
vector, G. f fuscipes (shaded in green) and major water bodies (in
blue). The red dot indicates the location of Brookes Corner livestock
market. The fly distribution was estimated by LIRI entomologists in
the late 1980s, and digitised from paper maps at ILRI, Nairobi.
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3.4.1 The significance of the reservoir in Soroti District
During 2001, Welburn et al. (2001b) sampled 200 cattle in markets and villages
within the Serere Health Centre catchment area9. Of these, 18% were reported to be
positive for the SRA gene (discussed in Section 2.4.2.1). The high prevalence of SRA
in samples from Soroti is of importance as it underlines the role played by the cattle
reservoir in the transmission cycle (see Figure 1.3). With a T.b. rhodesiense
prevalence of 18% in the reservoir, there is a great need to concentrate control efforts
at this component of the transmission cycle. In addition, the potential use of SRA as
a target for diagnostic tools would enable veterinary authorities to treat only those
cattle which were carriers, thereby reducing the need for block treatment with
trypanocides; the risk of promoting resistance to these drugs (Barrett, 2001) would
thus be diminished. The general implications of these results and the need for
improved intersectorial collaborations between medical and veterinary authorities are
discussed in more detail in Chapter VI.
9 This work is part of the output of this PhD project.
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Chapter IV:




Sleeping sickness has existed in Uganda for at least 100 years. The early outbreaks
and epidemics were studied from a traditional epidemiological perspective, by
observing patterns of disease distribution and, once their role had been established,
by closely studying the distribution of the tsetse vectors (Bruce et al., 1903a). Since
the advent of molecular tools and their application to the field of molecular
epidemiology (Hall, 1996; Holmes, 1998; Thompson et al., 1998), the origins and
dynamics of sleeping sickness outbreaks and epidemics have been studied more
closely (Gibson et al., 1980; Hide et al., 1996; MacLeod et al., 2000). The early
development of these tools was driven by the need to distinguish non-human
infective and human infective forms of T. brucei spp. isolated from a range of hosts.
The tools were essentially diagnostic, based on the presence or absence of a
phenotypic characteristic. Later DNA-based tests, however, were able to distinguish
parasites at the sub-specific level, and play an important part in furthering the
understanding of the relationships between strains of parasite; that is, an
understanding of the population structure.
The definitions of different terms applied to trypanosomes (such as 'strain,' and
'isolate') are given in Lumsden (1967) and WHO (1998). For example, an isolate is
a group of viable organisms from one naturally infected host. Of particular
importance in the context of the work that follows is the difference between a strain
and a stock, where a strain is a group of organisms sharing a unique genetic profile
(one genotype), while a stock is a population derived from the serial passage of one
individual isolate. In reality, when collecting organisms from naturally infected
hosts in the field, it is impossible to isolate individual strains, and the subsequent
analyses carried out on field samples have always been based on stocks, which may
consist of one or more strains. Indeed, Lord et al. (1999) have shown that there is
probably aggregation of strains among parasite hosts. Only if individual
trypanosomes are cultured and analysed would it be possible to refer to strains with
confidence.
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4.1.1 The available toolbox
4.1.1.1 Human serum resistance
Trypanosomes of the T. brucei s.l. complex are indistinguishable by microscopy.
Before the advent of sophisticated molecular tools for distinguishing parasites within
the complex, more basic tests based on reactions in hosts were used. Among the first
examples are Heisch et al. (1958) and Onyango et al. (1966), already mentioned in
Chapter I in the context of identifying non-human hosts for T.b. rhodesiense. In
eastern Africa, parasites from animals were inoculated to human 'volunteers,' and
the parasitological findings (that is, whether the infection became established or not)
determined whether the isolate was T. b. brucei or T.b. rhodesiense. To remove the
need for human experimentation, Rickman and Robson (1970) developed the Blood
Incubation Infectivity Test (BET), in which samples were incubated in human blood
in vitro for a period of time, following which they were inoculated into laboratory
rodents. Parasites surviving this ordeal were considered human infective and
therefore classed as T.b. rhodesiense. The technique is still used in the field,
although it has been superseded by more sensitive techniques. The most significant
problem with the BnT is the need for several passages through rodents, which can
result in the loss of some non-rodent adapted strains. More recently, Jenni and Brun
(1982) developed the Human Serum Resistance (HSR) test, a less crude in vitro test
using tissue culture plates based on an in vitro growth system (Brun et al., 1981).
Again, this technique involves the observation of the phenotypic characteristic of
survival in human serum, to characterise stocks as either human infective or not. As
such, it is unable to distinguish finer, genetic differences between stocks of
trypanosome. The most notable development in diagnostic tests for differentiating
T.b. rhodesiense from T. b. brucei is based on the direct detection of the SRA gene,
and has recently been published by Welburn et al. (2001b) - see Section 2.4.2.1.
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4.1.1.2 Isoenzymes electrophoresis
While the methods described above distinguish between human-infective and non-
human-infective trypanosomes, they are unable to differentiate parasites below the
sub-specific level. Isoenzyme electrophoresis was an early tool developed for this
purpose. Isoenzymes are functionally identical enzymes that catalyse the same
reaction but which may be structurally divergent in terms of amino acid construction
(Brewer, 1970). The minor changes in the amino acid construction of an enzyme are
phenotypic reflections of variation at the genotypic level, such as insertions or
deletions in the sequence of base pairs in the DNA coding for the enzyme. If these
enzyme variants are made up of amino acids with different molecular weights, their
total molecular weights vary, and when the enzymes are placed on a starch gel
(Brewer, 1970) and subjected to an electric current, they migrate through this gel at a
rate depending on their molecular weight; the same principle is applied to separating
DNA fragments following PCR (see Section 4.1.1.4). Isoenzyme electrophoresis
was first applied to trypanosomes by Bagster and Parr (1973), and can be carried out
on crude trypanosome material, where the parasitaemia has been amplified in a
suitable host such as rodents or tsetse flies. Following the separation of different
enzymes from this crude extract, a substrate is added which reacts with the enzyme.
This reaction is detectable, and enables the products of the electrophoresis to be
visualised on the gel.
Variations in isoenzyme patterns occur between stocks of trypanosomes, and
quantifying the differences between isoenzyme patterns between stocks has been
used as a measure of relatedness between parasites (Gibson et al., 1980). For such
work, it is usually necessary to analyse variations in the electrophoretic patterns of a
minimum of six enzymes. Nine commonly used isoenzymes are shown in Table 4.1.
The overall enzyme profile defined for a particular population of trypanosomes
relates to the pattern observed for all the enzymes used; the more enzymes used, the
greater the potential variation that can be observed. Parasites that are derived from
different populations but which have the same patterns are referred to as belonging to
one zymodeme (Godfrey et al., 1990). Enyaru et al. (1993) analysed a large number
of trypanosome isolates (151) collected from livestock, tsetse flies and humans in
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south-eastern Uganda. Thirty, 12 and 24 zymodemes were detected in isolates from
livestock, flies and humans respectively, demonstrating considerable variation
between parasites when compared by this method. Isolates from humans showed
less diversity than those from cattle and flies. Isolates from Tororo, which was a new
human sleeping sickness focus at the time, were similar to those previously seen in
Busoga; the Tororo focus was therefore considered an extension of the Busoga one,
although the actual method of spread of human sleeping sickness into Tororo was not
elucidated. Nine of the samples from domestic animals shared isoenzyme profiles
with isolates from humans, a finding which confirmed that domestic livestock had an
important role as reservoirs. In an earlier study with fewer isolates (Enyaru et al.,
1992), no differences were detected between Tororo and Busoga isolates, although a
diverse range of profiles was shown depending on the original host. In assessing the
phylogenetic relatedness of the isolates from both these studies, several groupings
resulted from domestic animal and tsetse fly derived isolates, while human infective
parasites grouped either together or with a small group of animal or fly derived











Table 4.1: Isoenzymes used by Hide et al. (1994)
4.1.1.3 Restriction Fragment Length Polymorphisms
Isoenzyme electrophoresis is limited in that it can detect only phenotypic variation in
trypanosome strains. A more powerful technique, which involves looking for
polymorphisms in restriction enzyme sites in parasite DNA, has also been used to
separate and classify different trypanosome stocks. The technique is termed
Restriction Fragment Length Polymorphism, or RFLP, and has yielded important
information on the epidemiology of human and animal trypanosomiasis.
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Briefly, trypanosome DNA is treated with a series of enzymes, which cleave the
DNA molecule where certain sequences of nucleic acids occur. These enzymes are
called restriction endonucleases, and different enzymes can be used that detect
different nucleic acid sequences. Variation between different parasite strains will
'reside' within these restriction sites, generating a diverse number ofDNA fragments
of different molecular weights. These segments can be separated by running them
out on an agarose gel, after which they can be transferred to a nylon filter by
southern blotting. The treatment applied to these filters results in single stranded
DNA bound to the filter itself, to which a complementary sequence in the form of a
radio-labelled RNA probe can bind. This radio-labelled marker can be resolved on
photographic paper and different banding patterns between stocks can be detected
and quantified (Hide, 1996).
4.1.1.3.1 RFLP studies in Uganda
During the sleeping sickness epidemic in south-eastern Uganda, that ended in the
early 1990s (Mbulamberi, 1990), a large number of samples were collected from the
Tororo and Busoga region, and analysed using RFLP (Hide et al., 1990; Hide et al.,
1991; Hide et al., 1994). It was found that the cattle were the most significant
reservoir of human infective parasites (Hide et al., 1996) since a large number of
stocks grouping with human-derived stocks were isolated from cows (group 10 in
their dendrogram). 23% of all cattle carrying T. brucei spp. were carrying parasites
that grouped with the stocks isolated from human sleeping sickness patients. The
stocks also grouped with others isolated in previous years from Busoga and other
areas around Lake Victoria, namely Busia in Kenya (Hide et al., 1991). The
northern lake shore appeared from the RFLP analysis to be composed of one parasite
population across isolated foci.
Earlier in this thesis (Chapter I), it was suggested that the spread of trypanosomes
(and particularly human infective trypanosomes) to new areas resulting in the
establishment of a focus might be driven by different epidemiological conditions
than those that result in the expansion of existing foci. Hide et al. (1998) compared
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the stocks of trypanosomes collected in Busoga and Tororo during the epidemic
period which ended in the early 1990s with stocks collected two years later during
the endemic period following that epidemic. All these stocks grouped together,
indicating that the parasites involved in epidemic transmission of sleeping sickness
persisted in endemic periods (although the time between the end of the epidemic and
the collection of the 'endemic stocks' was relatively short). This suggests that if the
processes resulting in spread or expansion of sleeping sickness are indeed different,
then parasite factors have little impact on these processes, and other explanations,
either related to cattle and human demography or environmental parameters, need to
be invoked. As the parasite populations in this part ofUganda appear to be relatively
stable in terms of their genetic similarities (Hide et al., 1991; Hide et al., 1996), and
if the Soroti outbreak (discussed in Chapter III) is indeed derived from the
Busoga/Tororo focus, it would be expected that the parasites circulating in the Soroti
outbreak should have been similar to those in Tororo/Busoga.
RFLPs have yielded important data which can be used in the analysis of the
relationships between trypanosome stocks, and the population structure of
trypanosomes in East Africa. However, the technique requires large amounts of
purified DNA, which requires culturing of parasites in vivo or in vitro.
Consequently, it is cumbersome to use, and a new technique has been developed
which is more rapidly and more simply carried out, and which identifies the variation
between parasite strains in an equivalent way. It is Polymerase Chain Reaction
(PCR)-based, and targets mobile genetic elements which naturally exist in the
parasite genome.
4.1.1.4 PCR
PCR is an in vitro method of amplifying specific sequences of DNA, and was
developed by Saiki et al. (1988), and is described in detail by Sambrock et al.
(1989a). From a small amount of target sequence in a sample, the repetitive
amplification cycles which use products from the previous cycles as a template
results in a large amount of the target sequence; 20 PCR cycles result in about 1 x 105
copies of the target sequence (Roche Diagnostics, 1999). It is dependent on the use
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of 7a<y-polymcrase, a DNA-polymerase enzyme derived from a heat-stable bacterium
called Thermus aquaticus (Chien et al., 1976). After running the amplified DNA on
an agarose gel and staining it with appropriate methods, the presence or absence of
the target in the original sequence can be determined by comparing banding patterns
at the appropriate molecular weight with a control sample. In standard PCR
protocols, two mirror-image oligonucleotide primers amplify the target sequence
from opposite ends of each strand of DNA. PCR is sensitive and specific, and is an
ideal tool for assessing the presence or absence of a particular target sequence in a
sample (such as the presence or absence of the SRA gene, discussed in Chapters II
and m). T. brucei s.l. consists of T. b. brucei and T.b. rhodesiense, both ofwhich are
composed of many strains reflecting the diversity of local populations of these
parasites. Some of the more involved molecular epidemiological tools that are
required for resolving these differences have been discussed above. The recent tool
used here is the mobile-genetic-element PCR, or MGE-PCR (Hide & Tilley, 2001;
Tilley, 2002).
4.1.1.5 Mobile genetic elements
The genomes of prokaryotic and eukaryotic organisms both contain sequences of
DNA termed 'transposable genetic elements' (Shapiro, 1995). These are sequences
of DNA which have the ability to move from one region of the genome to another,
by either conservative transposition, where they move as complete units in a 'cut
and paste' mechanism (Labrador & Corces, 1997), or by replicative transposition,
where they remain in the original site but make copies of themselves which insert in
another region of the genome (Berg & Berg, 1995). These changes occur over
evolutionary time, which, due to the rapid turnover of generations in some
organisms, may be short; a mobile genetic element in Drosophila spp. termed the P-
element transposes four times per element per generation (Hartl et al., 1997; Hide &
Tilley, 2001). By inserting into a gene, the transposable elements alter the pre-
insertion sequence, possibly inactivating that gene or changing the encoded product.
Drug resistance in some bacteria may be due, in part, to such a process (Arber, 2000;
Carattoli, 2001; Hiramatsu et al., 2001), and other evolutionary processes may be
driven by changes in genes that result from the insertion of these sequences. These
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changes accumulate, making them good markers for genetic diversity, a
characteristic that has been utilised for human genetic studies (Rowold & Herrera,
2000; Gagneux & Varki, 2001), and that is utilised here in the context of
trypanosome populations. The type ofmobile elements usually present in eukaryotic
organisms such as trypanosomes and humans, are termed transposons (the other
major type is termed an insertion sequence, but is important only in prokaryotes).
Transposons and other types of mobile element encode the enzymes required for
their own insertion into DNA (Shapiro, 1995); the natural ability of these elements to
insert into the genome may make them useful in designing and producing genetically
modified organisms. This has recently been proposed in relation to modifying
Anopheles gambiae, the principal mosquito species-complex responsible for malaria
transmission in sub-Saharan Africa, to render it malaria-refractory (Tu, 2001).
4.1.1.5.1 RIME
The major type of transposon found in trypanosome species is the retrotransposon
(Aksoy, 1991). Retrotransposons insert replicatively, by producing a DNA copy of
themselves via reverse transcription of an RNA intermediate (Kaiser et al., 1995;
Labrador & Corces, 1997). The retrotransposon targeted in the present work is
called RIME (Ribosomal Mobile Element). RIME, first described by Hasan et al.
(1984) is a useful element for detecting variation as it is both repetitive (Aksoy,
1991) and variable with respect to its position in the genome. RIME occurs several
times through the genome (high copy number), and is 1028 base pairs (bp) in length.
The entire RIME element is a dimer, made up of two identical halves called
monomers. Each monomer, in turn, consists of two halves termed RIME A and
RIME B (Hide & Tilley, 2001).
4.1.1.5.2 The MGE-PCR concept
Transposable elements, or Mobile Genetic Elements (MGE), can be detected by
PCR. An MGE-PCR for trypanosomes has been developed by Aimee Tilley at
Salford University (Tilley, 2002). The technique identifies positional variation of
different copies ofRIME in the whole genome. Unlike 'traditional' PCR, the MGE-
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PCR is carried out with only a single primer, designed to begin amplification from a
point within the mobile element (the end-terminal sequence) and amplify either (1)
an entire sequence between elements (Figure 4.1a) or (2) the end terminal sequence
itself and a small portion of the flanking region (Figure 4.1b) by mis-priming (Hide
& Tilley, 2001). Primers were designed to both the RIME A and RIME B
components of the monomer.
a)
b)
Figure 4.1: Diagram of the amplification of mobile elements using single
primers for the MGE-PCR. a) Using two elements to amplify the entire gene
sequence between these elements, b) using one element and relying on mis-
priming of the region flanking the element. Adapted from Hide and Tilley
(2001) and Terry et al. (2001).
Classically, the result of a PCR reaction would be a product of fixed length and
molecular weight, since two primers that work in opposite directions amplify a
highly specific region of a gene. In MGE-PCR, however, the single primer approach
results in amplification of products at several regions of the genome, resulting in
several products of different molecular weights (the weight of each product being
dependent on the distance between different copies of the RIME element as well as
mis-priming). RIME elements are often inserted in different orientations (Hasan et
al., 1984), and where this occurs (see Figure 4.1), the regions between these may be
amplified if the elements are close together. Electrophoresis of PCR products
produces banding profiles that represent amplification of flanking regions of RIME.
As the pattern of RIME element insertion varies between trypanosomes that belong
to different sub-populations (that is, strains), the banding patterns vary too. The
different patterns can be used to identify these different strains, and by applying
phylogenetic algorithms, the variations in banding patterns between strains can be
used for constructing phylogenies. MGE-PCR has already been used to successfully
differentiate strains of Toxoplasma gondii in a British sheep population (Terry et al.,
2001).
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The MGE-PCR methodology has two main strengths. Firstly, that a large proportion
of the genome can be screened for variation by the primers, reflecting the large
number of mobile element insertion sites. Secondly, that prior knowledge of the
flanking regions that are actually being amplified between the RIME elements is, in
itself, not required in the design of the primers (Hide & Tilley, 2001). In this, MGE-
PCR resembles another technique, Random Amplified Polymorphic DNA, or RAPD,
but unlike RAPD (Hide, 1997), MGE-PCR primers can only amplify the region
flanking a fixed point and do not anneal to different parts of the gene in a random
fashion. Amplification using MGE-PCR is always anchored to the RIME element.
The non-specific nature of the RAPD technique also means that it is not suitable for
use with samples that are contaminated with other DNA, such as DNA from a
parasite host.
4.1.2 Population structure
Three possible population structures have been proposed for trypanosome
populations (Welburn et al., 2001a). Trypanosomas might show a panmictic (Tait,
1980), a clonal (Tibayrenc et al., 1990), or an epidemic population structure
(Maynard-Smith et al., 1993). A panmictic population implies random mating
between organisms. Such a population structure for trypanosomes was first proposed
by Tait (1980), who carried out isoenzyme analyses on stocks of T. b. brucei isolated
in Busoga during the late 1960s. He demonstrated single banded isoenzyme profiles
as well as intermediate (hybrid) profiles, where the intermediate types were thought
to show mating between the single banded types. Mating (genetic exchange)
between trypanosomes has been demonstrated in laboratory adapted stocks (Jenni et
al., 1986). Clonality, which implies only asexual reproduction (Tibayrenc et al.,
1990) among trypanosomes, on the other hand, was proposed using previously
published data on T.b. rhodesiense and other trypanosome species stocks isolated in
Uganda and Kenya. Finally, the epidemic population structure (Maynard-Smith et
al., 1993), in which mating occurs as a rule but in which occasionally, successful
genotypes expand clonally (such as particular foci of human infective parasites), was
illustrated using data derived from a number of stocks, including human, cattle and
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antelope stocks from Kenya (i.e.: both T. b. brucei and T.b. rhodesiense). These
different hypotheses are important in terms of understanding how trypanosome
populations observed in the field relate to each other. McLeod et al. (2000) point out
that the conclusions in the above studies were derived from different parasite
populations, albeit originating from a similar geographical area; whereas the
panmictic conclusion was drawn from a principally T. b. brucei population, the
clonal conclusion was derived from analysis of T.b. rhodesiense stocks, and the
epidemic conclusion from a mixture of these. Only Hide et al. (1994) looked
specifically at both populations, which formed distinct groups in their analysis. T.b.
rhodesiense and T. b. brucei appear to be composed of independent (and non-
interbreeding) populations, possibly having evolved from a common ancestor but not
currently contributing to each other's diversity. Indeed, within the same host, they
may be in competition (P.G. Coleman & S.C. Welburn, pers. com.). In summary,
T.b. rhodesiense appears to be clonal, whereas T. b. brucei appears to be panmictic
with the occasional expansion of an epidemic strain (MacLeod et al., 2000).
By carrying out a thorough analysis of stocks collected in Uganda in 1988 and 1990
(Hide et al., 1994) and comparing these to stocks collected in a focus in Zambia
(Hide et al., 1991), it was shown that T.b. rhodesiense isolates from within a focus
(e.g.: Busoga, Uganda) show little variation (consistent with clonality), but that a
significant degree of variation is observed between T.b. rhodesiense isolates from
different foci (e.g.: Busoga, Uganda, vs. Luangwa Valley, Zambia). This is not
evidence of panmixia; rather, it supports the epidemic population structure
hypothesis put forward by Maynard-Smith (1993), were clonal foci may persist for
long periods of time. The geographical extent of the different foci has yet to be
determined, and the hypothesis does not preclude several clones of the parasites co¬
existing within one focus. The limited diversity seen in T.b. rhodesiense stocks is
not mirrored in T. b. brucei stocks, which show much greater diversity within limited
space and time (Hide et al., 1994). Tibayrenc and Ayala (1991) state that, even if
clonality is the principal mode of reproduction, it does not preclude some sexual
events, and that greater diversity among T. b. brucei might simply be the result of a
higher proportion of sexual activity among T. b. brucei as compared to T.b.
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rhodesiense, although both might ultimately be considered clonal. Welburn et al.
(2001a), however, note that an epidemic of T. b. brucei has never been observed (or
indeed searched for), that natural hosts of the parasite are rarely screened outside of
periods of T.b. rhodesiense epidemics, and that the population dynamics of T. b.
brucei s.s. itself are simply not understood.
Although studying the population structure of trypanosomes is important in its own
right, making the more practical distinction between strains of geographically and
temporally separated parasites is useful in addressing the question of the origins of
the Soroti district outbreak, which has been the subject of detailed epidemiological
studies in Chapters II and III; it is in the context of acquiring a more complete
understanding of the factors involved in causing that outbreak that MGE-PCR is used
here.
4.1.3 Specific objectives
In this study, MGE-PCR was used to compare stocks of parasites isolated in Uganda,
both from villages in Soroti district with active transmission of sleeping sickness and
from villages with active transmission in the established Busoga and Tororo sleeping
sickness foci in the southeast of the country. In both areas, parasites were collected
from livestock and from humans. In addition, isolates collected at the end of the last
epidemic in Tororo and Busoga were available for analysis. These stocks were
compared using MGE-PCR, and the results were analysed using a phylogenetic
analysis. The phylogenetic relationships were put in the context of the spatial and
temporal distributions of the parasites, to address three major questions:
1. Were T.b. rhodesiense parasites in Soroti related to parasites currently circulating
in the Busoga/Tororo focus in southeast Uganda?
2. Were the cattle in Soroti carrying similar T.b. rhodesiense parasites as human
sleeping sickness patients in this district, suggesting that cattle might be the
principal reservoir in the new focus?
3. Were the parasites currently circulating in the southeast Uganda focus similar to
those isolated there over 10 years ago (Hide et al., 1991; Hide et al., 1994; Hide
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Most of the recent trypanosome material used in the molecular analyses was
collected in Uganda in May/June 2000 during a large-scale field programme that
took place in four districts of the country, within the Lake Kyoga basin (see Figure
4.2). Villages that were included in the study were located in the traditional Busoga
focus (Kamuli district), the Tororo focus (Tororo and Busia districts) and in Soroti
district, the site of the recent outbreak discussed in Chapters II and III, which lies
outside the established foci. The human samples originating in Soroti District were
collected from sleeping sickness patients that had been referred to the Tororo
sleeping sickness hospital during active surveillance activities in Soroti at the start of
the outbreak in Serere, and the stock from a human patient originating in Kenya was
also isolated at the Tororo hospital.
0 80 Kilometers g^Wettand (swamps)
1 1 Bill Open water
Figure 4.2: Area of eastern Uganda from which samples were collected. Sampled
villages are shown in red.
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A number of stocks collected during the early 1990s by S.C. Welburn and I. Maudlin
were also analysed for comparative purposes, and these were extracted from the
cryo-bank held at the Centre for Tropical Veterinary Medicine, University of
Edinburgh. Details of these stocks have been published previously (Hide et al.,
1994; Hide et al., 1996). The analysis was carried out blind, the identity of the
stocks being revealed only once the phylogenetic analyses were complete. Details of
all the recently isolated stocks used and the host from which they were derived are
given in Section 4.3.
During the May/June 2000 sampling programme, three villages within each of the
foci were visited, such that sampling took place in nine villages altogether. These
were: Akoroi, Obar, and Obur villages (Soroti); Kinu, Bugondha and Bukafuga
villages (Busoga focus) and Bugwera, Mulanga and Manakor villages (Tororo/Busia
focus). Screening of the human population and of cattle and other livestock
populations took place. Any trypanosome-positive human was taken to the nearest
health facility for treatment, and farmers were given free treatment for any positive
animal. The general health status of livestock was assessed by a veterinary team, as
an additional incentive to farmers to bring their animals.
Fifty animals were screened in each village. Screening was done by two standard
field methods, viz: the haematocrit centrifugation technique, HCT (Woo, 1970) and
by direct dark ground/phase contrast microscopy observation of the Buffy Coat - the
BCT (Murray et al., 1977; Stephen, 1986; Uilenberg, 1998). For each animal found
to be T. brucei-positive by these microscopy methods, a 5 ml sample of blood was
taken from the jugular vein. In Tororo/Busia and Soroti, additional blood was taken
from all animals for preparation of a crude DNA sample for diagnostic PCR work.
To conform with Scottish Office importation regulations, animal blood from African
countries must be passaged twice through mice prior to importation to the UK. The
jugular blood sample from each T. brucei spp. positive animal was aliquoted and 0.2
ml was injected intra-peritonealy to each of two outbred Swiss white strain mice
directly in the field. Sixteen percent glycerol was added to phosphate-buffered saline
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with glucose (PSG) to make a 10% glycerol solution, which was added to the
remaining blood sample (one part glycerol+PSG: 1 part blood), which was slowly
frozen in evaporating liquid nitrogen and cryo-preserved in liquid nitrogen (see Table
4.2 for recipes). Mouse parasitaemias were checked daily by observing blood
extracted following a tail snip; when the parasitaemia was high (>50 parasites per
field under 400x magnification or 1.96xl08 parasites), the mouse was anaesthetised
and ex-sanguinated by cardiac puncture. The extracted blood was re-inoculated to a
second mouse for each sample. When the parasitaemia in the second mouse reached
>50 parasites per field, the mouse was exsanguinated as above, 10% glycerol was
added (1 part glycerol+PSG: 1 part blood) and the sample was slow cooled and frozen
in liquid nitrogen. All double-passaged samples were transported to Edinburgh for
further processing.
4.2.2 Parasite amplification
The samples of double mouse-passaged blood were defrosted and injected intra-
peritonealy to two To strain mice per isolate that had been immuno-suppressed with
cyclophosphamide. The blood was observed regularly under 400x magnification
after a tail snip. Slides were read according to the method described by Herbert and
Lumsden (Herbert & Lumsden, 1976). When the parasitaemia rose to approximately
o
1.96x10 parasites/ml blood (Herbert & Lumsden, 1976), the mice were euthanaised
and exsanguinated by cardiac puncture. Additional stabilates of this blood were
frozen and approximately 1 ml was used to extract trypanosome material.
4.2.3 Parasite extraction
A technique first described by Lanham (1968) was used to separate trypanosome
material from mouse blood. The technique relies on the fact that at an appropriate
pH (8.0 ± 0.05), the surface charge on the trypanosome cell surface is lower than that
on the surface of red blood cells, and a suitably equilibrated column consisting of
diethylaminoethyl (DEAE)-52 cellulose (Whatman®) will allow trypanosomes to
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flow through with a buffer, while the red cells are retained in the matrix. In this way,
a solution of trypanosomes in buffer, free of host (mouse) blood was obtained.
The DEAE-52 cellulose resin was suspended in PBS (Phosphate-Buffered Saline),
and the pH adjusted appropriately (using orthophosphoric acid and/or sodium
hydroxide). Fine particles were removed by repeated sedimentation. The resin was
loaded into a glass funnel and allowed to settle, at which point a heparin-treated
buffer (phosphate-buffered saline with glucose and heparin, or PBSGH) was allowed
to ran through the gel to prevent coagulation of the blood when it was loaded.
Buffers were made up according to Lumsden et al. (1973), as shown in Table 4.2.
Phosphate-Buffered Saline at pH 8.0 (PBS)
Sodium chloride (NaCl) 2.550 g
Sodium dihydrogen orthophosphate dihydrate 0.468 g
(NaH2P04.2H20
Disodium hydrogen orthophosphate dodecahydrate 20.414 g
(Na2HP04.12H20)
Double distilled water 1000 ml
Phosphate buffered saline (pH 8.0) with glucose (PSG)
D-glucose plus 53.31 g
PBS, made up as above 1000 ml




PBS, made up as above 1000 ml
Table 4.2: Recipes for solutions used in the preparation and
storage of trypanosome material
One part infected mouse blood was mixed with 5 parts PBSGH buffer, and loaded on
to the resin. The eluate was checked regularly for the presence of trypanosomes;
when parasites were seen, the eluate was collected in a beaker packed in ice. In
order to maintain flow through the resin, a head ofbuffer was maintained at all times.
Collection was stopped when the eluate contained less than 5 parasites per field in a
wet preparation at 400x magnification. The eluate was centrifuged at 2,000 rpm at
5°C for 10 minutes to pellet the trypanosomes, and the supernatant removed and
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replaced with 5ml PBS to wash the parasites. This was repeated a second time and
the washed trypanosome material was finally re-suspended in 5ml PBS and frozen at
-20°C.
4.2.4 Concentration of parasites
Following the DEAE-cellulose purification of the 1998/2000 samples, the parasite
DNA was extracted (see below); the concentration of the extracted DNA varied from
5-30 ng/ml. The lower concentration samples did not prove appropriate for the
MGE-PCR, which appeared to work best with concentrations over 25 ng/ml. As a
result of this, the parasite material obtained from the DEAE-cellulose columns was
re-concentrated two-fold and the DNA was extracted from this re-concentrated
sample.
A 1 ml sample of parasites in PBS was placed in a 1.8 ml micro-centrifuge tube,
which was centrifuged at 5000 rpm for 5 minutes. This resulted in a pellet of
parasite material in the tube. The supernatant was removed and 200 pi of PBS was
added, and the tube and contents were vortexed for 10-15 seconds. This resulted in a
200 pi DNA sample that was five times the concentration as the original eluate from
the above step.
4.2.5 DNA extraction
An aliquot (200 pi) of the trypanosome-rich solution was used in a genomic DNA
extraction protocol, performed using the Qiagen® QIAamp® DNA blood minikit
(Qiagen GmbH, Hilden, Germany), as per manufacturer's instructions. The
composition of the supplied solutions was not disclosed by the manufacturer.
Briefly, the purified trypanosomes were lysed with 200 pi of supplied lysis buffer
and in the presence of Proteinase K (20mg/ml), and the solution thoroughly mixed
and incubated at 56°C for 10-30 minutes. 200 pi of 96-100% ethanol was added to
the sample which was then mixed by pulse vortexing for 15 seconds. The solution
was then added to the QIAamp® spin column. The column was washed firstly with
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500 pi of buffer AW1 (supplied) and then again with buffer AW2 (supplied). The
DNA bound to the QIAamp® spin column was eluted in AE buffer (supplied), and
stored at 4°C.
The DNA concentration in each sample was measured by absorbance of
electromagnetic radiation at 260 nm (A26o), using a spectrophotometer (Cecil CE
2021, Cambridge, UK) as described by Sambrock et al. (1989b). For each sample,
10ml of distilled H20 was mixed with lpl of the DNA solution (1:1000 dilution) in a
2.5 ml optical polystyrene cuvette (Jencons PLS, Leighton Buzzard, UK), and mixed
using a dust-free mixing paddle. The absorbance at 260 nm was multiplied by 5,000
to give a DNA concentration in ng per ml.
4.2.6 DNA extraction from procyclic stocks
Samples collected in the early 1990s were held in the cryo-bank of the Centre for
Tropical Veterinary Medicine, University of Edinburgh. These were procyclic forms
that had been isolated from laboratory colonies of Glossina morsitans morsitans and
grown in vitro (Hide et al., 1994), rather than in mice as for the samples collected as
part of this study. The defrosted material (about 1 ml in each case) was centrifuged
to a pellet which was re-suspended in 200ul of PBS, and the DNA was extracted as
described above. These procedures were carried out by Dr Kim Picozzi at the
CTVM. DNA concentrations were not measured.
4.2.7 MGE-PCR
PCR was performed at the School of Environment & Life Sciences, University of
Salford, where the protocol used for this study was developed by Aimee Tilley (Hide
& Tilley, 2001; Tilley, 2002). All hardware required (tubes and other consumables)
was sterilised prior to use, and PCR preparations were carried out in an ultra-violet
(UV) radiation cabinet to minimize the chances of contamination. PCR
amplifications were performed in 50 pi reaction volumes consisting of 7 pi Taq
DNA polymerase (HT Biotechnology Ltd, UK); 70 pi PCR buffer containing 1.5
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mM MgCl (HT Biotechnology Ltd, UK); 37.5 jal sterile water (Sigma-Aldrich Inc.,
USA); 70 |a.l of primer at a concentration of 1 pM (MWG-Biotech AG, Germany); 14
pi dNTP mixture with 1 mM of each nucleotide (Bioline dNTP master mix, Bioline,
USA) and 1 pi of sample DNA.
All components other than the source DNA were combined to form a master-mix in a
micro-centrifuge tube which was stored on ice. Taq was added last. The source
DNA was added in a separate preparation area (in order to reduce the risk of
contamination). For each reaction, a negative control, consisting of all reaction
ingredients minus the source DNA was also prepared. The reactions were carried out
for each of three single primers (Tilley, 2002), as follows:
• RIME B (5'-AGCCATCACCGTAGAGCCCTG-3')
• REV RIME B (5'-CAGGGCTCTACGGTGATGGCT-3')
• REV RIME A (5'-ACGGTGTCCCAGCAAGACGCT-3')
Amplifications were carried out using a Stratagene Robocycler 96 with a hotlid; the
programme used varied with the primer, viz:
• For RIME B, the programme consisted of an initial 94° denaturing phase for 5
minutes, followed by 35 cycles of 94°C for 50 seconds (denaturing), 55°C for 1
minute (annealing), and 72°C for 2 minutes (extension), finishing with a further
10 minutes at 72°C to ensure complete extension of any remaining fragments
(Roche Diagnostics, 1999) and annealing of remaining single-stranded products,
• For REV RIME B, the programme consisted of an initial 94° denaturing phase
for 5 minutes, followed by 35 cycles of 94°C for 50 seconds (denaturing), 56°C
for 1 minute (annealing), and 72°C for 2 minutes (extension), finishing with a
further 10 minutes at 72°C,
• For REV RIME A, the programme consisted of an initial 94° denaturing phase
for 5 minutes, followed by 35 cycles of 94°C for 50 seconds (denaturing), 58°C
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for 1 minute (annealing), and 72°C for 2 minutes (extension), finishing with a
further 10 minutes at 72°C.
4.2.8 Electrophoresis
24 (j.1 of the PCR product was added to 6 pi of bromophenol blue loading buffer and
run on a 20 cm. 1.5% agarose gel in TBE buffer. The gel was stained in Ethidium
Bromide (100 pi of lOmg EtBr diluted in 500 ml distilled H2O) for 30 minutes
followed by destaining in water for at least one hour. Stained gels were illuminated
with a UV light source, and recorded using a Flowgen Alpha 1220 imaging system,
as described in Terry et al. (2001). Gels were resolved at different exposures, which
ensured that both low and high intensity bands were detected. The final banding
pattern recorded for each sample was the combination of the patterns seen for that
sample at the different gel exposures.
4.2.9 Measurement of banding patterns
A standard curve was constructed for each gel at each exposure using the 1 kb
molecular marker which was run alongside the samples on each gel. Individual band
sizes were determined by referring to this standard curve. Both the construction of
the curve and the band measurements were carried out using Bio-Rad Quantity
One® quantitation software version 4 (Bio-Rad, 1998), and corrected by eye. A
database of all possible bands for the samples was constructed, and the presence or
absence of a band of each molecular weight was recorded for every sample. The
result was a profile ofpresence or absence of each band for each sample.
4.2.10 Phylogenetic analysis
Band presence or absence was converted to a binary code, which served as the input
for the phylogenetic analysis. The "Clustering Calculator" software developed by J.
Brzustowski10 was used for clustering the samples based on their similarity. The
10 Available at http://www.biology.ualberta.ca/jbrzusto/cluster.php
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similarity measure used was the Jaccard Co-efficient (Jaccard, 1908), which is a
simple ratio of presence or absence of a band in a stock. It is used for this type of
analysis because the shared absence of a band in two samples does not imply that
they are similar. That is, two stocks are considered more similar if they both have a
band, than if they both lack it (Sneath & Sokal, 1973; Hide, 1996). The clustering
method used was the UPGMA, or Unweighted Pair Group Method using Arithmetic
averages (Sneath & Sokal, 1973), which has been used previously for phylogenetic
work involving trypanosomes, and gives comparable results to other methods (Hide,
1996). Jacknifing was used as the stability analysis (these options are all standard for
the software used). The output from the cluster analysis was exported to TreeView
version 1.511 (Page, 1996), in which dendrograms were constructed.
"
TreeView is available from http://taxonomy.zoology.gla.ac.uk/rod/treeview.html
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4.3 Results
4.3.1 In vivo parasite amplification
Of the 30 T. brucei-positive isolates that were collected and cryo-preserved in
1998/2000, 4 (13.3%) were not viable in the mouse amplification step in the UK.
Details of the successfully amplified isolates are given in Table 4.3. All the viable
isolates reached a parasitaemia between 50 and 200 parasites per field at 400x
magnification (1.96xl08 and 7.82x10s parasites per ml blood) measured by wet film
microscopy within 6 days, enabling the mice to be exsanguinated and the DEAE-
cellulose columns to be run. The variations in the parasitaemia between samples
probably depended on both the initial parasitaemia of the stabilate used for the















AKO C8 Cow Akoroi Soroti Soroti 27/05/2000
AKO C15 Cow Akoroi Soroti Soroti 27/05/2000 -
AKO CI6 Cow Akoroi Soroti Soroti 27/05/2000 +
AKO C20 Cow Akoroi Soroti Soroti 27/05/2000 +
AKO C43 Cow Akoroi Soroti Soroti 27/05/2000 -
LIRI16 Human Oburiekori Soroti Soroti 29/12/1998 +
LIRI24 Human Kangodo Soroti Soroti 1998/9 +
LIRI25 Human Oburiekori Soroti Soroti 17/01/1999 +
LIRI26 Human Kyere Soroti Soroti 1998/9 +
LIRI30 Human Orupe Soroti Soroti 1998/9 +
LIRI31 Human Oburiekori Soroti Soroti 24/01/1999 +
LIRI37 Human Abokony Soroti Soroti 1998/9 +
LIR139 Human Abokony Soroti Soroti 02/02/1999 +
BUWP1 Pig Bugwera Tororo Tororo 23/05/2000 -
MUL C22 Cow Mulanga Tororo Tororo 22/05/2000 +
KINU C21 Cow Kinu Kamuli Busoga 17/05/2000 +
KINUHBW Human Kinu Kamuli Busoga 17/05/2000 +








Table 4.3: History of successfully purified samples collected between 1998 and
2000, and used in the MGE-PCR analysis. The history of the older stocks
(1980s/1990s) has been described previously (Hide et al., 1991; Hide et al.,
1994).
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4.3.2 DNA concentration issues
The re-concentrated DNA samples were up to 100% more concentrated than the
samples prior to re-concentration, and the banding patterns on the gels were clearer
and easier to measure. It did not prove necessary to re-concentrate the stocks from
1988/1990, which were originally prepared from procyclic (tsetse salivary gland)
material. The differentiation of stocks using MGE-PCR is dependent on accurate
measurement of banding patterns, making clearly visible bands important. The final
banding patterns used in the analysis were measured on both the pre- and post-
concentration gels, which, taken together, resolved all the bands. The few samples
with questionable band quality were excluded.
4.3.3 MGE-PCR gels
The MGE-PCR technique was applied using the three primers, REV A, REV B,
RIME B (Tilley, 2002). However, the REV A primer did not generate enough
variation between stocks and RIME B produced only faint bands that were difficult
to reproduce. Conversely, REV B produced good quality bands (when the DNA
concentrations were sufficient) and the results from previous RFLP analyses (Hide et
al., 1994) could be reproduced using this primer alone. Therefore, although all three
primers were used in the initial phases of this work, the final analysis was based only
on REV B banding patterns. A representative gel, using the REV B primer, is shown
in Figure 4.3. It demonstrates that an appropriate concentration of DNA is essential
for accurate band measurement, especially for the lower molecular weight bands.
Figure 4.4 shows samples run with higher concentrations of DNA. All the REV B
PCR products were resolved on gels at different exposures, ensuring that bands of
different intensities could be clearly visualised.
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Figure 4.3: A typical MGE-PCR gel using the REV B primer. The samples on the
left of the gel (LIRI16, AKOC20, LIRI25, LIRI26, LIRI30, LIRI31, LIRI39) were
run prior to re-concentrating the DNA material, and show that the lower molecular
weight bands may be difficult to identify when the concentration of DNA is low. The
banding patterns are far less clear than those on the right of the gel, which were
prepared from procyclic stabilates and were at a higher concentration from the
outset. The extreme left hand lane is the marker (bp), the extreme right is the
negative control (no sample was run in that lane). Bumanda 146 and UGL are T. b.
brucei and T.b. rhodesiense (determined by the SRA PCR - see text) respectively and
were run as positive controls on this gel. LIRI16-39 and AKOC20 are T.b.
rhodesiense positive (SRA positive) stocks from Soroti. Buteba 135, Mawero 85,
Papol 264, Tira 17, Tira 68 and Bumanda 25 are T. b. brucei (SRA negative) from
Busoga/Tororo, and the remaining stocks are T.b. rhodesiense (,S7L4+), also from
Busoga/Tororo. Tira 68 bands were not measured using this gel (poor profile, as
shown), and Papol 264 was excluded from the analysis as lower molecular weight
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Figure 4.4: MGE-PCR gel using the REV B primer. The samples are a mixture of
Soroti and Tororo/Busoga samples from different time points. MULC22 is T.b.
rhodesiense positive (determined by the SRA PCR), and was derived from a cow in
the Tororo focus in 2000. AKOC43 and AKOC8 were collected from cows in Soroti
in 2000, and are SRA negative (T. b. brucei). AKOC20 was collected from a cow in
Soroti in 2000 and is SRA positive. UGB88 was collected from a human (SRA+) in
Tororo in 1988/90 and Buteba 135 was collected in Tororo in 1988/90 from a cow and
is SRA negative. The samples labelled LIRI 16-31 are human derived stocks (.S7L4+)
from patients in Soroti, collected in 1998. The BIDA sample was not used in the
analysis. Note that the marker increments (bp) are different to those in the previous
gel. Presence or absence of bands for each sample was recorded using several gels at
different exposures; for example, although MULC22 does not appear to have a band
present at 823bp in the Figure, it was faintly visible on a gel at a different exposure
(data not shown; see text for discussion).
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4.3.4 Banding patterns and phylogenetic analysis
Table 4.4 shows the complete set of banding patterns resulting from the MGE-PCR
using REV B, and the dendrogram resulting from Table 4.4 is shown in Figure 4.5.
The phylogenetic analysis clearly distinguishes between those stocks that are T.b.
rhodesiense and those that are T. b. brucei, as determined using the SRA PCR
discussed previously (Welburn et ai, 2001b). The dendrogram shows that the two
sub-species are at best 78% similar when compared with this set of stocks. There is
one exception (MULC22; collected in 2000), which is discussed below.
Within the T. b. brucei stocks, two sub-groups can be distinguished. These two
groups have been labelled Group 1 and Group 2, while the T.b. rhodesiense group
has been labelled Group 3. Among the stocks tested are several that were collected
in 1988/1990 that have previously been classified using the RFLP methodology
(Hide et al., 1994). With two exceptions (Tira 17 and Tira 68 - discussed below),
the classification of those stocks into the T. b. brucei and T.b. rhodesiense groups is
consistent using both techniques.
4.3.4.1 T.b. rhodesiense stocks: Group 3
4.3.4.1.1 Busoga/Tororo
KTNUHBW, KINUC21, BUGH1 are human-, cow- and human-derived stocks,
respectively (see Table 4.3). They are all SRA positive, and were collected in the
Busoga/Tororo foci in 2000. They are identical to stocks collected in these same foci
in the period 1988/1990, grouping on the same branch of the tree (100% similarity).
This branch is composed of both cow and human derived stocks. The dendrogram in
Figure 4.5 shows that all the T.b. rhodesiense stocks (other than MULC22) analysed
here are >85% similar.
4.3.4.1.2 Soroti
The T.b. rhodesiense positive stocks collected in Soroti between 1998-2000, during
the outbreak described in Chapter III, show a number of interesting characteristics.
108
Firstly, they are not all identical; although they all fall in Group 3 with the other T.b.
rhodesiense stocks, there are four distinct clusters (which show >90% similarity),
and within each of these clusters the stocks are >95% similar (see Figure 4.5). The
first cluster is made up of AKOC20, and LIRI31; the second of LIRI26 and LIRI30;
the third of LIRI37, LIRI24, LIRI39, LIRI16 and LERI25 and the last of AKOC16
and LIRI14. Within this small sample of T.b. rhodesiense from Soroti (a total of 168
confirmed cases reported to Serere Health Centre up to August 2001), there are thus
four possible strains of human infective parasites. Importantly, the SRA-positive
cow-derived stocks from Soroti (AKOC20 and AKOC16) grouped within clusters of
human-derived stocks. LIRI14 was collected from a patient residing in Teso District,
Kenya, adjacent to Tororo (the Tororo sleeping sickness focus extends across the
international border), and is very closely related (>95% similarity) to AKOC16 from
Soroti, which was derived from a cow. The differences between all the T.b.
rhodesiense stocks are explained by only 4 band differences (see Table 4.4).
4.3.4.2 T. b. brucei stocks: Group 2
As a whole, the T. b. brucei stocks show a great deal more diversity than the T.b.
rhodesiense stocks, a pattern consistent with previous studies. The T. b. brucei
stocks collected specifically in Soroti in 2000 are approximately 75% similar to each
other (despite all originating in the same village). This level of dissimilarity is well
within the overall pattern of diversity seen generally in the T. b. brucei stocks
analysed.
4.3.4.2.1 MULC22
The sample labelled MULC22, collected from a cow in Tororo in 2000, is the only
exception to the pattern of T.b. rhodesiense-T. b. brucei clustering seen in the
dendrogram (Figure 4.5). The sample tested positive for the presence of SRA, and
has thus been classified as T.b. rhodesiense. Similarly to the specificity of the SRA
PCR, certain bands on the MGE-PCR gels using the REV B primer are specific to
T.b. rhodesiense (A. Tilley, pers. com.), although it is not known what T.b.
rhodesiense-specific sequence is being amplified. Those bands are usually bright;
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although MULC22 had this band, it was only visible faintly on a high exposure gel
(data not shown). In addition, other bands resulting from the analysis of this sample
are characteristic of T. b. brucei stocks. These observations suggest that the cow
from which this sample was taken was carrying a mixed T.b. rhodesiense/T. b. brucei
infection. If this is the case, the result is interesting for two reasons. First, that the
MGE-PCR technique is unable to distinguish mixed and single infections. This is
also the case with the standard T. brucei spp. diagnostic PCR and the T.b.
rhodesiense-speciTic SRA PCR, which, by looking for presence or absence or a
particular sequence, cannot show if T.b. rhodesiense is present without T. b. brucei in
any one particular sample. RFLP is also unable to distinguish mixed infections.
Secondly, if the anomaly in this one sample is indeed the result of a mixed infection,
it suggests that mixed T.b. rhodesiense and T. b. brucei infections are rare - there are
a dozen cattle-derived T.b. rhodesiense samples in the group tested, and none of
those have the anomalous banding pattern shown by MULC22. In order to
determine whether MULC22 is a mixed infection, it will be necessary to type stocks
using MGE-PCR that have been cloned from individual parasites, obtained by
serially diluting the sample. This technique is termed cloning by limiting dilution,
and was described by Rosario (1981) for malaria parasites. It has been used for the
kinetoplastid parasites by Handman et al. (1983), who cloned parasites from an
isolate ofLeishmania tropica.
4.3.4.3 T. b. brucei stocks: Group 1
The T. b. brucei in Group 1 are sufficiently different from the other T. b. brucei to
merit separation into their own group (<75% similarity). The Group is made up of
Tira 68, Tira 17, Papol 371 and Mela 32 which also had distinctive patterns using
other techniques (Hide et al., 1994; MacLeod et al., 2000). In the RFLP analysis by
Hide et al. (1994), the stocks Papol 371 and Mela 32 formed their own separate
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Figure 4.5: Dendrogram resulting from the UPGMA cluster analysis based on MGE-PCR
banding patterns with the REV B primer. Three phylogenetic groupings are shown (see text).
Stocks marked in red are SRA positive (T.b. rhodesiense), those in green are SRA negative (T. b.
brucei). The blue rectangles highlight stocks collected in Soroti during 1998/2000.
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4.4 Discussion
The molecular evidence presented in this Chapter contextualizes the sleeping
sickness outbreak in Soroti District with respect to the other T.b. rhodesiense foci in
Uganda (Tororo and Busoga). The evidence presented supports the hypothesis that
the human infective parasites in the different foci are in fact part of the same T.b.
rhodesiense population, which is distinct from the T. b. brucei population circulating
in the same area.
4.4.1 T.b. rhodesiense in Soroti
Cattle in Soroti are harbouring similar stocks of human-infective parasites to those
that are presently affecting the human population in the district, confirming the role
of cattle as a reservoir of T.b. rhodesiense in Soroti. In addition, cattle and human
T.b. rhodesiense stocks from Soroti appear to be closely related to stocks of T.b.
rhodesiense presently circulating in both Tororo and Busoga, illustrated in particular
by the very closely related AKOC16 stock isolated from a cow in Soroti and the
LIRI014 stock isolated in Teso, Kenya, which is contiguous with the Tororo focus.
As T.b. rhodesiense was not present in Soroti prior to the large scale movement of
cattle into the district from the Tororo and Busoga endemic regions, it seems likely
that the human infective parasites now circulating in Soroti were brought into the
district from those areas with the cattle. Future studies should, however, process and
analyse a larger number of samples from Soroti, to further validate this finding.
The T.b. rhodesiense stocks analysed here are diverse, but this diversity is limited;
the T.b. rhodesiense parasites show >85% similarity, and the diversity among the
T.b. rhodesiense group is accounted for by only 4 band differences on the MGE-PCR
gels. In contrast to this limited diversity, the diversity within the T. b. brucei group
is more extensive, as some of the stocks are less than 70% similar to each other. As
the T.b. rhodesiense in Soroti are not all 100% identical, it can be concluded that
several strains of the human infective parasite are circulating in Soroti and are
responsible for the cases of sleeping sickness seen at Serere Health Centre, implying
that the importation of these parasites probably occurred several times, from different
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sources within Tororo and Busoga, during the restocking exercise. If the outbreak
had been the result of one, very effectively transmitted imported strain, the
expectation would be that all the T.b. rhodesiense parasites in Soroti would group
very closely, with almost 100% similarity. To minimise the risk of movement of
these parasites further afield, beyond Soroti, thus requires a constant monitoring
effort, as suggested in Chapter II; the fact that T.b. rhodesiense infected animals from
different parts of the established sleeping sickness affected regions were brought
together in the restocking exercise emphasises the need to screen animals at a central
point, such as a livestock market, rather than targeting specific areas within the
affected regions.
The diversity within the small number of T.b. rhodesiense stocks from Soroti also
illustrates that generalisations regarding strain relatedness should be made with
caution when relatively small numbers of samples are examined. Certainly, a larger
number of samples are needed from Soroti. However, the geographic range ofmany
of the older samples is also limited, possibly concealing the true level of diversity
that exists within T.b. rhodesiense from southeast Uganda. Figure 4.6 shows the
distribution of cases of sleeping sickness in Tororo district between 1987 and 1997,
as well as the geographical area covered by the sampling which took place during the
epidemic between 1988-1990 (Hide et al., 1994; Hide et al., 1996). The area
sampled had a radius of approximately 10 kilometres, and sleeping sickness in
Tororo is more widely distributed than the area from which the samples came. There
is thus potential diversity within the T.b. rhodesiense population that has not been
quantified as samples from the entire range have not been analysed. Analysis of the
1988-1990 data show that even within individual villages, there is diversity. For
example, in Mela village, Tororo, two T.b. rhodesiense stocks were collected from
cattle on the same day. These are Mela2 and Mela71, and are among the most
dissimilar stocks within the T.b. rhodesiense group (see Figure 4.5). These
differences are important in interpreting the data and understanding the origins of the
Soroti outbreak. Cattle imported to Soroti came mainly from Tororo and areas
within Busoga. The imported cattle are likely to have had a much more diverse
origin than the stocks that have been analysed, and the fact that some of the T.b.
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rhodesiense stocks are as much as 14% dissimilar (86% similarity) might be
explained by this. In short, a far greater number of samples are required from Soroti,
as well as the Tororo/Busoga regions, to have a complete understanding of the
population genetics of human trypanosomiasis in the region.
Figure 4.6: Outline of Tororo district, southeast Uganda.
Dark blue area in the south is Lake Victoria. Areas of
light blue are swamp. Sleeping sickness positive villages
are shown in red (data from M. Odiit, pers. com.), Tororo
town is marked by the black dot. The approximate area
from which the 1988-1990 stocks were isolated (Hide et al.,
1994; Hide et al., 1996) is shown by the black circle.
4.4.2 T.b. rhodesiense in Busoga/Tororo
Some of the stocks of T.b. rhodesiense recently collected in Busoga/Tororo have
exactly the same banding patterns (100% similarity) as stocks isolated over a decade
ago in the same region. This suggests that parts of the T.b. rhodesiense parasite
population circulating in those areas are reproducing clonally (otherwise some small
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degree of variation, at least, would be expected). In that respect, these data are in
agreement with Hide et al. (1998), who compared parasites that had been collected
during periods of both endemic and epidemic transmission. The time that had
elapsed between the end of the epidemic and the so called endemic period in that
study was short (less than 5 years), allowing room for uncertainty as to the true
nature of transmission (epidemic vs. endemic) at the time. However, the length of
time that has now elapsed since the epidemic period is certainly significant, and the
results of the present study thus provide additional support to the conclusions
regarding clonality drawn by Hide and colleagues (1998). Furthermore, the
continued similarity between T.b. rhodesiense parasites isolated from both cattle and
from humans in the Busoga/Tororo foci confirms the important role of domestic
livestock in the maintenance of the parasite during long endemic periods. T. brucei
spp. are poorly pathogenic to local breeds of cattle in East Africa (Killick-Kendrick,
1971; Angus, 1996), although mild symptoms, such as a self-resolving anaemia
might occasionally be seen. Therefore, T.b. rhodesiense sleeping sickness
eradication efforts, if they were ever to be seriously considered, would have to
concentrate on finding and treating this silent and possibly extensive reservoir of
infection.
4.4.3 T. b. brucei
The greater degree of diversity within T. b. brucei (<70% similarity) than T.b.
rhodesiense (>85% similarity) stocks suggests either that T. b. brucei parasites
exchange genetic material (that is, reproduce sexually) more often than T.b.
rhodesiense, or that the T. b. brucei population is also clonal but evolutionarily much
older than the T.b. rhodesiense population, which would therefore have had less time
for rare genetic changes to accumulate. The T. b. brucei parasites might thus fit with
the 'clonal population structure with occasional sexual events' model, proposed by
Tibayrenc and Ayala (1991). However, the apparent isolated population dynamics of
the two sub-species certainly suggests that the populations of T.b. rhodesiense and T.
b. brucei are quite separate and certainly do not regularly exchange genetic material.
The fact that the SRA-positive trait is found only in the more tightly clustered T.b.
rhodesiense group rather than being spread across both populations is further
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evidence for this. These results are in agreement with the conclusions ofWelburn et
al. (1995), who found heterogeneities in the maturation rates of T. b. brucei and T.b.
rhodesiense in both male and female tsetse flies, and suggested that this is an
indicator of divergence of the two sub-species. More recently, Victoir and Dujardin
(2002) suggested that sexual recombination events may not be necessary to explain
diversity among strains of parasites, basing this on observations made on Leishmania
spp., and the variable organisation of gp63 genes (coding for a surface glycoprotein).
Parasites may have evolved methods of generating diversity in their own genomes by
self-regulated genome re-organisation without reverting to sexual events. The
limited diversity seen in T.b. rhodesiense stocks (compared to T. b. brucei) might be
accounted for by such a mechanism.
4.4.3.1 Prior occurrence of T. brucei in cattle in Soroti
The epidemiological evidence for the recent importation of T.b. rhodesiense to Soroti
District has been discussed in Chapters II and III. As discussed in Chapter 1H, one
case had been previously identified there in the 1960s, but the case history suggested
that the infection had been acquired elsewhere. Similarly, there is little published
evidence of the occurrence of T. b. brucei in the district. Mwambu (1969b) sampled
2444 cattle in Serere and other parts of Soroti, and found, using a combination of
microscopy and the IFAT (Indirect Fluorescent Antibody Technique) that only T.
vivax was prevalent (57.5% prevalence - as this is an antibody test, it includes cured
as well as current infections). Ford (1971) cites Ugandan veterinary reports from the
period 1949-1955, showing a T. brucei prevalence of 0.12% (7 of 5967 positive
slides). Unfortunately, the data for recent cross-sectional surveys of cattle in different
parts of Soroti are not yet available, but early results show a high T. brucei spp.
prevalence. Those data refer to the period after the start of the sleeping sickness
outbreak in Soroti, and reliable prevalence information for the period prior to the
introduction of sleeping sickness will remain unavailable. Whether T. b. brucei has
previously been widespread in Soroti or not, the three stocks of T. b. brucei isolated
in the district as part of this study are both distinct from each other while also
showing some similarities to other T. b. brucei parasites from the Tororo/Busoga foci
(though none are identical). If it is the case that T. b. brucei was not widespread here
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prior to the importation of sleeping sickness, the diversity seen among the T. b.
brucei in Soroti adds weight to the suggestion that many parasite strains were
imported to the District at different times during restocking. If those strains of T. b.
brucei were present in Soroti prior to the outbreak, it suggests that the T. b. brucei in
the whole of eastern Uganda make up one intermixing population.
4.4.3.2 T. b. brucei: Group 1
Tira 17 and Tira 68, which are 6764-negative and which have been classified as
Group 1 in this study, were grouped with the T.b. rhodesiense parasites using RFLP
(Hide et al., 1994). However, McLeod et al. (2000), using minisatellite markers,
contradicted this finding and grouped them as T. b. brucei, a finding which is in
agreement with the results of this study. Further work on these stocks, particularly in
elucidating the reasons for their classification as T.b. rhodesiense using RFLP, is
required, but is beyond the scope of this project.
4.4.4 Concluding remarks
The following conclusions can be drawn as a result of the analysis conducted during
this study:
• Cattle in Soroti are carrying T.b. rhodesiense strains similar to those affecting
humans in the district, suggesting that cattle are a reservoir of human infective
parasites in Soroti.
• Cattle in Soroti are carrying strains almost identical to stocks isolated in the
Tororo/Busoga focus, which is consistent with the hypothesis that cattle imported
from sleeping sickness regions in Tororo and Busoga during restocking carried
T.b. rhodesiense to Soroti.
• More than one T.b. rhodesiense strain is present in Soroti, indicating that the
human infective parasite was probably imported on more than one occasion.
• Some T.b. rhodesiense strains collected over 10 years apart from Busoga/Tororo
are identical, a characteristic of a clonally reproducing population (no genetic
exchange).
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• Domestic animals are maintaining parasites in the stable, endemic foci of Tororo
and Busoga.
• T. b. brucei is diverse, and does not appear to exchange genetic material with T.b.
rhodesiense. The level of diversity among T. b. brucei is suggestive that at a
population level, more genetic exchange occurs in this sub-species than in T.b.
rhodesiense.
• Restocking may have also been responsible for an increased prevalence of T. b.
brucei in Soroti.
The phylogenetic similarity of the stocks in Soroti and Tororo/Busoga, from both the
cattle and the human population, when taken together with the evidence from the
field studies presented in Chapters II and III, suggests that the establishment of the
focus in Soroti is a direct result of the importation of T.b. rhodesiense-infected cattle
from Tororo and Busoga to Soroti, and that, more generally, cattle movements are
the driving force for the spread of sleeping sickness in regions affected by the
zoonotic form of trypanosomiasis. It is likely that the epidemic in Tororo in the
1980s/1990s was also instigated by similar livestock-related factors, although the
investigations of disease spread at the time concentrated on the fly component of the
transmission cycle, despite the fact that the significance of the cattle reservoir had
been established (Hide et al., 1994; Hide et al., 1996).
In terms of the expansion of existing foci during occasional epidemic periods (as
distinct from disease spread which has been investigated here), there is no doubt that
entomological factors, such as the rapid expansion of fly habitats as a result of
environmental changes, play an important role (Mbulamberi, 1989; Wellde et al.,
1989b; Lancien, 1991). However, for these epidemics to be initiated, the human
infective parasites must be surviving unnoticed in the foci outside of the epidemic
periods. As T. brucei spp. are not pathogenic to local East African cattle breeds such
as Zebu, and as T.b. rhodesiense appears to persist clonally, this is not difficult to
envisage. In this situation, the occasional chance infection of flies would result in
occasional human sleeping sickness cases, as is observed during endemic periods.
There is a need to further understand the detailed behaviour and biology of cattle
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populations, especially with regard to the way in which livestock, humans, tsetse and
the environment interact, in order to achieve accurate predictions of the timing and







5.1.1 Epidemic sleeping sickness in Uganda: 1901
At the start of the 20th century, Uganda was affected by a large scale and disastrous
epidemic of sleeping sickness. It is estimated that around 250,000 people died
(Langlands, 1967) during the period 1900-1920 in the Busoga and Buganda regions
of the country (the Buganda region extends west of Busoga - see Figure 1.4). The
first published description of sleeping sickness cases was made by the Cook brothers,
who were medical missionaries with the CMS - Church Missionary Society (Cook,
1901; Cook, 1902), and who had set up a mission hospital. The extent of the
epidemic became clear as the number of cases seen in their hospital and other
medical facilities increased, and as the disease was identified in many areas around
the northern shore of Lake Victoria (Bruce et al., 1903b; Christy, 1903).
The study of sleeping sickness was initially focussed on discovering the causative
agent. As well as being newly recognised in Uganda, the disease had not been
previously described in eastern Africa as a whole. Indeed, the discovery of
trypanosomes as a disease agent was relatively recent. The causative agent of
'Trypanosoma fever' in the Gambia, West Africa was noticed in 1902 by Forde
(1902) and described by Dutton (1902) as T. gambiense. Manson (1898) was of the
belief that the disease was linked to Filaria perstans (now known as Mansonella
perstans), a blood-dwelling nematode that is of no clinical importance. Manson had
limited evidence to support his claim (Cook, 1901; Foster, 1970), which may have
been promulgated, in part, for political motivations (Haynes, 2000). None-the-less,
before the causative link to trypanosomes was made, early diagnostic efforts in
Uganda and elsewhere on sleeping sickness patients focussed on finding this
organism. T.b. rhodesiense was only described (in present day Zambia) in 1910
(Stephens & Fantham, 1910), and the importance of T.b. rhodesiense in Uganda was
only confirmed during the next major epidemic to affect the country 40 years later
(MacKichan, 1944).
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In 1903, both Castellani (1903) and Bruce et al. (1903b) found an association
between the occurrence of trypanosomes and sleeping sickness in Uganda. From this
point onwards, the parasitological assessment of suspect sleeping sickness cases was
based on the observation of trypanosomes in blood or cerebro-spinal fluid. There
followed, in Uganda, much work on the distribution of the disease and the
distribution of various potential vectors. Bruce et al. (1903a) found that the
geographical extent of sleeping sickness corresponded with the distribution of the
tsetse fly, work which followed earlier observations in Zululand (1895) on the vector
responsible for a cattle disease termed nagana (cattle trypanosomiasis).
5.1.2 A new disease?
It is not known how long sleeping sickness had existed in Uganda prior to the
epidemic. Most of the pioneering scientists seem to have assumed it was a new
problem as they found little or no evidence for it having occurred there before. The
assumption was made, however, that such an epidemic disease would have always
occurred in the same epidemic proportions that were being observed. However,
Christy (1903), while travelling through southern Uganda, noted that sleeping
sickness had probably been present long before it was first discovered around 1901,
and that it probably originated in Busoga, the core of the present day T.b.
rhodesiense focus, and Duke (1918), on reviewing the available evidence, also states
that 'some form of human trypanosomiasis' had been present around the Ugandan
shores of Lake Victoria prior to the epidemic.
5.1.2.1 The causative organism
Confusion over the novelty or otherwise of sleeping sickness in this area was
intertwined with the available knowledge of the causative organism. During the
epidemic starting in 1901, only one species of human infective trypanosome had
been identified, to which the epidemic in Uganda was ascribed. This was the T.
gambiense parasite that had been observed in the Gambia (Dutton, 1902).
Furthermore, concurrently with the epidemic in Uganda, sleeping sickness was
recognised in many parts of central Africa (Morris, 1963). It had not been seen
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previously elsewhere in eastern Africa, and the understandable assumption was made
that the Ugandan disease was derived from the sleeping sickness epidemic raging
westwards in the (present day) Democratic Republic of Congo and elsewhere.
If sleeping sickness at the time had been due to T.b. gambiense, it would suggest, as
some have (Morris, 1963), that the parasite was imported from the west as part of
large scale human population movements that are known to have occurred at the
time. Only Koerner (1994) and Koerner et al. (1995) have seriously questioned the
identity of the parasite responsible for the first Ugandan epidemic. They argue that
as T.b. rhodesiense occurs in apparently stable endemic foci which occasionally
expand resulting in epidemics, that T.b. rhodesiense was probably present in Busoga
long before 1901. This is an attractive argument, as the wholesale replacement of
one parasite species by another {T.b. gambiense by T.b. rhodesiense) in a region
seems unlikely.
While working in Uganda at the start of the epidemic, Castellani (1903) noticed two
distinct clinical symptoms among the patients presenting. The first he called
Trypanosoma fever, as is was similar to the disease seen in The Gambia and ascribed
to T. gambiense. The second he called sleeping sickness, and tentatively called the
trypanosome that he found in those cases T. ugandense (Castellani, 1903). The
distinction was essentially clinical; what he called sleeping sickness was a much
more virulent infection than the Trypanosoma fever caused by T. gambiense. Bruce
et al. (1903a) described two cases of a disease 'not unlike Trypanosoma fever' in two
immigrants who had recently come to Uganda (whom he termed Nubians). These
were a policeman and a prisoner who had arrived from the present day Sudan (where
T.b. gambiense occurs today). Bruce et al. (1903a) later insisted that the
'Trypanosoma fever' symptoms were simply the first stage of full blown sleeping
sickness caused by T. gambiense.
5.1.3 Hypothesis
The analysis that follows tests the hypothesis proposed by Koerner et al. (1995), that
the parasite responsible for sleeping sickness in the Busoga and surrounding regions
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ofUganda from 1901 was due to T.b. rhodesiense. It is based on the examination of
a set of clinical records from the time, and the comparison of the information
obtained from these to recent epidemiological parameters collected in Tororo,
southeast Uganda. In the present day, T.b. gambiense and T.b. rhodesiense are
separated by a clear geographical boundary, that of the western Rift Valley (see
Figure 1.2), and geographical location is a major factor contributing to the
differential diagnosis of both diseases. The essential clinical differences between T.b.
gambiense and T.b. rhodesiense sleeping sickness have been discussed in Chapter I;
typically, T.b. rhodesiense is an acute disease, resulting in death after a period of 3-
12 months (Apted, 1970; Odiit et al., 1997b). T.b. gambiense, on the other hand, is a
chronic infection, with which an individual may continue to go about daily activities
for many months or years (Apted, 1970; Taelman et al., 1987), despite suffering




The Mengo Hospital archives (C.M.S. Mission Hospital at Mengo) which encompass
original patient case notes made by the Cook brothers, are held in the archives
section of the Mulago Hospital/Makerere Medical School in Kampala, Uganda12.
The Mengo Hospital itself is located in a suburb of present day Kampala, and some
of the original buildings remain. The first sleeping sickness case recognized in this
facility was admitted on February 11th 1901.
The geographical distribution of the cases that presented to this hospital is not clearly
defined, but can be surmised from the following "Bed Letter" referring to sleeping
sickness cases and found amongst the archives. It is dated December 1909:
"The area from which the patients have been drawn is a very
large one. Nassa at the south of the Lake has been
mentioned, Nimule, 300 miles to the north (one case),
Nairobi and Kikuyu 400 miles to the East furnished 3
patients, and many came from Busoga, Bunyoro, Toro and
intervening parts. The large bulk of the patients, however,
came from an area of which the centre is Mengo and the
circumference a line drawn around with a radius of 100
miles."
A number of cases that presented to Mengo would not have been recorded in these
archives, especially in the latter years of the epidemic. This was mainly due to the
sheer numbers of patients and the limited resources of the CMS mission. Many were
referred to the specialist hospital run by the Royal Society Sleeping Sickness
Commission in Entebbe, or later to the sleeping sickness isolation camps on islands
in Lake Victoria. Some details of the treatments prescribed and numbers of cases
seen in these camps are available (Hodges, 1902; Cook, 1940), and patient details for
cases seen by the Sleeping Sickness Commission are also available (Bruce et al.,
1903a). In either case, however, the details were not recorded by the Mengo team.
12
Many thanks to Mrs Eunice Sendikadiwa, Makerere Medical School Librarian, for allowing me
access to the archives.
128
An unsuccessful search was carried out for both the archives of the Royal Society
Sleeping Sickness Commission hospital (including at the Royal Society in London)
and the records of the sleeping sickness isolation camps set up on islands on Lake
Victoria. Some of the details of patients seen by the Royal Society Commission can,
however, be found in Bruce et al. (1903a). As early as 1902, J.H. Cook (Cook,
1902) stated that sleeping sickness patients were no longer admitted to the Mengo
hospital as a matter of routine. He also provides, in the same paper, basic
parasitological notes for a number ofpatients, but as these were not admitted, they do
not appear in the database of inpatients. The Mengo archives provide details,
therefore, of only a small sample of sleeping sickness patients at the time. They are




Data were collected from two sources among the Mengo archives, namely the case
notes for each patient and the hospital in-patient register. The case notes provided
full details for each patient, as well as clinical notes taken throughout the course of
the patients' hospital stay. The in-patient register provided only summary details.
For cases admitted prior to 1902, data were only available from this register as all the
case notes prior to 1903 were destroyed in a fire at the end of 1902 (Cook, 1945).
For each patient considered at the time, by the Cook brothers, to have been infected
with sleeping sickness (based either on clinical signs or parasitological diagnosis),
full details as they appeared in the archives were entered to a database (Microsoft
Excel®), which was used for later analyses. This electronic database is available for
consultation from the author and will be made available to the archivist in Mengo.
Full details were entered for patients presenting up to and including 1910; beyond
this time, most patients were referred to the Royal Society hospital, to the sleeping
sickness isolation camps, or turned away. In addition, the authorities were managing
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to bring the epidemic under control, and the number of cases generally was
diminishing.
The case notes and in-patient records were supplemented by additional 'peripheral'
data sources such as personal letters that are also held in the archives. The details of
one early case (case six in the database) were indecipherable from the records, but
appeared in a peer-reviewed publication of the time (Cook, 1901).
5.2.2.2 T.b. rhodesiense comparison
Odiit et al. (1997b) published data on duration of symptoms and case fatality rates
for 30 patients presenting with T.b. rhodesiense to LIRI sleeping sickness hospital in
Tororo between 1988 and 1990. The Odiit et al. (1997b) data are shown in Table
5.1.
Case no. Time in months Case no. Time in months
1 0.25 16 2
2 0.25 17 2
3 0.25 18 2
4 0.5 19 2
5 0.5 20 2
6 0.5 21 4
7 0.75 22 5
8 0.75 23 5
9 0.75 24 6
10 1 25 7
11 1 26 7
12 2 27' 8
13 2 28 11
14 2 29 12
15 2 30 24
Table 5.1: Comparative data (Odiit et al., 1997b) of
duration of illness to death of sleeping sickness patients
in Tororo, 1988-1990.
5.2.2.3 T.b. gambiense comparison
Although a number of published case histories for T.b. gambiense patients are
available (Robinson et al., 1980; Taelman et al., 1987; Petru et al., 1988; Benhamou
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et al., 1989; Otte et al., 1995; Kirchhoff, 1998), there are no published accounts of
time to death following infection with this parasite. Indeed, although Adams et al.
(1986) conducted post-mortems on 16 fatal T.b. gambiense cases, they state that
there are few observed fatal cases in the literature and that duration of illness prior to
death is 'rarely established.' Although survival analysis (see below) can not be
carried out on data where no deaths have occurred, it is possible to compare the
overall time of illness until treatment of the patients described in case reports to those
suffering from other diseases. The T.b. gambiense data are shown in Table 5.2.
Case no. Sex Time infected (months) Reference
1 M 144 Kirchhoff (1998)
2 F 24 Otte et al. (1995)
3 M 36 Robinson et al. (1980)
4 F 25 Petru et al. (1988)
5 M 24 Taelman et al. (1987)
6 F 72 Taelman eta/. (1987)
7 F 38 Taelman et al. (1987)
8 F 13 Benhamou et al. (1989)
Table 5.2: T.b. gambiense cases with reported period of infection
5.2.3 Statistical analyses
5.2.3.1 Survival analysis
A survival analysis (Parmar & Machin, 1995) was conducted to compare the total
time from infection to death of the patients in both 1901-1910 and in Tororo between
1988 and 1990. The criteria for inclusion of a patient from the archive dataset were
that the patient had been recorded as a sleeping sickness death following in-patient
stay in the hospital, that the length of the hospital stay was recorded and that the
length of time of illness prior to admission had been recorded in the clinical notes.
That is, an estimate of the total time of the clinical course of the illness, from onset of
symptoms to death, was available.
Survival analysis is a technique designed to compare times from one point event to
another in a group of subjects (such as time from infection with a pathogen to death
or recovery), and is thus ideally suited to the analysis of the Mengo and Odiit et al.
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(1997b) datasets available in this study (Parmar & Machin, 1995; Altman, 1997). It
may also be useful for the analysis of right-censored datasets, that is, when a
proportion of, say, the patients, do not die and therefore do not present a temporal
endpoint in the analysis. Other forms of statistical analysis deal poorly with this sort
of data. This strength of survival analysis techniques is not exploited in this study, as
the end point, death, is known for all the patients. The variable lengths of time
between onset of symptoms and death never-the-less make it a useful technique. For
data such as the time of illness of T.b. gambiense patients, in which no deaths
occurred, survival analysis is not a valid methodology. Essentially, the probability of
a patient surviving to a given time following the self-reported onset of symptoms is
calculated. The Kaplan-Meier survival estimate S(t), or the probability of surviving
until time t (also called the product-limit estimator), is given by
The expression (l-d,/nt) is evaluated at each occurrence of a death, and S(t) is, in
effect, the product of multiplying this function each time a death occurs. dt is the
number of deaths between time intervals, and n, is the number of patients alive at the
start of a time interval. The survival analysis was conducted in S+ 2000 (MathSoft,
Inc.), and the survival curves were compared using the log-rank (Mantel-Cox) test.
5.2.3.2 Mann-Whitney-t/test
The Mann-Whitney-17 test, conducted in MINITAB version 13.1 (Minitab Inc.), was
used to compare the length of illness until diagnosis of the eight T.b. gambiense
cases to the length of illness until death of the T.b. rhodesiense and Mengo archive
datasets. This test is suited for non-parametric data (Altman, 1997). These patients
were all immigrants or visitors to Europe or the USA and in this study, the date of
infection has been recorded as the date of the last visit to Africa. Cases of congenital






Between 1901 and 1910, 11,767 patients were recorded in the Mengo in-patient
records. This excludes all patients admitted in 1902 as all the records from that year
were destroyed in a fire. Just over 1% of these (204 cases) were sleeping sickness
cases. The age distribution of the sleeping sickness cases is shown in Figure 5.1.
The male:female sex ratio was 3:1. The age-distribution of recent sleeping sickness
cases in Soroti is shown in Figure 3.2. T.b. gambiense studies (Stanghellini &
Duvallet, 1981; Pepin et al., 1994; Meda et al., 1995) have also shown a similar age-
prevalence for that parasite, reflecting similarities in exposure risks to both parasites.
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Figure 5.1: Age distribution of 204 sleeping sickness cases in Mengo
The outcome of admission was biased in favour of discharge (see Figure 5.2). Five
patients were referred to the Entebbe sleeping sickness hospital, and 24 deaths
recorded. Of these 24 deaths, 12 (details shown in Table 5.3) had complete records
of date of admission and death, and of the amount of time ill prior to admission.













Discharged Death Sleeping sickness Sent to Entebbe Left as hopeless Ran away
camp
Outcome
Figure 5.2: Outcome of admission for 204 probable sleeping sickness patients reporting
to the Mengo hospital between 1901-1910.
Months Time in
Approx. sick pre- Admission Date of hospital Time sick pre-
No. Sex age admission date death (months) death (months)
1 M 25 72 11/02/1901 04/06/1901 4 75.77
2 F 11 3 13/02/1901 08/03/1901 0.77 3.77
3 M 30 1 20/04/1901 08/05/1901 0.60 1.60
4 F 10 6 25/04/1901 08/05/1901 0.43 6.43
13 M - 3 29/07/1901 28/08/1901 1.00 4.00
18 M - 3 16/09/1901 19/10/1901 1.10 4.10
26 M 18 0.03 28/06/1903 04/07/1903 0.20 0.23
133 M 20 0.20 23/06/1907 08/07/1907 0.50 0.70
136 M 40 24 03/07/1907 10/07/1907 0.23 24.23
171 F 40 1 24/04/1909 04/05/1909 0.33 1.33
181 M 20 5 01/03/1910 12/03/1910 0.37 5.37
189 M 45 1 09/06/1910 24/06/1910 0.50 1.50
Table 5.3: Time sick pre-admission and total time to death for 12 patients admitted
between 1901 and 1910
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5.3.2 Survival curves
The Kaplan-Meier Survivorship curves resulting from the analysis of this data are
shown in Figure 5.3. The analysis was run twice. Case number 1 in the Mengo
dataset, which had a time until death considerably longer than the other patients, was
included on the first occasion, and excluded on the second. The Tororo 1988-1990
dataset was kept constant in both analyses. The median survival times were 2.0
months, 3.8 months and 3.8 months for the Tororo 1988-1990, Mengo (with the 75
month case) and Mengo (without the 75 month case) datasets respectively.
5.3.3 Log-rank test
The log-rank test showed no significant difference between the Mengo and Tororo
1988-1990 survival rates, when computed with both the 75 month case (x = 1; d.f.
=1, p>0.05) and without (x2 = 0.1; d.f. =1, p>0.05). Therefore, the clinical course
from onset of symptoms to death in this sample of patients from the 1901-1910
epidemic in southern Uganda was not significantly different to that of patients
reporting to LERJ sleeping sickness hospital in Tororo between 1988 and 1990.
5.3.4 Mann-Whitney-I/Test
A significant difference was found between the length of illness until treatment of the
eight T.b. gambiense cases and the length of illness until death of the T.b.
rhodesiense cases (JT=274; /?<0.001) reported by Odiit et al. (1997b). A significant
difference was also found between the eight T.b. gambiense cases and the Mengo
archive cases, both with (W=122; /?<0.05) and without the 72 month case (W=\2\\
p<0.001).
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Figure 5.3: Kaplan-Meier survival curves. Green lines denote S(t), dotted lines are 95%
confidence intervals, calculated by the log-rank method, a) Published data from Odiit et al.
(1997b); Mengo archives relating to the period 1901-1910 including b) 75 month and c)
excluding 75 month case.
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5.4 Discussion
The clinical picture of sleeping sickness, measured in terms of the time to death from
infection, does not differ between the T.b. rhodesiense cases that presented in the last
decade in Tororo (Odiit et al., 1997b) and sleeping sickness cases that presented at
the Mengo Mission Hospital during the period 1901-1910. In addition, the duration
of illness of documented T.b. gambiense cases did differ significantly from both the
Mengo patients and Tororo patients. From this, it can be concluded that the patients
included in the analysis from the 1901-1910 epidemic were probably infected with
trypanosomes belonging to the T.b. rhodesiense sub-species, and that this parasite
was circulating in the region at the time. The hypothesis proposed by Koerner et al.
(1995) appears to be correct.
Given these results, how might the observations made by Castellani (1903), that two
distinct clinical pictures were seen, be explained? The designation as 'Nubians' of
some of the cases he describes (see Section 5.1.2.1) suggests that these patients were
from Sudan. They were migrants, and may well have been carrying T.b. gambiense
parasites with which they were infected before migrating, and which were only
discovered on examination in Uganda. Although local transmission of these
parasites can not be excluded, T.b. gambiense is unlikely to have been responsible
for the widespread deaths in the Busoga region generally. Most of the cases
described by Christy (1903) as he roamed around Uganda were of an acute disease.
Hodges, who was the Medical Officer for the Uganda Protectorate, states, based on a
great many observations at the time, that the time to death of Ugandan patients from
first realising they were sick was between 3-4 months (Hodges, 1902), and that the
total duration of illness rarely exceeded 10 months. T.b. gambiense, if it did exist
concurrently, would have been limited in distribution to those areas where migrant
workers, working for the British authorities, were allowed to settle. These settlement
areas were purposefully designated to be away from tsetse infested bush, in the
efforts to control the epidemic (Anon., 1909).
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Two points for discussion arise from the data themselves. The first, of historical
interest, is that the sex ratio observed in the sleeping sickness patients during 1901-
1910 favours males, possibly indicating greater priority given to males in seeking
health care at the time. Secondly and more importantly, if both species of human
infective trypanosome (T. b. gambiense and T.b. rhodesiense) were present in Uganda
during the 1901-1910 epidemic, and both were presenting at the Mengo hospital, the
data for deaths acquired from the archives would be biased towards clinical
descriptions of T.b. rhodesiense. The comparative data for length of illness until
treatment for T.b. gambiense show that most T.b. gambiense cases are treated before
death occurs (the length of illness to death has proved difficult to come by for this
disease as patients with T.b. gambiense die only rarely in hospital, when they present
with very advanced stages of the disease). For similar reasons, T.b. gambiense
would be poorly represented among deaths in Mengo - patients would have been
discharged as the symptoms would not have been considered serious enough to allow
them to remain in the scarce hospital beds. The case of sleeping sickness that was
included in the analysis that was 72 months ill was possibly such a case that
presented with T.b. gambiense in its final stages. The results of this analysis cannot
therefore exclude T.b. gambiense as a cause of illness among some patients, but can
positively include T.b. rhodesiense as a cause of sleeping sickness at the time. It is
likely that the epidemic was a principally T.b. rhodesiense epidemic with occasional
cases of T.b. gambiense in patients that had migrated from T.b. gambiense foci on the
present north-western border ofUganda (for example, 'Nubians').
5.4.1 Rinderpest and cattle restocking
If, as these data suggest, the 1900-1910 epidemic was in fact due to T.b. rhodesiense,
the question arises as to its causes, and of the cause of the spread of sleeping sickness
through the whole of the region, to previously unaffected areas. There is no doubt
that the onset of the colonial administration in Uganda resulted in social changes and
population mobility (Ford, 1971; Musere, 1990), which also had important
environmental consequences (Ford, 1971). Musere (1990), in particular, is damning
of the colonial powers and the changes they made to the biogeography of southern
Uganda. Lyons (1992), in referring to the causation of T.b. gambiense epidemics in
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central Africa, also blames the disruptive effects of colonization. Human movements
had, however, occurred regularly throughout Africa's history (Koerner, 1994;
Koerner et al., 1995). Some other trigger, in conjunction with these factors, is likely
to have been involved in spreading sleeping sickness from the endemic foci
outwards. This might have been an infectious disease of livestock, rinderpest. The
timing of the start of the sleeping sickness epidemic coincides with the end of the
great rinderpest pandemic in cattle (Ford, 1971; Rossiter, 1994; Reader, 1997).
In the early 1890s, and for the decade that followed, rinderpest, or cattle plague,
ravaged most of Africa, and eastern Africa was not spared (Reader, 1997). Millions
of cattle died from this virulent viral infection (Rossiter, 1994), causing sociological
and ecological upheavals throughout the continent. Rinderpest is rightly often linked
to the sleeping sickness outbreaks in eastern Africa, although possibly for the wrong
reasons. The disease-induced cattle depopulation is thought to have resulted in a
change in the dominant vegetation in the whole region; pasture lands reverted to bush
and the distribution of tsetse expanded (Waller, 1990; Reader, 1997). Although these
ecological changes certainly occurred, they may not have been directly responsible
for the spread of sleeping sickness.
In Chapters II and III, it has been shown that the movement of cattle during livestock
restocking may be linked to the introduction of sleeping sickness to previously
unaffected areas, resulting in serious outbreaks of disease. With the large scale
movements of animals that would have occurred after the rinderpest pandemic, as
animals were moved across ecological zones and traded in the cattle-depopulated
areas, trypanosomes would have been moved with them. In conjunction with the
expansion of tsetse distributions as the ecology changed, the setting was ripe for a
major sleeping sickness problem. Ford (1971) notes that in the setting up of the
Uganda Protectorate, there was a great deal of cattle movements, either for groups
moving away from areas under British control or in search of post-rinderpest pasture.
He also points out that Rhodesia, now Zambia, was restocked after rinderpest, by
trade routes from north of the Zambezi river, and discusses the fact that cattle routes
and the culture of large scale cattle trading over great distances was well established.
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These facts are indicative of great regional cattle movements. T.b. rhodesiense could
have spread from Busoga and other endemic foci in Buganda all around the northern
Lake Victoria shore with the post-rinderpest restocking.
Conventionally, T.b. rhodesiense is thought to have spread through east Africa and to
Uganda from Zambia (MacKichan, 1944). However, the data presented in Chapter
IV and elsewhere (Hide et ai, 1996; Hide et al., 1998) suggest that the parasite
retains a stable genetic constitution through time. Strains from Zambia have been
shown (Hide et al., 1991; Hide et al., 1994) to be quite distinct from T.b. rhodesiense
in Uganda. It is therefore unlikely that the parasite spread from there to Uganda.
Rather, as Koerner et al. (1995) suggested, T.b. rhodesiense has probably been
present, either at endemic or epidemic levels, in southeast Uganda for many
hundreds of years. The results obtained in Chapters II, III and IV explain the spread
of sleeping sickness in present day East Africa; the dynamics of the spread of the
disease have probably been similar since the first association of cattle and humans in





This thesis has explored the epidemiology of sleeping sickness caused by T.b.
rhodesiense in Uganda, and has focussed on the interactions between the parasite
reservoir and humans to explain the spread of the disease. Chapters II-IV examined
the origins of a recent sleeping sickness outbreak in Soroti District, assessing the risk
of introducing parasites to parasite-free areas (as well as assessing methods of
preventing this in the future), observing the geographical spread of the disease from a
point source and suggesting the underlying causes of this spread, and finally
explaining the phylogenetic origins of the parasites involved and examining
trypanosome population structures in the region using molecular epidemiological
techniques. In Chapter V, evidence was presented to support the hypothesis that the
1900-1910 epidemic of sleeping sickness in Uganda was, in part at least, due to T.b.
rhodesiense, which may have spread as a result of the same processes that resulted in
the establishment of sleeping sickness more recently in Soroti.
6.1 Disease spread
T. b. rhodesiense parasites have clearly spread beyond the established endemic foci in
southeast Uganda as a result of the movement of livestock, and have become
established in Soroti. Cattle movements originating in both sleeping sickness-
affected and sleeping sickness-free areas are continuing on a wide scale across
Uganda, well beyond the boundaries of the outbreak described, as part of the national
restocking programme. Sleeping sickness is therefore an actively re-emerging
zoonosis in the region, particularly where livestock, humans and tsetse interact.
Early results from follow-up surveys connected with this thesis (E.M. Fevre, pers.
obs.) have demonstrated that in a village well outside the Serere focus
(approximately 40 kilometres north of the outbreak described in Chapter El), cattle
are carrying SRA positive infections (K. Picozzi, pers. com.). It is likely that these
infections have also been imported with cattle as this area, in parallel to the situation
in Serere before 1998, has never reported sleeping sickness. The results of the
analysis in Chapter II show that, as cattle movements continue through time in other
parts of Uganda, there is a real possibility of importing sufficient human infective
parasites to start further outbreaks. This risk exists anywhere within the tsetse belt
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where cattle movements are ongoing. Control programmes must therefore account
for the potential spread of sleeping sickness, and put in place appropriate
interventions.
6.1.1 Demographic factors: humans and livestock
The analysis of the cattle trade into Soroti and the spatial distribution of sleeping
sickness around Brookes Comer livestock market, is consistent with the hypothesis
that cattle carried human infective trypanosomes into Soroti District; in contrast,
there was no evidence showing that infected humans imported the parasite. In
general terms, population movements, both of livestock and of humans, are
significant risk factors for the spread of directly transmitted and vector-bome
diseases. Human population movements have been identified as significant in the
epidemiology of malaria due to both P. falciparum and P. vivax in the Mekong delta
region of Southeast Asia (Kidson et al., 1999), and have been implicated in the
spread of T.b. gambiense for which the principal reservoir is humans (Jannin et al.,
2001; Sonne, 2001; Moore et al., 2002), although the magnitude of the impact of
these movements on T.b. gambiense epidemiology remains unquantified. Animal
population movements, both domestic and wild, are no less important in the spread
of many other diseases affecting them. For example, Trypanosoma evansi may have
spread through the Philippines with movements of buffalo in livestock breeding
programmes (Reid, 2002); elimination of rabies in the European fox population has
encountered setbacks due to the mobility of foxes across national borders
(Breitenmoser et al., 2000); foot-and-mouth disease is thought to have spread rapidly
in the UK during 2001 partly as a result of the large-scale movements of domestic
livestock (Woolhouse et al., 2001a); the introduction of beef animals to dairy herds is
thought to be a factor in the genesis of outbreaks of bovine tuberculosis caused by
Myobacterium bovis (Marangon et al., 1998). Understanding the demography of
human and livestock populations and other reservoirs of re-emerging and zoonotic
diseases is fundamental to understanding the epidemiology of these diseases.
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6.2 Disease prevention
Vector control in the form of fly trapping was undertaken at the very start of the
outbreak in Serere, and while such activities remain an important option for sleeping
sickness control in the area, they may not be cost effective to maintain in the
resource-poor rural communities affected by sleeping sickness. In particular, the cost
of extending vector control over a larger area may become prohibitive and
unsustainable. Sleeping sickness in Serere may now have spread far enough from
Brookes Corner market to make this the case even there. In Uganda, the cost of one
impregnated tsetse trap is approximately US$ 15 using imported materials and US$ 7
using local materials (B. Dransfield, pers. com.), and ten traps are required for each
square kilometre to be effective at reducing fly densities sufficiently to interrupt
sleeping sickness transmission during an epidemic (Lancien, 1991). Okoth et al.
(1991) have demonstrated some limited success with community-based tsetse
trapping interventions in Tororo using local materials, but these are unlikely to ever
achieve the extensive coverage required. Other wide-area methods for tsetse control,
such as the release of sterile male flies, may be successful in confined areas (IAEA,
1997), but are unlikely to present a cost-effective and sustainable solution for long-
term disease management (Molyneux, 2001a), in terms of both livestock and human
trypanosomiasis. Pour-on insecticides, targeted at tsetse but applied to cattle, are
another potential control option in some settings. This method of control is
expensive, however (Kamau et al., 2000), and may not always be effective at
reducing trypanosome prevalence over large areas (Rowlands et al., 2001). In
particular, the effective long-term use of pour-ons has been shown to require
coverage of an unsustainably high proportion of the cattle population (Okiria et al.,
2002).
6.2.1 Treatment of cattle
The treatment of cattle is an important option for preventing the importation to, and
transmission of human infective parasites in unaffected areas. Control strategies such
as the obligatory testing and treatment of cattle with a single curative dose of a
trypanocide prior to sale in markets have been evaluated in terms of risk reduction in
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Chapter II, and more generally by Welburn et al. (2001a). A major trade-off to
consider is the potential adverse effect such a strategy would have on the selection of
drug resistance on the one hand (see Section 6.2.2, below) and the benefits of animal
treatments as a public health prevention measure, in terms ofDALYs averted, on the
other. The DALY impact of T.b. rhodesiense sleeping sickness was highlighted in
Chapter I, and any intervention that might substantially reduce the disease burden
should be given consideration. Treating cattle would have the added effect of
improving animal health by clearing other, non human-infective trypanosomes of
livestock such as Trypanosoma vivax and T. congolense. A full cost-effectiveness
analysis of the possible interventions is required and must thus consider both medical
and veterinary inputs and outcomes. Cost-effective prevention strategies are a
necessity in countries such as Uganda where human and animal health services are
increasingly decentralised and where few funds are available generally for health
improvement activities (Jeppsson & Okuonzi, 2000; Jeppsson, 2001; Bossert &
Beauvais, 2002). Molyneux (2001b) highlights the conflict between the trend
towards decentralisation and the need for a vertical approach to sleeping sickness
control.
Interventions aimed at domestic livestock which ultimately improve human health
are also relevant in other contexts. Hewitt and Rowland (1999) and Rowland et al.
(2001) treated cattle with deltamethrin pour-on insecticides to prevent transmission
of malaria by zoophilic mosquitoes in peridomestic habitats in Pakistan, and the
effective control of schistosomiasis caused by Schistosoma japonicum may depend,
in some areas, on control of the parasite in the cattle reservoir (Guo et al., 2001).
Understanding the biology and epidemiology of zoonotic diseases in their reservoir
hosts (Cleaveland et al., 2001; Woolhouse et al., 2001b) is essential to the
appropriate design of public health interventions and disease control programmes.
The implementation of integrated control, targeting cattle, humans and possibly
tsetse, would benefit from co-ordination between veterinary and medical authorities,
and such intersectorial collaborations, leading to improved human and animal health,
would contribute generally to rural development in tsetse infested countries across
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East Africa. Some of the findings of this thesis (Fevre et al., 2001) have already led
to a potential implementation of a control policy - that cattle from sleeping sickness
risk areas should be treated prior to migration as part of restocking activities (Wendo,
2002). Although it remains unclear what treatment regimens might be used, the
initial suggestion is for the farmers or traders involved in restocking to pay for these
treatments themselves.
6.2.2 Drug resistance
The development of drug resistance threatens the effective control ofmany diseases,
such as tuberculosis, HIV/AIDS and malaria. Mass treatment, advocated as a useful
trypanosomiasis control tool in Chapter II, is one of the many ways by which drug
resistance may be selected. For example, mass treatment of P. falciparum malaria
through chloroquinized salt in Cambodia in the early 1960s (Verdrager, 1986) may
have provided the appropriate conditions for resistance to chloroquine to develop.
Geerts et al. (2001) argue that preventing drug resistance in animal trypanosomes
may in fact depend on limiting treatments to clinical cases, as mass treatment of
herds may impose a strong selection pressure on the trypanosome population
(Matovu et al., 2001b). The potential impacts ofmass drug use on trypanosome drug
resistance in Uganda need therefore to be considered in the formulation of control
policies. Drug resistance mechanisms are poorly understood for the trypanosomes
(Barrett, 2001); there is evidence in laboratory strains, however, to suggest that there
may be cross-resistance between diminazene (drug of choice for therapeutic - rather
than prophylactic - treatment of cattle) and melarsoprol (most significant drug for
late stage sleeping sickness, especially due to T.b. rhodesiense), as the mode of
uptake of both compounds by trypanosomes is similar (Barrett & Fairlamb, 1999).
In both cases, uptake of the drugs is through an amino-purine transporter across the
trypanosome membrane (termed the P2 transporter), first described by Carter and
Fairlamb (1993).
If anti-trypanocidal drugs are used appropriately and in a controlled manner during
mass drug administration, the impact on the development of drug resistance would be
limited while the reduction in the risk of spreading human infective parasites to
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previously non-sleeping sickness areas within the Ugandan tsetse belt would be
substantial. This requires, as already mentioned, collaboration between medical and
veterinary sectors in the formulation of policy. A field diagnostic test based on the
presence of the SRA gene or the protein product for which it codes (Welburn et al.,
2001b), would be of great value in this context, as animals carrying T.b. rhodesiense
could be targeted selectively in livestock markets, further reducing the selection
pressure that could result from the use ofmass treatments.
6.3 The way ahead
Research on disease control and prevention must continue in those regions of
Uganda that lie within the tsetse belt and that are currently, or scheduled to be,
involved in restocking activities. Monitoring of cattle movements, and an in-depth
understanding of the economic and social factors that drive the cattle trade from one
region to another are necessary, both during and outwith periods of restocking. In
addition, the risk of future outbreaks must be assessed in conjunction with landuse
issues, by building a geographical information system in which economic variables,
human and cattle demography and landuse come together. Sentinel sites, such as key
cattle markets, might be identified for long term monitoring of infections in the
highly mobile cattle population. Satellite imagery analysed in a geographical
information system is an important epidemiological tool (Beck et al., 1994; Pope et
al., 1994; Thomson et al., 1999; Beck et al., 2000; Zhou et al., 2001), in particular in
relation to landuse and vector-bome disease risk. Assessing trypanosomiasis risk by
seeking associations between disease prevalence and remotely sensed variables has
already been carried out at a continental scale (Rogers & Williams, 1993; Rogers,
2000), and on a regional scale (Robinson et al., 1997; Robinson, 1998; Hendrickx,
1999; Hendrickx et al., 2001), mainly using entomological parameters. Local scale
work using remotely sensed satellite imagery and detailed geo-referenced databases
has been successful in Burkina Faso, in assessing the risk from animal
trypanosomiases (de la Rocque, 1997; de la Rocque et al., 1999; Michel et al., 1999).
Combining the technologies used for large-scale and local-scale studies would
provide new insights into the epidemiology of both human and animal
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trypanosomiasis in Uganda and other East African trypanosomiasis foci. In
particular, predicting the spread of the parasite and the local expansion of foci in
newly affected areas would be of value to public health initiatives.
6.3.1 The immediate future
Areas of Uganda of particular concern with regard to the future spread of T.b.
rhodesiense sleeping sickness include the districts of Lira, Apac and Masindi on the
northern side of Lake Kyoga (see Figure 1.4). Masindi may already be affected;
Enyaru et al. (1999) passaged one trypanosome isolate derived from a human in
Masindi through mice, and on the basis of the short pre-patent period and novel
isoenzyme profile concluded that the parasite was T.b. rhodesiense. The identity of
this parasite isolate has not yet been confirmed using the SRA methodology (Welburn
et al., 2001b). It remains, however, that the Lake Kyoga basin, which is well within
the G. f. fuscipes fly belt (see Figure 3.6), and where extensive cattle movements are
occurring, presents an area for possible spread of T.b. rhodesiense. Masindi and Lira
are of particular interest as they border the T.b. gambiense focus in north western
Uganda, and the spread of T.b. rhodesiense to this area would result in mixing of T.b.
rhodesiense and T.b. gambiense in the same human population and transmitted by
the same fly population. This could have serious implications, not least because of
the different control policies required for the different diseases. Other than the
possible co-habitation of the sub-species during the 1901-1910 epidemic (see
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Summary
Background The expansion of sleeping sickness caused by
Trypanosoma brucei rhodesiense beyond its traditional focus in
southeast Uganda has been linked with large-scale livestock
restocking. To assess the risk presented to the human
population by domestic livestock, human-infective
T b rhodesiense must be distinguished from non-human-
infective T brucei brucei, since both parasites can be present
in cattle. We investigated the use of a simple genetic marker
to characterise parasites collected from cattle in villages within
the new sleeping sickness focus in Soroti District, Uganda.
Methods 70 T brucei si samples of known human infectivity
status collected from human beings and cattle in Tororo
District, Uganda, from 1989 to 1991 were screened for the
presence of the human-serum-resistance-associated (SRA)
gene by conventional PCR. In 2000-01, blood samples from
200 randomly selected cattle in six villages and two markets
in Soroti District were screened for T brucei si parasites by
PCR; positive samples were screened for the presence of
the SRA gene.
Findings The SRA gene was present in all 29 samples from
patients with sleeping sickness in Tororo District. Of the 41
samples collected from cattle at the same time, the SRA
gene was present in the eight samples that tested resistant
to human serum in vitro, whereas it was absent from all 33
isolates that were sensitive to human serum in vitro. Of the
200 cattle sampled in Soroti District, we estimated that up
to 18% (95% CI 12-23) were infected with T b rhodesiense.
Interpretation Detection of the SRA gene could provide the
basis for a simple diagnostic test to enable targeted control
of T b rhodesiense in the domestic livestock reservoir,
thereby reducing the public-health burden of sleeping
sickness in east Africa.
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Introduction
Sleeping sickness is endemic in east Africa and has, in the
past, given rise to epidemics on a large scale. At the turn
of the past century, more than 500 000 people are
estimated to have died during an epidemic in southeast
Uganda.' Sleeping sickness, caused by Trypanosoma brucei
rhodesiense and transmitted by the tsetse fly, is fatal if not
treated. Drug treatment can be associated with severe
side-effects, and up to 5% of people die as a result of
chemotherapy.2 The disease continues to incur a
significant public-health burden in sub-Saharan Africa,
and a more in-depth understanding of its epidemiology is
necessary for the development of appropriate control
methods.
In southeast Uganda, domestic livestock are known to
be a reservoir of human infective T b rhodesiense.1 The
ability of cattle to maintain human infective
trypanosomes for long periods poses a serious threat to
the health of rural people at a time when increased use of
cattle is desperately needed to intensify rural
productivity.
During the past 2 years, there have been serious
concerns about the spread of sleeping sickness to areas
previously free of the disease—ie, north of the traditional
disease focus in southeast Uganda. In December, 1998, a
case of human sleeping sickness was detected in Soroti
District, Teso region, for the first time.4 Since then, the
disease has spread 25 km from the original focus, and
caused more than 150 recorded cases (which probably
represents only a small proportion of those truly affected,
many of whom almost certainly did not present for
treatment). A study in which hospital records were used
to map the spread of the disease indicated that early cases
were centred on the main cattle market, suggesting that
restocking of cattle was responsible for the spread of
sleeping sickness.4 The restocking of livestock in Teso has
been identified as a central activity for the development of
the region.
Calculation of the extent of T b rhodesiense carriage in
cattle is difficult because the parasite that causes human
disease is morphologically, serologically, and biochemically
identical to another parasite, T brucei brucei, which is
symptomless in animals but which cannot infect humans.
Survival in human serum forms the basis of
distinguishing human infective T b rhodesiense from non-
infective T b brucei. Laboratory tests to distinguish the
two are based on analysis of DNA (restriction-fragment-
length polymorphism [RFLP] analysis) and in-vitro
assays of serum sensitivity (human serum resistance
[HSR] test).57 These methods are laborious, time
consuming, and impractical for application to the field
situation. The molecular differences between human
infective T b rhodesiense and non-infective T b brucei are
still not clearly understood, but ectopic expression of the
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human-serum-resistance-associated (SRA) gene has been
found to allow T b brucei to survive exposure to normal
human serum." The discovery of a gene that confers
resistance to human serum offers the prospect of a simple
one-step diagnostic test for T b rhodesiense.
We aimed to validate the SRA gene as a diagnostic
indicator of T b rhodesiense, and to apply the diagnostic
test to calculate the prevalence of T b rhodesiense in the
cattle population at the centre of the recent sleeping
sickness outbreak in Soroti District.
Methods
70 T brucei si isolates were collected from sleeping sickness
patients and cattle in an endemic focus of T b rhodesiense
sleeping sickness in Tororo District, southeast Uganda,
between 1988 and 1991 as previously fully described."
Genomic DNA was prepared from all 70 isolates (29
human and 41 cattle). An in-vitro HSR test" was done on
all cattle isolates, and RFLP analysis was done on all catde
isolates and 16 of the human isolates." Cluster analysis'"
assigned the RFLP-analysed samples to ten groups:
groups 1-9 comprised T b brucei, and group 10
T b rhodesiense.6
During 2000-01, we sampled 200 randomly selected
cattle from six villages and two markets within a 25 km
radius of Brooks Corner market—the epicentre of the
sleeping sickness outbreak in Soroti District."
For the Tororo District isolates, 1 mL samples of
trypanosomes that had previously been cryopreserved"
were thawed and centrifuged at 6000 rpm in a microfuge
for 5 min. The pellet was then resuspended in 200 p,L
phosphate-buffered saline. Genomic DNA was isolated
by use of the QIAamp DNA Blood MiniKit (Qiagen,
Crawley, UK); DNA was eluted in TE buffer.
For the Soroti District samples, DNA was prepared
directly from cattle blood. Genomic DNA was isolated
from heparinised blood by use of DNAzol BD Reagent
(Invitrogen, Groningen, Netherlands) and resuspended
in TE buffer.
Primers used to amplify species-specific DNA targets
for T brucei si were as follows: TBR 1 and 2," Orphon 1
and 2,12 and Museq 1 and 2." The concentrations of each
primer pair were 0-4, 0-2, and 0-8 pmol/L respectively.
The amplification programmes were as follows: TBR (30
cycles) 94°C for 30 s, 60° C for 60 s, and 72°C for 30 s;
Orphon (40 cycles) 94°C for 30 s and 68°C for 90s;
Museq (30 cycles) 94°C for 60 s, 60°C for 60 s, and
72°C for 60 s. PCR products were visualised by
electrophoresis through 1-5% (w/v) agarose containing
0-5 mg/L ethidium bromide.
All isolates from Tororo and Soroti districts were first
confirmed as T brucei si by established PCR
techniques," "and were screened for the presence of the
SRA gene.14 The specificity of the SRA screening assay
was dependent on the design of the primers and on the
length of the amplification product. The T brucei genome
contains variable surface glycoprotein genes that have
some sequence identity with SRA. Compared with these
variable surface glycoprotein genes, SRA has an internal
deletion of 378 bp that encodes the central part of the
variable surface glycoprotein N-terminal domain. The
PCR primers were designed to amplify across this
deletion and thus distinguish the SRA product (743 bp)
from any SRzf-related variable surface glycoprotein
(1121 bp).
Amplification of the SRA gene was done with primers
B537 (CCATGGCCTTTGACGAAGAGCCCG) and
B538 (CTCGAGTTTGCTTTTCTGTATTTTTCCC)
at 2 p,mol/L. The primers were based on the published
SRA gene sequence (EMBL accession number
AF097331)." The amplification programme was
dependent on the source material: DNA purified from
Tororo samples, enriched for parasite DNA by mouse
passage, was amplified through 30 cycles of 94°C for
45 s, 55°C for 45 s, and 72°C for 90 s; DNA isolated
directly from cattle blood from Soroti contained
predominantly bovine DNA and was amplified through
10 cycles 94°C for 20 s, 55°C for 30 s, and 72°C for 60 s,
followed by 25 cycles of 94°C for 20 s, 63-8°C for 30 s,
and 72°C for 60 s (the time at 72°C was increased by 2 s
per cycle). Routinely, 25 p.L reaction volumes were used,
which contained either 1-25 U TaqBead Hot Start
polymerase (Promega, Southampton, UK) or a
combination of 1 U HotStarTaq DNA polymerase
(Qiagen) supplemented with 1 U Pfu polymerase
(Promega) and 4 mmol/L MgCl2. In each individual
experiment, positive controls for T b brucei, T b rhodesiense,
and T b gambiense were used. The identity of the PCR
product was confirmed by cloning directly into the
plasmid pGEM-T Easy (Promega), and sequencing at the
Molecular Genetics Analysis Facility, Ninewells Hospital,
Dundee, UK. All SRA PCR products sequenced
contained intact open reading frames and had more than
99% identity with the Genbank SRA sequence.
Results
The results of the various characterisation analyses done
on the 70 isolates from Tororo District are shown in the
table. The SRA gene was present in all isolates that were
positive in the HSR tests, and absent from all the samples
that were negative in these tests. All 29 isolates from
human beings with sleeping sickness were positive for the
SRA gene. Additionally, eight isolates from cattle that were
shown to be resistant to human serum in vitro were also
positive for SRA. The SRA gene was absent from all 33
cattle isolates that were sensitive to human serum in vitro.
Of the 200 cattle sampled in Soroti District, 89 (45%)
tested positive for the presence of T brucei si by PCR. Of
these, the DNA from 45 cattle were sufficiently well
preserved to be screened for the SRA gene, and 18 of
these 45 (40%) were SRA positive and therefore
characterised as T b rhodesiense. The minimum
prevalence of SRA was 9% (18 of 200; 95% CI 5-13).
However, assuming that the SRA gene was present in the
same proportion of those 44 samples from cattle infected
with T brucei si but not screened for the SRA gene, the
prevalence of T b rhodesiense in cattle was estimated to be







Group 10 16f iot
Groups 1-9 0 31
PCR detection of SRA
Positive 29 8*
Negative 0 33
HSR=human serum resistance. RFLP=restriction-fragment-length polymorphism.
•The same eight cattle isolates were human-serum resistant in vitro and SRA
positive. tOnly 16 of the 29 human isolates were RFLP analysed. tThe two
cattle isolates assigned by RFLP to group 10 were human-serum sensitive in
vitro and SRA negative.
Comparison of screening for the SRA gene by PCR analysis
with characterisation by isolation from a human being, the
HSR In-vitro test, and RFLP analysis of 70 T brucei si isolates
from Tororo District, Uganda
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Discussion
Aside from isolation directly from human beings,
trypanosome sensitivity to human serum is regarded as the
benchmark for human infectivity. We have shown that in-
vitro HSR and SRA test results for the previously
characterised Tororo District samples were identical. The
presence of the SRA gene seems to be sufficient within the
southeast Uganda sleeping sickness focus to discriminate
between T b rhodesiense and T b brucei.
If expression of SRA is necessary to confer resistance to
human serum," detection of the SRA gene in cattle isolates
that were phenotypically resistant to human serum in vitro
is suggestive of continued gene expression even outside the
human host. The results described here contain a minor
inconsistency with the findings of Hide and colleagues."
Previously, two isolates from cattle (Tira 68 and Tira 17)
had been grouped with the human-serum-resistant
genotypes by RFLP analysis despite being sensitive to
human serum in vitro. The finding here that these two
isolates do not contain the SRA gene is consistent with the
serum sensitivity test and also with minisatellite data
analysis that suggested these same two stocks were not
human-serum resistant," and that they are T b brucei.
Application of the SRA test to recent field samples
from an active sleeping sickness focus suggested that
up to 18% of domestic cattle within the focus are
now infected with human infective T b rhodesiense. These
results are consistent with the finding that cattle are the
major reservoir of human sleeping sickness in eastern
Uganda. Moreover, the results underline findings that
movement of infected animals is more important than
migration of infected human beings in the spread of
sleeping sickness throughout tsetse-infested areas.4
Uganda is the only country to have endemic foci of both
infectious agents of sleeping sickness, T b rhodesiense and
T b gambiense.' The recent re-emergence of both forms of
sleeping sickness across sub-Saharan Africa" and the geo¬
graphical spread of T b rhodesiense4 suggest that there could
be overlap between T b gambiense, which is believed to be
predominantly anthroponotic, and T b rhodesiense in
Uganda. In the event of such overlap, testing for the SRA
gene, which is absent in T b gambiense,14 will be invaluable
in ensuring that inappropriate treatments are not
prescribed (the drugs for late stage-sleeping sickness differ
for the two forms of the disease).'" In light of the findings
presented here, we are in the process of sampling domestic
livestock across Uganda and other sleeping-sickness foci
across east Africa to determine the spatial distribution of
T b rhodesiense.
The central role of cattle in the spread and persistence
of T b rhodesiense sleeping sickness provides important
opportunities for human disease control by targeting the
animal reservoir, for example through chemotherapy.4
Affordable and effective veterinary trypanocides are readily
available and widely used throughout Africa. However, the
emergence of drug resistance is an increasing problem.1" If,
as recently suggested, the mechanism for resistance to the
major veterinary drug diminazene is similar to that
involved in resistance against the human drug melarsoprol,
widespread veterinary drug use could affect animal health
and public health.20 The use of SRA detection as a
diagnostic tool provides the opportunity to target drug use
to cattle infected with T b rhodesiense, thereby reducing the
transmission of the parasite to human beings while keeping
the potential for drug resistance to a minimum. We
suggest that efforts should be directed at the development
of appropriate diagnostic and control strategies that take
into account the risk presented by the animal reservoir and
the opportunity that SRA screening presents.
Contributors
The study was conceived by S C Welburn, P G Coleman, and I Maudlin.
The Tororo District samples were collected by I Maudlin, S C Welburn,
and M Odiit. The Soroti District survey was developed by S C Welburn,
P G Coleman, and E M Fevre, and carried out by E M Fevre and
K Picozzi. Molecular analysis was done by S C Welburn, M Carrington,
K Picozzi, and E M Fevre. All investigators were responsible for
manuscript preparation.
Acknowledgments
We thank Ian Anderson, Joseph Magona, Aimee Tilley, and
Vinutha Gowda for assistance with the field sampling in Soroti district.
This study was part of a project funded by the UK Department for
International Development (DfID) for the benefit of developing countries
(SCW, EMF, PGC, MO and IM). EMF is also supported by the UK
Medical Research Council. SCW and MC are funded by the Wellcome
Trust and Leverhulme Trust.
References
1 Koerner T, de Raadt P, Maudlin I. The 1901 Uganda sleeping sickness
epidemic revisited: a case of mistaken identity? Parasitol Today 1995;
11: 303-05.
2 Odiit M, Kansiime F, Enyaru JCK. Duration of symptoms and case
fatality of sleeping sickness caused by Trypanosoma brucei rhodesiense in
Tororo, Uganda. EastAfrMedJ 1997; 74: 792-95.
3 Welburn SC, Fevre EM, Coleman PG, Odiit M, Maudlin I.
Sleeping sickness: a tale of two diseases. Trends Parasitol 2001; 17:
19-24.
4 Fevre EM, Coleman PG, Odiit M, Magona JW, Welbum SC,
Woolhouse MEJ. The origins of a new Trypanosoma brucei rhodesiense
sleeping sickness outbreak in eastern Uganda. Lancet 2001; 358:
625-28.
5 Hide G, Cattand P, Leray D, Barry JD, Tait A. The identification of
Trypanosoma brucei subspecies using repetitive DNA sequences.
Mol Biochem Parasitol 1990; 39: 213-26.
6 Hide G, Welburn SC, Tait A, Maudlin I. Epidemiological relationships
of Trypanosoma brucei stocks from South East Uganda: evidence for
different population structures in human infective and non-human
infective isolates. Parasitology 1994; 109: 95-111.
7 Hide G, Angus SD, Holmes PH, Maudlin I, Welburn SC.
Trypanosoma brucei: comparison of circulating strains in an endemic
and an epidemic area of a sleeping sickness focus. Exp Parasitol 1998;
89: 21-29.
8 Xong HV, Vanhamme L, Chamekh M, et al. A VSG expression site-
associated gene confers resistance to human serum in Trypanosoma
rhodesiense. Cell 1998; 95: 839-46.
9 Brun R, Jenni L. Human serum resistance ofmetacyclic forms of
Trypanosoma brucei brucei, T brucei rhodesiense and T brucei gambiense.
Parasitol Res 1987; 73: 218-23.
10 Hide G, Tait A. The molecular epidemiology of parasites. Experientia
1991; 47: 128-42.
11 Artama WT, Agey MW, Donelson JE. DNA comparisons of
Trypanosoma evansi (Indonesia) and Trypanosoma brucei spp.
Parasitology 1992; 104: 67-74.
12 de Almeida PP, Ndao M, Van Meirvenne N, Geerts S. Diagnostic
evaluation of PCR on dried blood samples from goats experimentally
infected with Trypanosoma brucei brucei. Acta Trop 1998; 70: 269-76.
13 Kabiri M, Franco JR, Simarro PP, Ruiz JA, Sarsa M, Steverding D.
Detection of Trypanosoma brucei gambiense in sleeping sickness suspects
by PCR amplification of expression-site-associated genes 6 and 7. Trop
Med Int Health 1999; 4: 658-61.
14 de Greef C, Imberechts H, Matthyssens G, Van Meirvenne N,
Hamers R. A gene expressed only in serum resistant variants of
Trypanosoma brucei rhodesiense. Mol Biochem Parasitol 1989; 36:169-76.
15 Milner JD, Hajduk SL. Expression and localization of serum resistance
associated protein in Trypanosoma brucei rhodesiense. Mol Biochem
Parasitol 1999; 104: 271-83.
16 MacLeod A, Tweedie A, Welbum SC, Maudlin I, Turner CMR,
Tait A. Minisatellite marker analysis of Trypanosoma brucei:
reconciliation of clonal, panmictic, and epidemic population genetic
structures. Proc Natl Acad Sci USA 2000; 97: 13442-47.
17 Smith DH, Pepin J, Stich AHR. Human African trypanosomiasis: an
emerging public health crisis. BrMed Bull 1998; 54: 341-55.
18 Van Nieuwenhove S. Present strategies in the treatment of human
African trypanosomiasis. In: Dumas M, Bouteille B, Buguet A, eds.
Progress in human African trypanosomiasis, sleeping sickness. Paris:
Springer, 1999: 235-80.
19 Geerts S, Holmes PH, Diall O, Eisler MC. African bovine
trypanosomiasis: the problem of drug resistance. Trends Parasitol 2001;
17: 25-28.
20 Barrett MP. Veterinary link to drug resistance in human African
trypanosomiasis? Lancet 2001; 358: 603-04.
THE LANCET • Vol 358 • December 15, 2001 2019
For personal use. Only reproduce with permission from The Lancet Publishing Group
ARTICLES
The origins of a new Trypanosoma brucei rhodesiense sleeping
sickness outbreak in eastern Uganda
E M Fevre, P G Coleman, M Odiit, J IV Magona, S C Welburn, M E J Woolhouse
Summary
Background Sleeping sickness, caused by two trypan-
osome subspecies, Trypanosoma brucei gambiense and
Trypanosoma brucei rhodesiense, is a parasitic disease
transmitted by the tsetse fly in sub-Saharan Africa. We report
on a recent outbreak of T b rhodesiense sleeping sickness
outside the established south-east Ugandan focus, in Soroti
District where the disease had previously been absent.
Soroti District has been the subject of large-scale livestock
restocking activities and, because domestic cattle are
important reservoirs of T b rhodesiense, we investigated the
role of cattle in the origins of the outbreak.
Methods We identified the origins of cattle entering the
outbreak area in the 4 years preceding the outbreak. A
matched case-control study was conducted to assess
whether the distance of villages from the main market
involved with restocking was a risk factor for sleeping
sickness. We investigated the spatial clustering of sleeping
sickness cases at the start of the outbreak.
Findings Over 50% (1510 of 2796) of cattle traded at the
market were reported to have originated from endemic
sleeping sickness areas. The case-control study revealed that
distance to the cattle market was a highly significant risk factor
for sleeping sickness (p<0-001) and that there was a
significant clustering of cases (27 of 28) close to the market at
the start of the outbreak (p<0-001). As the outbreak
progressed, the average distance of cases moved away from
the cattle market (0-014 km per day, 95% CI 0-008-0-020 km
per day, p<0-001).
Interpretations The results are consistent with the disease
being introduced by cattle infected with T b rhodesiense
imported to the market from the endemic sleeping sickness
focus. The subsequent spread of the disease away from the
market suggests that sleeping sickness is becoming
established in this new focus. Public health measures
directed at controlling the infection in the animal reservoir
should be considered to prevent the spread of sleeping
sickness.
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Introduction
Sleeping sickness is a parasitic disease, unique to sub-
Saharan Africa, imposing a considerable public health
burden on affected rural populations.' Two protozoan
subspecies, Trypanosoma brucei rhodesiense and
Trypanosoma brucei gambiense, both transmitted by the
tsetse fly (Glossina spp), cause the disease, which is fatal if
not treated. Uganda is the only country to have endemic
foci of both parasites, T b gambiense in the north-west and
T b rhodesiense in the south-east of the country.13 A new
T b rhodesiense sleeping sickness outbreak has been
identified in an area outside the established focus.
The spatial distribution, pathogenesis, and epi¬
demiology of sleeping sickness caused by the trypanosome
subspecies differ notably.4 T b gambiense tends to occur in
western and central Africa, causing a chronic infection
that can last several years. T b rhodesiense infections, by
contrast, are restricted to eastern Africa and are
characteristically acute, with untreated cases dying within
3-6 months of infection.' An animal reservoir is
considered essential to the long-term persistence of
T b rhodesiense sleeping sickness,6,7 while the importance of
a non-human reservoir in the epidemiology of
T b gambiense is less certain.' Evidence from studies
conducted in south-east Uganda implicates domestic
livestock, particularly cattle, as the principal reservoir of
T b rhodesiense parasites.7-'
Data from previous studies in south-east Uganda,
where Glossina fuscipes fuscipes is the vector, reported the
prevalence of T brucei species in the domestic cattle
population to be 5%, and of these, 23% were human
infective T b rhodesiense.'' Neither T b brucei nor
T b rhodesiense are pathogenic to cattle. These data also
showed that a tsetse fly was five times more likely to pick
up an infection from a cow than from a human.
There have been three major epidemics of sleeping
sickness recorded in south-east Uganda since the 1890s.10
The documented geographic extent of T b rhodesiense
transmission in this region has, however, remained fairly
unchanged for the past century, with cases confined to the
area extending east of Kampala up to the Kenyan border,
north of Lake Victoria and south of Lake Kyoga
(figure 1). In late December, 1998, however, the first
reports of local sleeping sickness transmission outside this
area, in Soroti District, were recorded.
Soroti District lies to the north of the established
T b rhodesiense focus in the south-east of the country.
Although large tracts of the district were thought to be
infested with the tsetse vector G f fuscipes, before
December, 1998, only one case of sleeping sickness was
recorded in the district in the mid-1960s." However,
follow-up investigations concluded that this case most
likely acquired the infection in the endemic area to the
south. The first case in the present Soroti District
outbreak was reported on Dec 31, 1998, and after
identification of G f fuscipes in the area, tsetse control
measures were implemented from February to July, 1999.
Despite these measures, the outbreak persisted, and
between Dec 31, 1998, and June 2, 2000, a total of 119
cases were recorded.
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Figure 1: The study area In Soroti district, central Uganda
Locations of case villages (red circles) and control villages (blue squares)
are shown in relation to Brookes Comer livestock market (black star) and
Serere Health Centre (black cross). The size of the circles/squares
marking the case and control villages is proportional to the number of
patients from that village (classes for circle/square size are 1, 2-3, 4-5,
6-8, and 9-13 patients). Dark blue represents Lake Kyoga, light blue
areas of swamp. Inset: districts in Uganda showing Soroti (hatched) and
the established focus in south-east Uganda (speckled).
Understanding what triggered the Soroti District
outbreak is important in both controlling the current
outbreak, and preventing future outbreaks in other tsetse-
infested but disease-free areas. Soroti experienced a
period ofmajor civil unrest at the end of the Ugandan civil
war in 1979, leading to mass movement of people and
livestock out of the district. More recendy, since the
return of civil stability, there has been a net migration of
people back into the region and Soroti District has been
the target of major rural development activities financially
supported by both foreign donors and the Ugandan
government. Central to these rural development activities
have been large-scale cattle restocking programmes,
undertaken without any surveillance of trypanosome
prevalence in the cattle moved in the restocking exercise.
Our investigations of the origin of the Soroti District
outbreak centred on the role of the domestic livestock
reservoir. We investigated the hypothesis that the
outbreak resulted from the importation of cattle infected
with T b rhodesiense into Soroti District from the sleeping
sickness endemic area to the south, leading to local
transmission around the main cattle market, Brookes
Corner market. We aimed to identify the origin of cattle
imported into Soroti District and traded at Brookes
Corner market, and using a matched case-control study
assess the distance from Brookes Corner market as a risk
factor for sleeping sickness, and detect spatial clustering of
sleeping sickness cases over the initial period of the
outbreak before any control activities.
Methods
Determination of cattle origins
District veterinary officials routinely recorded the district
of origin, as well as the owner of each animal traded at
Brookes Corner market. These written market records
were cross-checked for the 4 years (April, 1995, up to and
including December, 1998) preceding the current
outbreak by consultation with traders and officials at
Brookes Corner market.
Case-control study
We did a retrospective matched case-control study in
June, 2000 to investigate whether the distance to Brookes
Corner market was a risk factor for sleeping sickness.
All 119 sleeping sickness cases recorded between Dec 31,
1998, and June 2, 2000, came from within the catchment
area of Serere Health Centre (figure 1). We recruited
patients with sleeping sickness with complete records
detailing age, sex, date of admission, and village of
residence at time of contracting the disease. A total of 113
(mean 29-8 years, SD 19-9 years, 60% male) of 119
patients with sleeping sickness met these selection criteria.
Detailed patient histories of all 119 patients revealed that
none had a history of travel outside Soroti District during
the likely time at which the infection was contracted.
Each case was matched with one control by age (<1,
1-9, 10-14, 15-19, 20^19, 50-64 and 3=65 years), sex
and month of admission to Serere Health Centre. Patients
diagnosed with any vector-borne disease were excluded,
given the possibility of similar vector habitat biasing the
results. We also excluded patients as controls if a
definitive diagnosis or details of village of residence were
not reported or if they had been referred from another
health unit. All controls resided within the Serere Health
Centre catchment area, which is homogeneous in terms of
ethnicity, the principal occupation of the inhabitants
(subsistence agriculture), livestock production systems,
and other population characteristics.
Geographical data
We recorded village location for each participant with a
hand-held Global Positioning System (GPS, Garmin,
Olathe, KS, USA). All GPS readings were taken at the
central meeting point of each village as indicated by the
village chairman. The locations of Brookes Corner market
and Serere Health Centre were also recorded. The error
in the GPS readings was less than 20 m.
All case and control geographical locations were
entered into the ArcView (version 3.1) Geographic
Information System (ESRI Systems, Redlands, CA,
USA), in which Euclidean (straight line) distances from
each case and control to Brookes Corner market were
calculated.
Statistical analyses
We did an analysis of covariance (ANCOVA) using
GLIM (version 4) to determine how the distance of cases
and controls to Brookes Corner market (km) varied with
time since the start of the outbreak. Case-control status
was defined as a categorical variable with two levels, while
time (in days) since the start of the outbreak on Dec 31,
1998, was judged a continuous covariate. Significance of
the model was tested using an F test and the residuals
were inspected for normality.
We undertook conditional logistic regression with the
PROC PHREG procedure in SAS (version 8) to test
whether distance from Brookes Corner market was a risk
factor for sleeping sickness, and whether this changed over
the time course of the outbreak. The case-control status
was used as the response variable, a unique number
(1-113) was used to identify each pair of matched cases
and controls, and the distance to Brookes Corner market
(km), the time (in days) since Dec 31, 1998, and the
interaction between the two were fitted as continuous
explanatory variables. We tested for significance by
comparing the reduction in deviance against the value in
the x2 table.
Cluster detection
We used the spatial scan statistic12 to determine the most
significant spatial cluster of cases, if any, over the first
32 days of the outbreak, from the first recorded case to
just before vector control was implemented in February,
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Figure 2: Results of the ANCOVA analysis
Blue squares are controls, and red circles are cases. The blue line is
fitted to controls and the red line to cases.
1999. Analysis was done using SaTScan (version 2.1.3),
and with the assumption that cases and controls followed
a Bernoulli distribution.
Results
Of the recorded 2796 heads of cattle traded from
April, 1995, to December, 1998, at Brookes Corner
market, 54% (1510) originated from within the
T b rhodesiense endemic sleeping sickness focus in the
south-east ofUganda. This is an average of 18 animals per
weekly market day sourced from sleeping sickness
endemic areas.
Figure 2 shows the results of the ANCOVA. The
minimum adequate model (F ratio=131-3, df=2;223,
p<0-001) contained significandy different intercepts
(Fratio=95-l, df=l;224, p<0-001) for the cases (3-70 km,
95% CI 2-22-5-18 km) and controls (10-22 km,
8-44-12-00 km), and a positive slope for distance of cases
from Brookes Corner market with respect to time since
the start of the outbreak (0-014 km per day, 95% CI
0-008-0-020 km per day, F ratio=17-5, df=l;224,
p<0-001). The slope for distance of controls from Brookes
Corner against time since the start of the outbreak was not
significantly different from zero and was removed from
the model without any significant loss of explanatory
power (F value=0-45, df=l;224, p>0-05).
When tested by itself using conditional logistic
regression, increasing distance from Brookes Corner
market was highly significantly associated with lower risk
(X!—69-30, df=l, p<0-001). Distance from Brookes
Corner market was therefore a significant risk factor for
sleeping sickness. Time since start of the outbreak (in
days), when tested individually, was not significant
(X2=0-168, df=l, p>0-05). When both continuous
Variables (distance and time) and their interaction were
Term Parameter estimate* SE
Distance from Brookes Corner market -0-5472 per km 0-0258
Time since start of outbreak -0-0229 per day 0-1533
Distance xtime interaction 0-00098 per kmxday 0-00036
'Expressed as natural log odds.
Parameter estimates from the conditional logistic regression
with two continuous variables and the interaction term
Figure 3: Clustering of sleeping sickness case villages during
the first month of the outbreak
Key as figure 1. The circle describes the area of the cluster (the triangle
marks its centre) defined in the analysis, and includes 27 of 28 of the
cases during the time period.
tested together, the statistical model was highly significant
(X2=81-98, df=3, p<0-001) and could not be simplified by
removal of the interaction term without a significant loss of
explanatory power (x2=12-60, df=l, p<0-001). The table
shows the parameter estimates for this model. These
parameters suggest that there is no change in overall risk
through time, but that the spatial distribution of risk does
change with time, moving away from the market.
Figure 3 shows the statistically significant cluster
(overall relative risk=l-93, log-likelihood ratio=30-19,
p<0-001) detected by the spatial scan statistic. The
cluster, with a predicted radius of 4-2 km, included
Brookes Corner market and 27 of 28 of cases recorded
over the first 32 days of the outbreak (before
implementation of control activities).
Discussion
Preventing the spread of sleeping sickness is important in
averting the considerable disease burden and the high
control costs associated with sleeping sickness. The results
of our investigations on the causes of the outbreak suggest
an association between the introduction of human-
infective parasites to the new disease focus and the
movement of cattle into the area from regions where
sleeping sickness is endemic.
The outbreak was initially centred close to Brookes
Corner cattle market. The clustering of cases detected in
the first month, before tsetse fly control, is consistent with
tsetse fly acquiring infections near the market and
transmitting the disease in the local area. The market and
the surrounding landscape lie within an area of tsetse fly
habitat, and, after sale, most of the animals were taken to
homesteads close by. Although there is another market
within the catchment area of Serere Health Centre, it is
over 20 km from Brookes Corner and there was no
association between this market and sleeping sickness
cases. Our analyses suggest that sleeping sickness spread
outwards from the initial focus during the time of the
study. How far that spread will continue remains to be
determined.
The movement of infected people into Soroti is unlikely
to have resulted in the introduction of the parasite, as
none of the cases of sleeping sickness at Serere Health
Centre had a history of travel outside of the district. In
addition, the prevalence of T b rhodesiense in cattle is much
higher than that in human beings,5 and tsetse blood meal
analysis shows that G ffuscipes is much more likely to feed
on cattle than on human beings.5 Molecular
characterisation of T brucei" species isolates from Soroti,
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and their comparison with isolates from the known
endemic foci, allowing detailed studies on the population
genetics of the parasites involved in the outbreak, is in
progress. Material for genetic studies is available from
all the recorded human cases and from cattle living in
the vicinity of Brookes Corner market throughout
the outbreak. There was, however, no screening of
cattle brought to the market itself at the start of the
outbreak.
Given that the restocking activities in Uganda are being
implemented on a country-wide scale as part of a long-
term poverty eradication plan, it is conceivable that
sleeping sickness could spread to other tsetse-infested
districts of Uganda as a result of cattle movements. The
region around Lake Kyoga where this outbreak occurred,
and beyond, is well endowed with riverine forest
vegetation ideal for G f fuscipes; much of this habitat
became established during the times of civil unrest when
the area was depopulated and left uncultivated, and
reverted to a bush habitat more suitable for the fly. Since
then, the return of the human population has led to
significant contact with this habitat and a large increase in
the cattle population from restocking. The resultant
interactions between human beings, their livestock, and
the tsetse-infested environment led to an increased risk of
introduced parasites being transmitted. The continued
spread of sleeping sickness would be expected in an
area such as this, where marginal lands are being
exploited.
Vector control was undertaken at the very start of the
outbreak, and although such activities remain an option
for sleeping sickness control in the area, they might not be
cost-effective to maintain in the resource-poor rural
communities affected by sleeping sickness. In particular,
the cost of extending vector control over a larger area may
become prohibitive and unsustainable. We suggest that
the treatment of cattle is an important option for
preventing importation and transmission of human-
infective parasites in new areas. Control strategies such as
the obligatory testing and treatment of cattle with a single
curative dose of a trypanocide before sale in markets need
to be evaluated,4 and the cost-effectiveness of such
interventions must consider both medical and veterinary
inputs and outcomes. The implementation of integrated
control, targeting tsetse, cattle, and human beings, would
benefit from coordination between veterinary and medical
authorities. Such intersectoral collaborations would lead
to improved human and animal health, and contribute
generally to rural development in tsetse infested countries
across East Africa.
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Sleeping sickness: a tale of two
diseases
Susan C.Welburn, Eric M. Fevre, Paul G. Coleman, Martin Odiit and Ian Maudlin
Sleeping sickness presents clinically as two distinct diseases, reflecting the fact
that two very different trypanosomes are responsible. The African Rift
separating East and West Africa defines the distribution of the two diseases. In
this review, Susan Welbum, Eric Ffevre, Paul Coleman, Martin Odiit and Ian
Maudlin discuss the biology and distribution of these two diseases in relation
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African trypanosomiasis has re-emerged as amajor
health threat to rural Africans, with an epidemic,
extending from the southern part ofSudan through
Uganda and Congo to Angola, resulting in >100 000
new infections per year. The disease takes two forms
in humans, presentingwith distinct clinical pictures.
Gambian sleeping sickness has a long asymptomatic
stage, which is eventually succeeded by a subacute
febrile illness followed by late-stage chronic
meningoencephalitis; death might occur several years
after onset of the disease1. Rhodesian sleeping
sickness progressesmuch more rapidly, with >80% of
deaths occurringwithin sixmonths of the onset of
illness2. These clinical differences are reflected in the
methods adopted to control the disease. The control of
Gambian sleeping sickness relies on case
identification (principally using the card
agglutination test3) and chemotherapy of the largely
asymptomatic human reservoir. Rhodesian sleeping
sickness is zoonotic, with a reservoir inwild animals
and in domestic livestock, which, combinedwith the
acuteness of the disease, demands amuch more
aggressive response, including control of the tsetse
vector (Box 1). Previously, Rhodesian sleeping
sickness epidemics have even led to the large-scale
removal of human populations at risk; in recent
times, large-scale tsetse control operations4,
including aerial spraying, have been deployed
togetherwith medical interventions. The present
transcontinental epidemic is almost exclusively of the
Gambian form of the disease5; a serious epidemic of
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Box 1. The animal reservoir and strategies for sleeping sickness control
Differences in the epidemiology of Trypanosoma brucei gambiense
and Trypanosoma brucei rhodesiensemight have profound effects
on the relative effectiveness of sleeping sickness interventions.We
have used a mathematical model of sleeping sickness transmission
to examine how the effectiveness of different interventions - early
curative treatment of humans, chemoprophylatic treatment of
animals and vector control - will vary between the two species
under different assumptions of the existence of an animal reservoir.
Gambian and Rhodesian sleeping sickness show different
clinical manifestations, particularly in the duration of infection
(and so infectiousness). In the absence of any treatment, the
natural duration of infection of Rhodesian sleeping sickness is, on
average, about six months"-6, which is much shorter than the
average two-year duration of untreated Gambian infections". In
the model used here, the basic reproduction number of infection,
R0 (that is, the number of secondary infections arising from one
infectious host in a population of fully susceptible hosts), is
linearly related to the duration of infectiousness, such that Rq
increases with increasing length of infectiousness.
Although the role of a non-human animal reservoir in
T. b. rhodesiensetransmission has long been recognized" ", the
importance of non-human hosts in the maintenance of
T. b. gambiense ismore uncertain. Rogers" argued that domestic
animalsmight be essential in the maintenance of T. b. gambiense
because Rq in humans alone might fall below unity. This led to
suggestions that the existence of a non-human animal reservoir in
T. b. gambiense infections might have contributed to the failure of
human population surveillance and treatment campaigns to
eradicate sleeping sickness in certain settings"-'. However, it has also
been argued that the existence of an animal population onwhich
tsetse flies preferentially feed might result in humans receiving
infectious bites at a lower rate thanwhen flies feed only on humans^.
Here, we have extended the multi-host model of African
trypanosomiases developed by Rogers" to incorporate the effects
of different control options (Fig. I). Our outcome of effectiveness
is the reduction in the effective reproductive number (i.e. the
number of secondary infections resulting from a primary case in
a population in which some individuals might not be susceptible)
relative to no intervention (i.e. RJ. The results show that early
case treatment is most effective against Gambian infections
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animal reservoir reduces the relative effectivenessmore for
Rhodesian than for Gambian infections because the duration of
infectiousness is greater in the latter and so transmission in
humans accounts for a greater proportion of the total f^. In Fig. lb,
we see that chemoprophylaxis of animals is most effective for
the Rhodesian form, which occurred in Uganda in the
1980s, is now largely under control.
The causative organisms, Trypanosoma brucei
gambienseand Trypanosoma brucei rhodesiense, are
morphologically indistinguishable, but a glance at a
distribution map of the disease reveals a clear-cut
boundary that roughly follows the great geological
divide ofAfrica, the Rift Valley (Fig. 1). This divide is
closely bound upwith the epidemiology of the disease,
whichmight have been an important factor in the
evolution of hominids.
Genetic comparisons
There are three tsetse-borne species of the subgenus
Trypanozoorr. T. b. gambiense, human infective and
found in foci to thewest of the Rift Valley;
T. b. rhodesiense, also human infective and found in
both wild and domestic animals to the east of the
Rift; and Trypanosoma brucei brucei, non-human
infective and found in animals across sub-Saharan
Africa. All three species are morphologically
indistinguishable. Before the advent of DNA
technology, human infectivity of animal isolates of
T. bruceis.l. was determined using either human
'volunteers' or parasite survival in human serum6-7.
Many attempts have been made to identify the
factors in human serum thatmight cause lysis of
non-human infective T. bruceiparasites (for review,
see Ref. 8). Recently, a single gene has been
identified in T. b. rhodesiense that renders human
http://parasites.trends.com
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T. b. rhodesiense infections, as the animal reservoir is a more
important component of the overall Rg. When we assume no
livestock reservoir for Gambian infections, chemoprophylaxis of
the livestock population has no effect. Finally, vector control
(here, simply described by increasing tsetsemortality) is equally
effective for all three scenarios, regardless of duration of infection
or existence of a livestock reservoir (Fig. Ic).
The effectiveness of early treatment of human cases (Fig. la),
chemoprophylaxis of domestic livestock reservoir (Fig. lb) and
vector control (Fig. Ic) are expressed as a percentage reduction in
the effective reproductive number, R, of infection relative to no
control. For each intervention, the results are shown for
I b. rhodesiense infections assuming a livestock reservoir, and
T. b. gambiense infections with and without a livestock reservoir.
From the model described by Rogers", an expression for R
under different levels of control is given as Eqn 1:
for transmission in domestic livestock (L) and human (untreated
U, and treated H) populations. The variables are as follows: uis
the tsetse mortality rate with 1/uthe average life expectancy: a is
the tsetse feeding rate, which is the sum of the feeding rate on
livestock (at) and humans (au+ aJ such that the time between
feeds is 1/a; cis the probability of teneral flies feeding on infected
hosts acquiring trypanosome infection within tdays of
emergence; Tis the time between a fly acquiring infection and
becoming infectious; bis the probability that the host will acquire
a trypanosome infection if fed on by an infectious tsetse; m is the
ratio of tsetse to hosts; 11r is the length of time a host is infectious,
so MrL is the time between a domestic animal host developing
u + a a+u
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serum-sensitive T. b. bruceiclones resistant to lysis
in human serum9. The fact that this gene is not
expressed in T. b. gambiensehighlights the
fundamental difference between these parasites.
Early attempts to differentiate T. bruceis.l. using
isoenzymes revealed that T. b. gambiensevjas
genetically homogeneous, but this technique could
not consistently distinguish T. b. rhodesiense from
T. b. bruceistocks'0-13. Restriction fragment length
polymorphism (RFLP) analysis has since confirmed
the monophyletic nature of T. b. gambiense1415 but,
more importantly, has allowed the separation of field
isolates of T. b. rhodesiense from non-human infective
T. b. brucei. The apparent genetic homogeneity
within natural populations of both species ofhuman
infective African trypanosomes has stimulated
debate on the genetic structure of T. brucei s.l.
populations. The origins of this controversy lie in the
fact that, although T. bruceistocks are able tomate
and undergo sexual recombination in the
laboratory16-18 .evidence ofgenetic exchange among
field populations has never been conclusively
demonstrated19-20 .This debate as towhethermating
takes place at all in natural populations is of interest
outside the confines ofpopulation genetics because, if
recombination is a normal part of the trypanosome
life cycle, then such a panmictic (randomlymating)
structure16would inevitably lead to the spread of
human infectivity throughoutAfrica via the animal
reservoir of T. b. brucei. Both Cibulskis21 and
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Fig. I. The geographical separation of Trypanosoma b. gambiense (Tbg. yellow) and T. b. rhodesiense
(Tbr, red) foci follows closely the western edge of the African Rift Valley, shown here on a digital
elevation model of the continent (USGS digital elevation model).
Tibayrenc22 questioned the panmictic structure of
trypanosome populations, suggesting that theywere
essentially clonal, with sexual recombination rarely,
ifever, occurring22. Between these apparently polar
positions lay the suggestion that population
structures seen in the wild were the result of the
clonal expansion of a few genotypes during epidemics,
but that frequent sexual recombination was the
norm23. Frequent sexual recombination was
predicated on the assumption that all stocks
examined were obtained during epidemics, and on a
misunderstanding of the nature ofsleeping sickness
epidemics. Although disease outbreaks might have
been considered epidemic by medical authorities, in
reality theymight have involved an incidence not
much greater than the endemic situation at the
time15. (A disease is said to be endemic when
constantly present to a greater or lesser degree in
people ofa certain class or in people living in a
particular location; an epidemic is awidespread
outbreak ofan infectious disease where many people
are infected at the same time.)
RFLP analysis led to the clear conclusion that
71 b. rhodesiense and 71 b. bruceihad very different
population structures14. Recently, a study of the
same isolates, using the more informative
minisatellitemarker system, confirmed the clonal
nature of 71 b. rhodesiensebut, again, suggested that
7! b. brucei populations are probably sexual in
nature and that this is obscured by the clonal
expansion ofa few genotypes during an epidemic19.
However, we have no wayof knowing what
constitutes a 71 b. bruceiepidemic, as the natural
hosts of this parasite (game and domestic livestock)
are not normally screened, except under the
exceptional circumstances ofa human outbreak. A
comparison ofcattle isolates from adjoining areas
endemic and epidemic for 71 b. rhodesiense (western
Kenya and eastern Uganda, respectively) found little
difference in population structure of T. b. bruceiZ4.
Moreover, studies of trypanosome populations in
Uganda have shown that only two closely related
genotypes were present in humans over long periods
of time. There is no clear evidence that
T. b. rhodesiensemates in the wild nor that it simply
'switches' to and from being T. b. brucei.
Origins of human infectivity
The origin ofhuman infectivity ofAfrican
trypanosomes remains an intriguing question for
evolutionary biologists and historians. The idea ofa
monophyletic origin for human infectivity came from
isoenzyme studies that suggested that subspecies of
T. brucei s.l. are the product of radiation from an
ancestral group of 7! b. rhodesiense-type parasites
that are now found in East Africa12. (A monophyletic
group contains an ancestor and all its descendents.)
RFLP analysis readily separated Ugandan
71 b. rhodesiense isolates from 71 b. gambiense, but
the same study showed that 7! b. rhodesiense isolates
from Zambiawere more closely related to
7! b. gambiense than to Ugandan isolates of
7! b. rhodesiense14. The phylogenetics of the subgenus
Trypanozoon remains the subject of debate, but the
most recent authoritative study based on 18S rRNA
sequences groups T. b. rhodesiensewi th 71 b. brucei
within a tight but undifferentiated Trypanozoon
clade, again emphasizing the genetic homogeneity of
the subgenus Trypanozoon25. However, RFLP and
minisatellite studies all suggest that human
infectivity has evolved independently in T. brucei in
eastern Africa on at least two occasions, forming the
Ugandan and Zambian foci of 71 b. rhodesiensd9-29-27.
Geographically, Uganda forms ameeting point of
the two diseases, with ancient but active foci of
71 b. gambiense in the northwest and 71 b. rhodesiense
in the south east. Some confusion exists about the
nature of the parasite involved in the first recorded
major epidemic in Busoga in the south east, around
1900. This confusion seemingly arose from the
differing opinions ofmembers of the Royal Society
Sleeping Sickness Commission sent to investigate the
causes of the epidemic at the time. Castellani was in
no doubt that there were two different diseases
present at that time in Uganda28. The first was similar
to 71 gambiensedescrihed byDutton inWest Africa
and identified as trypanosoma fever byCastellani; the
second, called sleeping sickness, presented with acute
symptoms and was named 71 ugandense by
http://parasites.trends.com
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Castellani. Trypanosoma feverwas observed only
rarely, often in immigrant Sudanese soldiers, whereas
sleeping sickness was at the root of the serious
epidemic among the population ofBusoga. Bruce later
considered the possibility of there being two diseases
but concluded that trypanosoma feverwas simply the
first stage ofsleeping sickness29; this despite the fact
that he observed three Sudanese who had
bloodstream infections for long periods yetwere on
duty and were not ill (i.e. they had chronic
T. b. gambiensesymptoms).With hindsight, we can
see that Castellani might have been correct: the
Sudanese had probably carried chronic infections with
them to southern Uganda from the ancient Sudanese
T. b. gambiense focus thatCastellani identified as
trypanosoma fever. The examination ofexisting
clinical records from the time of the great epidemic
shows that T. b. rhodesiense-\ike symptoms were
clearly observable in patients from Busoga
(E.M. Fevre, unpublished). The native Busoga people
were indeed suffering from a different acute disease,
identified as sleeping sickness. However,
T. b. rhodesiensewas not recognized as the causative
organism of this form ofsleeping sickness in Busoga
until the 1940s (Ref. 30) andwas thought to have been
brought to Uganda from Zambia where it had been
identified31 in 1910. However, as we have seen, isolates
of T. b. rhodesiense from Zambia bear little genotypic
relation to Ugandan isolates14. Furthermore,
T. b. rhodesiense isolates from Busoga have remained
genetically unchanged for several decades19.
East- and west-side stories
The recent DNA studies support the view formed by
Dutton and Todd32 a century ago that 'no district in
which sleeping sickness has once existed is known to
become entirely free from the disease.' These ancient
foci exist to this day, with the disease advancing and
contracting, a process dependent on several
ecological and sociological factors. Again, Uganda
provides good examples of the timelessness of these
foci, with the T. b. rhodesiense focus in the south east
based around Busoga and the T. b. gambiense focus
in the north west around West Nile. It is the very
antiquity of these disease foci that brings us to the
most intriguing question concerning the distribution
of this disease. Figure 1 shows a clear demarcation
between T. b. gambienseand T. b. rhodesiense,
roughly following the north-south divide ofAfrica
formed by the Rift Valley. How could this have come
about?
The answer to this might lie in the evolution of
hominids, which is intimately connected with the
Rift. Fivemillion years ago, the climate of the earth
began to change, going through diy periods that
reduced the forest and increased the savannah areas
in East Africa. The forest habitat ofour human
ancestors, the apes, would have been reduced, forcing
those that lived in the eastern part of the continent to
forage in open country. This change ofhabitat
resulted in the evolution ofbipedalism and
eventually the evolution ofhominids in the Rift
Valley33-34. This change ofhabitat would also have
brought the apes and early hominids into contact
with a new set of parasites circulating in savannah-
adapted game animals, in particular the
trypanosomes. Savannah populations of T. bruceiat
some time in evolution would have acquired the
gene(s) encoding human serum resistance and
become a threat to the health of early hominids.
T. b. rhodesiense is known to be a zoonotic parasite,
having been transmitted experimentally from both
wild6 and domestic7 animals to humans. We can
assume that the apes had become adapted, over
long periods, to T. b. gambiense'vn the forested areas
to the west of the Rift Valley. Experimental work
bears this out, as the susceptibility ofapes to
T. b. gambiense and T. b. rhodesiensehas been shown
to vary between primate species. Several studies35-39
in which different species of primate were infected
with tiypanosomes show that the death rate for
untreated animals infectedwith T. b. rhodesiense
reaches 99%. Infectionswith T. b. gambiense, by
contrast, usually lead to chronic infections and long-
term survival of the animal in question40. In
experiments testing the serum sensitivityofa
T. b. gambienseclone, serum from five ground-
dwelling primates (two species ofbaboon, amandrill,
a gorilla and humans) gave similar results,
indicating a period of common evolution and
exposure to the parasite41. The significance of the
animal reservoir for T. b. gambiense remains unclear;
evidence ofan animal reservoir for this trypanosome
is based on isoenzyme analysis, in vitro tests42 and
RFLP techniques43 but, as far as we are aware,
human experiments have never been attempted.
Trypanosoma brucei rhodesiensecauses an acute
disease in apes and monkeys aswell as in humans
and, we can assume, was also rapidly fatal to the
evolving populations ofearly hominids. We know
from DNA studies that human serum resistance
evolved at least twice in T. bruceis.l., resulting in
genetically different populations of T. b. rhodesiense
in southern and eastern Africa19. Unlike other
important parasites such as malaria, there is still no
evidence for the evolution ofany heritable immunity
to T. b. rhodesiense in humans [although we are not
aware ofstudies ofmajor histocompatibility complex
(MHC) distribution in humans in relation to sleeping
sickness]. The only strategy early hominids could
adopt in these circumstances would have been the
avoidance of tsetse-infested areas. In so doing, they
might have inexorably been forced out of the Rift
Valley and so 'out ofAfrica'. We know that early
human populations remained small for long periods of
time in Africa and only started to increase rapidly in
number on leaving the continent44. Humans settling
inWest Africawould have carried with them partial
tolerance to T. b. gambiense, which remains largely a
chronic disease; it has been pointed out that humans
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and their closest relatives are essentially
trypanotolerant to T. b. gambiensd15. In the east of
sub-Saharan Africa, population pressures and
agricultural practices would eventually have reduced
or removed threatening tsetse populations
sufficiently to allow long-term settlement there,
despite the continued presence ofan animal reservoir
of T. b. rhodesiense.
However, recent evidence shows that the ranges
covered by the two human infective subspecies might
be approaching each other46; both types of disease are
re-emerging and expanding in range. Given the clonal
nature of tiypanosome populations, it is unlikely that
human infectivitywould have spread across Africa as
a byproduct ofmating between infective and non-
human infective members of the Trypanozoon
subgenus. As we have seen in the past century,
epidemics ofsleeping sickness ofeither form arise at
intervals over time as human and tsetse populations
come into conflict47.
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muMT mice with parasite-specific
immunoglobulin 1 purified from the serum
of resistant mice prevented worm
establishment, thus clearly indicating the
role of antibodies in disease evasion. SHK
Bednets and teachers
controlling malaria
While waiting for the development of an
effective malaria vaccine, attention has
focused on prevention and treatment of the
disease. Intervention strategies to reduce
malaria transmission rely upon the use of
insecticide-treated bed nets (ITBN) and
residual house spraying (RHS). In a
comparative study in South Africa, the use
of ITBN, although more costly, was
significantlymore effective in preventing
malaria than RHS [Goodman, C.A. etal.
(2001) Trop. Med. Int. Health6, 280-295],
Instead of relying upon government-
instituted medical surveillance, an increase
in public awareness appears to be
essential, which could be further
implemented through the health and
educational authorities. From a recently
published study carried out in Tanzania, it
was apparent that schoolteachers could
play an important role in diagnosing
malaria. The presence of symptoms such as
headaches, joint pains, muscle pains,
feeling feverish and measuring oral
temperatures in schoolchildren were used
to diagnose malaria. Over 70% of children
diagnosed by teacherswere positive for
malaria [Magnussen, P (2001) Trop. Med.
Int. HealthG, 273-279]. Children diagnosed
with malaria were subsequently treated
during school time. The authors conclude
that teachers could play a major and vital
role in school health programmes. TS
Ticks and climate change
From the mid-980s, the incidence of tick-
borne encephalitis (TBE) around Stockholm
substantially increased, as indicated by
serological tests on all cases of encephalitis
from 1960 to 1998. This rise is significantly
related to a combination ofmilder winters
and extended autumns (temperatures of
5-8°C), thus favouring spring development
of the vector Ixodes ricinus. The highest
mean temperatures recorded in the
northern hemisphere occurred in 1990,
1995 and 1997. Since the mid-1990s, spring
has arrived in Sweden about 12 days earlier
than it did in the 1960s. Ticks become active
when night temperatures rise to above
4-5°C. Blood-sucking larvae, nymphs and
adults can become infected with TBE virus
or carry other zoonoses. Although the
presence ofmore people in endemic areas
and an enlargement of host reservoirs (e.g.
roe deer) might have influenced the figures,
the expansion in the tick population might
actually be underestimated as a TBE
vaccine has been available since 1986 and
the public is more aware of the disease.
[Source: Reuters Health Online via ProMED-
mail; E. Lindgren and R. Gustafson (2001)
Lancet 358,16-18] JT














In a recent letter to Trends in
Parasitology, Coles1 questioned the need
to control trypanosomiasis in domestic
cattle in sub-SaharanAfrica, suggesting
that game animals could be farmed
instead. Game animals are naturally
resistant to most economically important
trypanosome species and, he argues, such
resistance would remove the need for
using treatments aimed at killing flies
and/or parasites. As Coles points out, the
elimination of the tsetse vector of
trypanosomes on a large scale might not
succeed formany biological, logistical and
economic reasons.
Although the production ofgame
animals is a reality in some parts ofAfrica
(e.g. South Africa) and elsewhere (e.g.
Canada), these activities usually take
place on a large scale, intensively
managed commercial farms. Although
there might be financial gains to be made
for some, such systems are entirely
unsuitable for small-scale, subsistence
agriculturalist and pastoralist societies,
and displacing domestic cattle in favour of
tamedwild game, even in only a few areas,
is unrealistic. This is because the farming
ofgame animals is unlikely to satisfy the
variety of economic needs met by cattle
and cattle-derived products, including
meat and leather production, but
especially milk production, dung
production (for both building and as a fuel
source), traction and simply as a type of
financial investment. Perhaps more
importantly, cattle are an integral part of
the social fabric ofmany societies in sub-
SaharanAfrica and have been so formany
thousands of years2.
With regard to the threat of developing
drug resistance, it is more appropriate to
advocate the optimal, rational use of
existing treatments than to change entire
well-established production systems.
Providing simple tools that would improve
diagnoses and prevent the inappropriate
use ofexisting drugs, and ensuring that
reputable drugs reach the market in the
first place3, would be more compatible
with the needs ofAfrican farmers. There
are also public-health implications for
continued parasite-control measures in
livestock; in particular, the reduction in
prevalence ofhuman-infective
trypanosomes in the cattle reservoir host4.
Even ifgame-animal production were
to be socially acceptable inAfrican rural
communities, the impacts on animal
health and on the productivity of
concentrating game in enclosed areas
might be substantial. They would have
little chance to roam naturally, and from a
human-health perspective, there are
many zoonotic diseases that might be
introduced as a result of the proximity to
human settlements5'6. Trypanosomiasis
itself is a good example: although wild
game such as bushbuck are
trypanotolerant, they are an excellent
reservoir host for trypanosomes, and
http://parasites.trends.com 1471-4922/01/$ - see front matter © 2001 Elsevier Science Ltd. All rights reserved.
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increasing their densities in tsetse-
infested areas close to human habitation
might have a serious impact on sleeping
sickness incidence.
Eric Ffevre
Centre for Tropical Veterinary Medicine,
University of Edinburgh, Easter Bush,
Roslin, Midlothian, UK EH25 9RG.
e-mail: eric.fevre@ed.ac.uk
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Sterile insect release
and trypanosomiasis
control: a plea for
realism
The January 2001 issue of Trends in
Parasitology provided an excellent series
ofpapers on several aspects ofAfrican
trypanosomiasis and contained a poster
about the ProgrammeAgainstAfrican
Trypanosomiasis (PAAT); a campaign has
now been established called PanAfrican
Tsetse and Trypanosomiasis Eradication
Campaign (PATTEC) which will be
formally launched in October 2001.
Most of the aspirations ofPAAT are
laudable, albeit self-evident. However, a
programme that advocates Glossina
eradication using the sterile insect
technique (SIT) seems distant from
reality. It is disappointing to see that
PAAT, which includes scientists and
concerned international organizations, is
prepared to endorse eradication as a goal,
and has persuadedAfrican heads ofstate
that it is feasible and presumably
affordable. Janice Taverne1 quotes Guy
Freeland's response to PeterHolmes'
remarks in the 7th PAAT newsletter
where Freeland criticizes the approach
only to be roundly rebuked by Brian
Hursey who quoted the problems of
sleeping sickness as a justification for SIT
supported by the success ofSIT in
screwworm1.
The position of theWHO Expert
Committee is distinct from that of
PAAT2'3. In 1986, theWHO Expert
Committee report concluded that the SIT
was not relevant in terms ofcontrol of
African Human Trypanosomiasis2. The
WHO 1998 report states that 'Since
eradication of tsetse populations is not
considered realistic, the objectives of
vector control campaigns in an epidemic
focus is to reduce rapidly and drastically
the vector population to a level at which
disease transmission is significantly
reduced or interrupted'3.
Impregnated traps and non-residual
ultra-low volume (ULV) insecticide
application allied to diagnosis and
treatment, controlled the Uganda sleeping
sickness epidemic in the 1980s (Ref. 4,5).
Hursey's comments that the PAAT
objective should be effectively sacrosanct
and protected from 'the personal agenda of
scientists and donors...will contribute
very little to direct disease elimination'.
Surely, communities affected by sleeping
sickness should notwait two to three
years for sterile males to be bred, a
situation where Freeland's argument
applies. Large-scale trials ofSIT have
failed in Nigeria, Burkina Faso, Tanzania
and Ghana through lack of sustainability
and through re-invasion. Only Zanzibar
can claim any success6. Glossina austeni
was eradicated at a cost ofUS$7 941 000
between 1994 and 1997. Msangi et al.
remarked that, while the cost was US$7
941 000, only US$5 788 000 was spent6.
However, not included in these costs were
the original capital costs ofestablishing
the mass rearing facility at Tanga, the
earlier suppression studies on Zanzibar
and support costs at the International
Atomic EnergyAgency (IAEA) in Vienna7.
Tb boost the colony, 3 861 242 pupae were
shipped from Vienna, but no costs of this
effort are available. A calculation of the
projected costs ofa continent-wide SIT
release programme to eradicate Glossina
on the basis of the Zanzibar (Unguja
Island) experience would suggest that the
following should be considered. An
assumption of 22 Glossina species, a cost
per 1600 km2 eradicated ofUS$5 700 000
(not including costs referred to above) and
Fig. 1. A pyramid of over 2million tsetse flies caught
using 900 Harris traps in onemonth in Zululand10.
an area of tsetse infestation of8.5-9.0
million km2 (Refs 7,8). The calculation
discounts Zanzibar because G. austeni
also occurs on the Kenya and Tanzania
mainland, and taking the 8.5million km2
as the area infested (8.5 x 106) x (5.7 x 106)
divided by 1600 = US$6.67 x 1010!
However, in many areas, up to four
different species of Glossina coexist; hence
ifSIT-based eradication is envisaged, this
costwill escalate, depending onwhich of
the 22 species are present. The capital
costs ofGlossina factories have also yet to
be calculated. Given the speed ofprogress
on Zanzibar an equivalent calculation
reveals that the timescale of the operation
would be roughly three years to control
one species in 1600 km2 therefore,
3 years x 22 species x (8.5 x 106) (divided
by 1600 km2) = 350 000 years to eradicate
22 species.
PAAT should be reminded that
Portuguese workers eradicated Glossina
from Principe in 1905 using sticky
backpacks on plantation workers9. Harris
was spectacularly successful in catching
G. pallidipes in Zululand in 1921 (Fig. 1)
and Morris controlled sleeping sickness in
Ghana during 1938-1944 by bush
clearing and later insecticide (DDT)
impregnated traps11'12. Overall, sleeping
sickness was controlled by a variety of
approaches, and the success was
sustained until health services collapsed
through under-resourcing and civil
unrest prevailed. The expectation that
SITwill contribute uniquely to the
eradication ofGlossina against the
background and reality of the health
services in sub-SaharanAfrica is
unrealistic - given the current problems
ofHIV, TB and malaria, and the likely
success ofachievable public health
objectives for the eradication ofGuinea
worm and elimination ofonchocerciasis
and lymphatic filariasis as public health
problems. In all these diseases, the
involvement of communities is essential
http://parasites.trends.com 1471-4922/01/$ - see front matter © 2001 Elsevier Science Ltd. All rights reserved.
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Sleeping Sickness Rediscovered
S.C. Welburn, E. Fevre and R Coleman
Antwerp, Belgium
December 1998
This meeting focused on human sleeping
sickness, which, despite improvements
in diagnosis and control, has returned
with a vengeance across central Africa.
Control Activities
National Programmes. Simon Van
Niuewenhove (WHO, Geneva, Switzer¬
land) outlined recent trends in the distri¬
bution of human sleeping sickness, and
the current extent and scale of Trypano¬
soma brucei gambiense infection. The dis¬
ease is often consigned as a problem of
the past, but its resurgence was displayed
through a series of brief reports of the
situation in the worst affected countries
[The Democratic Republic of Congo
(RDC), Angola, Sudan and Uganda],
where existing surveillance strategies are
failing to capture the true extent of the
current epidemic. For example, within the
RDC, over 100000 new cases have been
detected in the past six years - a quarter
of these in 1997 alone. These cases were
detected through an active surveillance
system covering only 9% ofthe I 3 million
people considered to be at risk. War,
civil unrest and human population move¬
ments are exacerbating the problem. The
lack of sufficient funds and the logistical
difficulties of working with deteriorating
infrastructures in their respective countries
were identified by Theophilejosenando
(Angola) and Constantin Miaka Mia Bilenge
(RDC) as critical constraints to the ef¬
fective implementation of large-scale sur¬
veillance and early treatment activities.
International and Bilateral Agencies and
Programmes. The response of international
agencies to the resurgence of human
sleeping sickness was also presented by
representatives from WHO, European
Union and Programme Against African
Trypanosomiases (PAAT). A failure in the
'co-ordination' of national programmes
with bilateral initiatives implemented
through non-governmental organizations
(NGOs) was considered, by Pierre Cattand
(WHO, Geneva), to be detrimental to the
efficiency ofcontrol operations. The new
WHO Programme against Human Tryp¬
anosomiasis (established 1995) is seen as
providing a cohesive and co-ordinated
direction to public and private stake¬
holders, so optimizing the efficiency of
disease control at the national level.
NGOs. The presentations of the vari¬
ous NGO activities perhaps highlighted the
lack ofcentralized co-ordination. Although
the field activities ofNGOs such as Med-
ische Missie Samenwerking (MEMISA),
Medecins Sans Frontieres (MSF) and
Fond Medical Tropicale (FOMETRO) are
invaluable in the control ofhuman sleep¬
ing sickness, the epidemiological data
generated from such work could be bet¬
ter used if itwere made available through
a centralized database. Regional initiatives
[such as the Organisation de Cooper¬
ation et de Coordination pour la Lutte
Contre les Grandes Endemies en Afrique
de I'Ouest (OCCGE)], and bilateral ini¬
tiatives (including those funded by the
French and Belgian governments) also
play a role.
Control Tools
Diagnosis. Little has changed in the
past decade regarding the technologies
for trypanosomiasis control in the field.
Philippe Buscher (ITM, Antwerp, Belgium)
discussed improvements to existing di¬
agnostic tools, emphasizing that efforts
had concentrated on improving existing
technologies such as blood smear, quan¬
titative buffy coat technique (QBC), the
card agglutination test fortrypanosomo-
sis (CATT), ELISA, microcentrifuge and in
vitro inoculation kits. Veerle Lejon (ITM,
Antwerp, Belgium) went on to discuss
tools for stage determination in making a
diagnosis. The two methods are the de¬
tection in the cerebro-spinal fluid (CSF)
of: (I) trypanosome specific antibody;
and (2) IgM. Laurent Penchenier [Organ¬
isation de Cooperation et de Coordin¬
ation pour la lutte contre les Grandes
Endemies en Africa I'Ouest (OCEAC)]
compared the CATT test with the latex
agglutination test for T. gambiense. while
Andrea Garcia [Office de Recherches
Scientifiques Technquies Outre Mer
(ORSTOM)] looked at the problem of
aparasitaemic individuals (who remain
seropositive) in longitudinal surveying:
do these people contribute to focus
persistence?
Vector control. The different methods
of tsetse control in Southern Africa
were summarized by Peter van den
Bossche [Regional Tsetse and Trypano-
somiosis Control Programme (RTTCP),
Harare, Zimbabwe], The objective must
be to involve communities in small-scale
projects with appropriate technology,
where a social approach must accompany
the technical and economic aspects of
the programme. Joshua Okoth [Live¬
stock Health Research Institute (LIRI),
Tororo, Uganda] discussed human ecol¬
ogy and its relation to tsetse ecology,
with reference to southern Uganda, sug¬
gesting that changing agricultural prac¬
tices might result in peridomesticity in
Glossina fuscipes fuscipes.
Treatment and follow-up. Simon Van
Nieuwenhove (WHO, Geneva) stressed
that to be most effective, a treatment
regime should cure the patient quickly
and avoid disability. With no ideal drugs
available, and with commercial devel¬
opment of new compounds unlikely, as
the market is too small to justify heavy
investment in new drugs by the private
sector, we are left with the old, toxic
drugs. Production of suramin, most used
in T. b. rhodesiense treatment, was to
be stopped by the manufacturer, but
requests from WHO and others man¬
aged to maintain production for human¬
itarian reasons. Even when drugs are
available at the community level, they
are often unaffordable (eg. Nifurtimox
costs US$ 20 for 21 days treatment, and
Eflomithine US$ 1070 for 14 days intra¬
venous treatment). Donors are needed,
as local communities cannot afford these
drug costs. Christian Burri (Swiss Tropi¬
cal Institute, Basel) presented a poss¬
ible method of reducing the treatment
time of late stage trypanosomiasis, by
changing the administration schedule of
melarsoprol, to reduce hospitalization
costs; and Sylvie Bisser, Instituut voor
Tropische Geneeskunde, Antwerp (ITG)
presented the results of a clinical trial in
the RDC that showed that melarsoprol
could be combined with nifurtimox.
Another clinical trial, in northern Uganda
[Dominique Legros, Groupe Europeen
d'Expertise en Epidemiologic Pratique
(EPICENTRE)] found Pentamidine to
be less effective than expected against
T. b. gambiense, which raised the ques¬
tion as to whether drug efficacy is focus
specific. Finally, Ron Kaminsky (Swiss
Tropical Institute, Basel) discussed
the tolerance of T. b. rhodesiense to
Eflomithine (DFMO).
Public Health. Public heath aspects
of human sleeping sickness in terms
of community health care provision,
were discussed by Claude Laveissiere
(OCEAC) who emphasized that local
knowledge is an essential part of disease
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control. Paul Coleman (University of
Edinburgh, UK and International Live¬
stock Research Institute, Nairobi) had
modelled the human public health im¬
pact of controlling the T. b. rhodesiense
reservoir in cattle. He suggested that
targeting chemotherapy in reservoir
populations can reduce significantly the
number of cases of human sleeping sick¬
ness. Joseph Ndung'u [Kenya Trypano-
somiaisis Reseach Institute, (KETRI),
Kenya] highlighted the techniques that
can be bought into play to prevent an
outbreak of sleeping sickness caused by
T. b. rhodesiense.
Research
Parasite and Vector Biology. The neuro¬
pathology of sleeping sickness was dis¬
cussed by Krister Kristenson (Karolinska
Institute, Sweden) in terms of inter¬
actions between trypanosome-released
molecules and the host defence system,
and the effect that these might have on
clinical features of the disease. Moiz
Bakheit (Karolinska Institute, Sweden)
outlined the bi-directional signalling pro¬
cesses believed to be responsible for
immune and neuronal dysfunction in
the host. A trypanosome lymphocyte-
triggering factor has been identified that
stimulates production of IFN-y, which
then stimulates parasite growth. Stefan
Magez examined the association be¬
tween TNF-a induction and disease sev¬
erity in mice. TNF-a was shown to be
crucial for control of parasitaemia in in¬
fected animals but did not influence sur¬
vival. TNF-a also appeared to be directly
trypanocidal.
Alain Buguet (CRSSA, France) showed,
using human patients, that as sleeping
sickness progresses in severity, major
disruptions occur in circadian rhythms,
and that release of Cortisol, growth hor¬
mone and prolactin are all affected poss¬
ibly due to the release of active com¬
pounds by the host and/or parasite.
Victor Pentreath (Salford University, UK)
showed that the gut is profoundly af¬
fected showing altered permeability in
a mouse model of experimental sleep¬
ing sickness. Jerry Sternberg (University
of Aberdeen, UK) used a mouse model
to show that NO is involved in suppres¬
sion of splenic lymphocyte function and
dyserthropieisis, which leads to anaemia.
Philippe Vincendeau (Universite de
Bordeaux, France) showed that macro¬
phages from infected mice produce
NO, which is required for parasite killing.
Little is known about the mechanics of
parasite death. SueWelbum (University of
Edinburgh, UK) showed that, after stimu¬
lation with a lectin to induce parasite
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death, several novel genes are upregu-
lated in dying parasites. Knowledge of the
hitherto unknown pathways that lead
to cell death of these parasites might
lead us to novel mechanisms of parasite
elimination.
Progress in the development of the
first generation genetic linkage map for
T. brncei was presented by Mike Turner
(Glasgow University, UK). Genetic map¬
ping is important in that: (I) it compli¬
ments physical mapping and thus under¬
pins genomic sequencing; and (2) indicates
functional (as opposed to structural)
genomic organization, which allows the
analysis of the inheritance of traits of
medical and biological interest (eg. human
infectivity, drug resistance). The meth¬
odological approach relies on a large
number of polymorphic markers gener¬
ated using amplified fragment length
polymorphism (AFLP) analysis. In the Fl
progeny resulting from a cross between
clones of two stocks of T. brucei, 16 link¬
age groups containing 155 polymorphic
markers were identified.
Perhaps the most exciting new work
presented was by Luc Vanhamme [Insti-
tuut voorTropische Geneeskunde (ITG),
Brussels], who described a series of el¬
egant experiments, spanning a decade,
which have led to the identification of
the SRA gene that appears to confer
resistance to human serum lysis. This
gene for human serum resistance can be
transferred to a previously susceptible
parasite conferring the human resistance
phenotype.
Phillipe True (ORSTOM, France) de¬
scribed how new methods of diagnosis
for T. b. gambiense sleeping sickness have
been applied. It appears that parasites
present during an infection might not be
clonal and that patients might be carrying
more than one clone of T. b. gambiense
at any given time.
Much interest has been shown in the
composition of surface coats oftrypano-
somes, both bloodstream forms and
procyclic forms. Mark Carrington (Uni¬
versity of Cambridge, UK) gave an over¬
view of the role of the VSG, the pre¬
dominant surface protein on bloodstream
form trypanosomes, as a protective mol¬
ecule. Similarly, Isabel Roditi (Universitat
Bern, Switzerland) described the surface
composition of procyclics (insect form
parasites) and showed that this parasite
has two types of coat protein, one of
which ceases to be expressed after para¬
site establishment. Jan Van den Abbeele
(ITM, Antwerp, Belgium) revisited differ¬
entiation in tsetse, and looked at the
processes involved during maturation to




C.C. Wang (University of California,
USA) suggested that advances in our
knowledge on the African trypano¬
somes in recent years provide greatly
improved opportunities for discovering
more efficacious and safer new anti-
sleeping sickness drugs in the 21 st cen¬
tury. Felix Kuzoe discussed DFMO and
its use for treatment of T. b. gambiense.
The drug is costly, and the regime un¬
pleasant, but DFMO remains the only
drug that can be used to treat melarso-
prol-resistant strains, and a lower-cost
oral formulation of the drug is needed.
Jorge Atouguia (Institute de Higiene e
Medicina Tropical, Lisboa, Portugal) de¬
scribed the successful treatment of in¬
fected mice with topical applications of
melarsoprol. Bernard Bouteille (IENT,
France) described experimental cure of
mice with Megazol. Louis Maes (Tibotec,
Belgium) highlighted the pros and cons
of screening for 'new' antitrypanosomal
drugs. Reto Brun (STI, Switzerland) dis¬
cussed novel compounds that have
been tested for anti-trypanocidal ac¬
tivity. KETRI are looking at a Chinese
compound, SIPI 1029, using green mon¬
key populations as models, but relapse
has occurred in all treated animals.
Novartis (Switzerland) is looking at CGP
40215, but have so far reported prob¬
lems with stage II disease treatment, as
the drug does not seem to cross the
blood-brain barrier. Aciel Haemers [Uni-
versitaire Instelling Antwerpen (UIA),
Belgium] took a different perspective,
and, rather than screening drugs for ac¬
tivity, is attempting to synthesize a cus¬
tom-designed compound with a specific
biochemical target, and test it both in
vivo and in vitro. Mike Barrett (University
of Glasgow, UK) discussed drug up¬
take via nutrient transporters, where it
should be possible to transpose the part
of the active compounds that enable
novel compounds to cross the parasite
membrane. Curtis Powell (Applied Im¬
munology Research and Development
Corporation, USA) discussed the po¬
tential for using components of the fla¬
gellar pocket of trypanosomes as the
basis of development of a vaccine for
trypanosomiasis. Edith Authie [Centre
de Cooperation Internationale en Re¬
cherche Agronomique pour le Devel¬
opment (CIRAD), France] described a
series of elegant experiments that show
that immunization against cysteine pro¬
teases in cattle might assist the host in
establishing resistance to the pathology
normally associated with trypanosome
infection.
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Where do we go from here? A special
session was chaired by Alvaro Moncayo
(TDR,WHO, Geneva), The need for in¬
tegration of trypanosomiasis control with
the rest of the public health care system
was emphasized by Constantin Miaka
(RDC) and by Dawson Mbulamberi
(Uganda). For this, cheap and reliable di¬
agnostic tools, as well as a proper evalu¬
ation of the relative merits of the exist¬
ing tests, were considered essential. The
question of integrating trypanosomiasis
control with other diseases for surveillance
and treatment purposes, making full use of
the public health care system, was raised
by David Molyneux (Liverpool School of
Tropical Medicine, Liverpool, UK); such
integration would result in sustainability.
The already important role of NGOs
should be extended, and integrated to
maximize limited resources. Until country
representatives ask their governments
to make trypanosomiasis control a pri¬
ority, the international community will
not take more interest.
Without good epidemiological data
on the extent of the problem of sleep¬
ing sickness within a country, control
measures cannot be effective. Claude
Laveissiere took an entomological view¬
point, suggesting that actual transmission
sites, the relative importance of domes¬
tic and wild animals as reservoirs of infec¬
tion, and the best risk indicators for dis¬
ease contraction should all be investigated
further. Mickey Richer [International Medi¬
cal Corp (IMC), Los Angeles, USA] was
concerned with the animal reservoir, in
that diagnostic techniques for field test¬
ing animal infections are needed to de¬
termine the importance of this reservoir.
Christophe Paquet expressed concern
at the lack of knowledge of risk factors
for disease development in seropositive
patients. Simon Van Meirvenne con¬
cluded by emphasizing that sustainability
must be kept in mind in drug, diagnostic
test and vector control research.
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The challenge of this meeting was to
identify new chemotherapeutic targets
from the myriad of parasite enzymes,
receptors, genome data and metabolic
pathways that have recently been iden¬
tified. Onchocerca volvulus, Wuchereria
bancrofti and Brugia malayi afflict more
than 100 million people, worldwide.
Filarial drug discovery research atWHO
has three specific goals: (I) discovery of
new macrofilaricides; (2) discovery of
anthelmintics that effect sterilization of
adult female worms; and (3) identifi¬
cation of new microflaricides, to com¬
bat any emergence of ivermectin resist¬
ance. Clinically, new drugs must be safe,
curative, effective in few doses, cheap and
chemically stable1 (K. Awadzi, Honhoe
Hospital, Ghana).
Second Generation Drugs
Two groups of anthelmintics in com¬
mon use today act at ligand-gated ion
channels in the nematode nervous sys¬
tem. Levamasole exerts its effects at the
nicotinic acetylcholine receptor (nAChR),
and avermectins act as irreversible agonists
J. Lazdins and M. Kron
at glutamate-gated chloride channels
(Glu-CL). Nematodes possess a variety
of receptors, receptor subunits and chan¬
nels, and their expression can be devel-
opmentally regulated. Using model or¬
ganisms, it may be possible to determine
which genes encoding nAChR, Glu-CL
and their subunits are expressed at spe¬
cific life cycle stages. Functional expres¬
sion ofsuch ligand-gated ion channels can
serve as assays to screen chemically modi¬
fied avermectins for desirable pharmaco¬
kinetic properties. In Caenorhabditis el-
egans, co-expression of the (3-subunit of
Glu-CL with the a-subunit can produce
ivermectin-potentiated glutamate-gated
channels2 (A. Wolstenhome, University
of Bath, UK). The genetics of ivermectin
resistance in C. elegans and veterinary
parasites can lead to identification of
resistance mechanisms and responsible
genes, which have homologues in human
filarial parasites3 (W. Grant, Flinders Uni¬
versity, Australia). Transgenic strains of
C. elegans expressing filarial targets will
help to identify crucial genes. Imidazoles
exert their antiparasitic effects by target¬
ing tubulin (G. Lubega, Makere Univer¬
sity, Uganda). Benzimidazole (BZ) binds
filarial tubulin and binding studies of tubu¬
lin of Haemonchus contortus show that
binding constants of several new fluor-
inated derivatives of BZ correlate with
anthelmintic potency at recommended
therapeutic doses4. However, mutation
in few amino acids is correlated with
drug resistance to BZ and clinical devel¬
opment of one of the most promising
new macrofilaricidal imidazole deriva¬
tives, UMB078, was terminated because
of potential carcinogenicity in animals.
Novel Targets
Intracellular bacteria have been de¬
tected in most filarial worms. The phy-
logeny ofthese organisms, Wolbachia spp,
has been shown to be congruent with the
host phytogeny5. Since co-divergence of
hosts and symbionts can result in evolu¬
tionary co-adaptations, as in the case of
arthropods and their endosymbionts,
several research groups suggest that by
eradicating filarial endobacteria, parasites
may also die (C. Bandi and C. Genchi, Uni-
versita degli Studia, Italy; and A. Bianco,
Liverpool School of Tropical Medicine,
UK). Evidence supporting this view is the
observation that tetracycline therapy re¬
duces the number of Wolbachia in filarial
oocytes and embryos6 while inhibiting
filarial embryogenesis.
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